Louisiana Tech University

Louisiana Tech Digital Commons
Doctoral Dissertations

Graduate School

Spring 2009

Discrete nondeterministic modeling of
biochemical networks
John R. Jack
Louisiana Tech University

Follow this and additional works at: https://digitalcommons.latech.edu/dissertations
Part of the Bioinformatics Commons, and the Computer Sciences Commons
Recommended Citation
Jack, John R., "" (2009). Dissertation. 429.
https://digitalcommons.latech.edu/dissertations/429

This Dissertation is brought to you for free and open access by the Graduate School at Louisiana Tech Digital Commons. It has been accepted for
inclusion in Doctoral Dissertations by an authorized administrator of Louisiana Tech Digital Commons. For more information, please contact
digitalcommons@latech.edu.

DISCRETE NONDETERMINISTIC
MODELING OF BIOCHEMICAL
NETWORKS
by
John R. Jack, B.A., M.A.

A Dissertation Presented in Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy

COLLEGE OF ENGINEERING AND SCIENCE
LOUISIANA TECH UNIVERSITY

May 2009

UMI Number: 3360811

v

INFORMATION TO USERS

The quality of this reproduction is dependent upon the quality of the copy
submitted. Broken or indistinct print, colored or poor quality illustrations and
photographs, print bleed-through, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if unauthorized
copyright material had to be removed, a note will indicate the deletion.

:®

UMI

UMI Microform 3360811
Copyright2009 by ProQuest LLC
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest LLC
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor, Ml 48106-1346

LOUISIANA TECH UNIVERSITY
THE GRADUATE SCHOOL

April 23rd, 2009
Date

We
by.

hereby- recommend-

that

the- dissertation

prepared

under

our

supervision

John Jack

entitled

Discrete Nondeterministic Modeling of Biochemical Networks

be

accepted

in

partial

fulfillment

of

the

requirements

for

the

Degree

of

Doctor of Philosophy in Computational Analysis and Modeling

JUJ

/Supervisor yof Dissertation Research
of Department
Department

Recommendation concurred in:

Advisory Committee

V*-/ Vr^r-wsAh

Approved:

director of Graduate Studies

<

J

H^fY^

Approve

Dean of the Graduate School

Dean of the College^/ '
GS Form 13a
(6/07)

ABSTRACT
The ideas expressed in this work pertain to biochemical modeling. We explore
our technique, the Nondeterministic Waiting Time algorithm, for modeling molecular signaling cascades. The algorithm is presented with pseudocode along with an
explanation of its implementation. The entire source code can be found in the Appendices. This algorithm builds on earlier work from the lab of Dr. Andrei Paun,
the advisor for this dissertation. We discuss several important extensions including:
(i) a heap with special maintenance functions for sorting reaction waiting times, (ii)
a nondeterminstic component for handling reaction competition, and (iii) a memory
enhancement allowing slower reactions to compete with faster reactions.
Several example systems are provided for comparisons between modeling with
systems of ordinary differential equations, the Gillespie Algorithm, and our Nondeterministic Waiting Time algorithm. Our algorithm has a unique ability to exhibit
behavior similar to the solutions to systems of ordinary differential equations for certain models and parameter choices, but it also has the nondeterministic component
which yields results similar stochastic methods (e.g., the Gillespie Algorithm).
Next, we turn our attention to the Fas-mediated apoptotic signaling cascade.
Fas signaling has important implications in the research of cancer, autoimmune and
neurodegenerative disorders. We provide an exhaustive account of results from the
Nondeterminstic Waiting Time algorithm in comparison to solutions to the system
iii

iv
of ordinary differential equations described by another modeling group. Our work
with the Fas pathway led us to explore a new model, focusing on the effects of HIV-1
proteins on the Fas signaling cascade. There is extensive information in the literature
on the effects of the HIV-1 proteins on this pathway. The model described in this
work represents the first attempt ever made in modeling Fas-induced apoptosis in
lantently infected T cells.
There are several extensions for the Fas model discussed at the end of the work.
Calcium signaling would be an interesting avenue to investigate, building on some
recent results reported in the literature. For the HIV model, there are several extensions discussed. We also suggest a new direction for the Nondeterministic Waiting
Time algorithm exploring parallelization options.
Keywords: Discrete, Stochastic, Nondeterminism, Fas, Apoptosis, HIV, Computational Biology, Systems Biology.
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CHAPTER 1
OVERVIEW OF THE LITERATURE
The focus of this dissertation is the simulation of molecular signaling cascades,
specifically the Fas-mediated apoptotic pathway. The discussion centers around living
systems - e.g., biological cells - and the changes in their biochemical compositions,
which is brought about through the various interactions of the intracellular proteins.
Indeed, signal transduction (and molecular signaling cascades) describes the systematic interactions of different cellular proteins, starting with some sort of signal (e.g.,
an external ligand binding to a cell surface receptor) and reaching some sort of endpoint (e.g., the upregulation of a protein eliciting physical changes to the cell). Our
group wishes to explore the molecular mechanisms behind biochemical evolution with
implied physiological responses through computational modeling.
We are at the start of a new millenium and a (relatively) new science. We are
beginning to understand ourselves on a level virtually incomprehensible at the beginning of the last century. Humanity is on the brink of incredible technological breakthroughs -- the power to engineer/manipulate our own genomic data, the stuff that
makes up who and what we are. However, as with any engineering project, we will
need computational models to be successful. Genetic-based manipulations, changing
the biochemical nature of ourselves (and our cells) for the betterment of mankind, will
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require an exceptional degree of certainty, which is only knowable through computerdriven modeling. We need reliable and predictable circumstances as we go diving into
our own genome.
The human genome project has given us a rich text on humanity. The initial
draft sequence of the human genome was first reported in [67]. So, we now have the
sequence, but we lack any sort of deep understanding of it. With our current level
of knowledge, the situation is analogous to handing a tome written in Japanese to
a person who understands only English and requesting that they translate the text.
There are still many uncertainties about DNA - for instance, the precise number of
genes encoded in the human genome. At first, scientists estimated that there could
be two million genes in the entire human genome. The results of [67] put the number
of genes at 30,000-40,000. Now, it seems like there are more like 20,000-25,000 genes.
Indeed, only 2% of the human genome is believed to encode for genes.
There has been an enormous thrust for computer science to address and understand the relevance of the genomic biological data. Besides the modeling of molecular
signaling cascades discussed herein, there is a large thrust into protein-folding prediction. Computer algorithms have been designed to decipher the three-dimensional
folding of a protein based on its amino acid sequence. Understanding this structure
will give insight into the function, since these two elements - structure and function
- are intrinsically linked. With the sequencing of the entire human genome, scientists
are looking to computer models in order to understand all that the Human Genome
Project and similar efforts have uncovered for us.
Although the number of genes encoded in a cell is alarmingly small, given the vast

3

physical differences in the life of this planet, we look for another aspect to explain
the diversity of living things. To understand ourselves, we need to quantify the
interactions of the things encoded by the genes. The complexity of the machinery
we call life stems from relatively basic components (proteins) interacting through
intricate reaction networks. Simplicity breeds complexity.
Consider the picture of a famously studied biochemical network: the EGFR network [86]. Looking at the picture of this network diagram, there is a disquieting
moment when we realize how intensely complex and intricate even one cellular signaling pathway can be. We are struck with a sense of awe, when we try to imagine
a network diagram illustrating all of the signaling pathways at work in a normal,
healthy functioning cell. Dysfunctional cells - for instance, a cancerous cell or one
infected by a retrovirus - does not paint a picture any less complicated.
The scientific community is right now attempting to unlock the molecular'mechanisms underlying the functionality of the scariest and deadliest of diseases and disorders. We do not yet understand how all of the puzzle pieces fit together. We are only
beginning to uncover and understand the components behind the most complicated
- in terms of finding a cure - diseases and disorders. Discovering the methods to cure
diseases, such as cancer, will require an unprecedented degree of cooperation between
computer scientists, mathematicians, and biologists.
In the twentieth century, we saw an explosion of breakthroughs in the physical
sciences. With the help of mathematicians and computer scientists, we were able to
unlock incredible mysteries from the very large (black holes, stars, and the planets) to
the very small (harnessing the power of the atom). We have even begun venturing to

4

other planets. However, we are now on the cusp of a new thrust in mathematics geared
towards assisting biologists. As we turn our eyes towards the implications of genome
sequencing, nanotechnology, DNA computing, and gene therapy, we see a future where
predictions by computer models are a very important aspect in a fantastic new realm
of science, leading to breakthroughs in therapies to fight diseases, aging, or any other
ailments associated with the biochemistry of life.
For the rest of Chapter 1, we will introduce some of the existing techniques for
modeling the dynamics of intracellular proteins in a reaction network.

Differential

equations have been the predominate form of modeling for a very long time. However,
a promising algorithm was developed in the late 1970s using stochastic

fluctuations

to more accurately predict protein dynamics. Since then, both methods have been
improved, developed, modified, adapted and even combined to give us fast, accurate
simulations of molecular signaling cascades.

1.1 M o d e l i n g w i t h Differential Equations
Systems of ordinary differential equations are employed to model a wide range of
phenomena, including but not limited to modeling the dynamics of molecules in a
biochemical reaction network. In fact, due to their simplicity and the speed in which
they can be solved, systems of ordinary differential equations are quite popular in the
modeling of molecular signaling cascades. However, a recurrent theme in this work
will be the fact that molecular modeling with ordinary differential equations does
not always yield desireable results. Moreover, the solutions to systems of ordinary
differential equations can often yield misleading results, failing to accurately represent

the minority behavior of a few cells in favor of results illustrating the average behavior
of the majority of cells. In later chapters, we will continue to comment on this
shortcomming of the differential equations. For now, we will briefly discuss how we
can model biochemical systems with systems of ordinary differential equations.
We set up an ordinary differential equation for each type of molecule in the system.
For each species Xi} we have
dXr

dt

=fl{Xl)...,Xn),

(l.l)

where /j's are functions (possibly nonlinear and nonhomogeneous). For example,
the Hill function, which was initially developed to describe the binding of oxygen
to hemoglobin [46], is a classic nonlinear function now having widespread use in
describing cooperative binding (such as ligands binding to receptors). In fact, many
biological phenomena are being modeled with nonlinear functions.
Essentially, to model the dynamics of protein interactions, you will need a differential equation for each protein with the functions defined according to how the
proteins react to eachother in the system. For example, we consider an early investigation into chemical equilibrium, which was made by L. Wilhelmy [75, 127]. His
studies were focused on the following sucrose reaction:
H20 + CuH22Ou

- C6H1206 + C6H1206.

(1.2)

If we let S(t) represent the concentration of sucrose, then Wilhelmy was able to
show that

- £ = *S,

(1.3)
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where k is a kinetic rate constant. He designed this equation to match the empirical
evidence that the rate of decrease of sucrose concentration was proportional to the
concentration remaining unconverted (the law of mass action discussed further in
Chapter 2).
If we let So, represent the initial concentration of sucrose, then we have
S(t) = S0e~kt.

(1.4)

Since the time of Wilhelmy, chemical kinetics have received a great deal of attention. To address interesting problems in the biochemistry of life, we need much more
complex systems. These systems will involve many reactions with a large degree of
interdependence. Indeed, we will see increasingly complex systems of ordinary differential equations in the coming chapters of this work. This complexity will be driven
by the number of interacting elements and reactions, but not necessarily from complicated nonlinearity such as the Hill Function. With more complex systems, we will
need to approximate the solutions to the systems of ordinary differential equations.
Once the system of differential equations is written out, mathematically describing
the molecular mechanisms, it is time to apply approximation methods.
The most common method for approximating a system of ordinary differential
equations is the fourth order Runga-Kutta method. This is the method employed by
a large majority of computational biology labs. Often, MATLAB is used, and the
ode23 and ode45 solvers are built-in functions utilizing Runga-Kutta to provide an
approximate solution to the system of ordinary differential equations. For an example
of the MATLAB code we have used to determine solutions to systems of ordinary
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differential equations, we refer the interested reader to Appendix A (describes the
circadian rhythm model from Chapter 3).
We have hinted that differential equations are not the only way to model biochemistry. We will now briefly discuss the stochastic techniques for modeling biochemical
reaction networks.
1.2 Stochastic M e t h o d s and t h e Gillespie
Algorithm
There are situations where ordinary differential equations fail to adequately represent cellular populations. The biochemical reason for this usually stems from situations of low molecular multiplicity. In one of the most important works on stochastic
approaches to chemical kinetics, McQuarrie [75] provided a rich description of the
historical background to stochastic techniques as well as some exactly solvable systems.
Kramers was the first to use stochastic ideas for modeling the kinetics of chemical
equations [63, 79]. The idea of stochastic approaches for modeling chemical systems
revolves around the chemical master equation.

This equation describes the proba-

bility of every possible state of the cell (with respect to biochemical composition).
Instead of a differential equation for each protein, one would essentially have a differential equation for every possible state of the cell. For very small systems, the
chemical master equation can be solved directly (see [75] for some systems). However, it becomes difficult or impossible to directly find the chemical master equation
for systems of nontrivial size. It is this reason which led D.T. Gillespie to formulate
his now ubiquitous algorithm for exactly solving the chemical master equation.

8

Gillespie published two landmark papers in 1976 and 1977. In [35], he presents
the framework for an exact stochastic method, which accurately predicts the chemical
master equation. Then, in [36], Gillespie describes the Stochastic Simulation Algorithm (SSA); the algorithm is now aptly named the Gillespie Algorithm, and it is the
most commonly applied/adapted technique for stochastic simulation of biochemical
networks. The Gillespie Algorithm is at the heart of most discussions on stochastic
modeling.
In [36], Gillespie discusses two important points on the failure of classical modeling
(differential equations); the approach assumes that the time evolution of a chemically
reactive system is both continuous and deterministic. However, in nature, chemically
reacting systems evolve in a discrete manner, since molecular multiplicities can obviously change only by integer amounts. Also, it is impossible to predict the future
molecular population levels through deterministic systems (a system of ordinary differential equations), because we cannot know the exact positions and velocities of
all the molecules in the system. Hence, time evolution for simulations must be a
nondeterministic process, in order to account for all of the possibilities.
We will forgo an explanation of the algorithm, since it has been reported o,d
nauseum in the literature. However, we would like to mention the main limitation of
the algorithm. As stated in the original paper [36], the Gillespie Algorithm places a
high premium on the speed of the computer's CPU. The limitations are dependent on
the number of reactions in the system. Also, the algorithm requires multiple runs to
correctly quantify the system. This works in conjunction with the speed limitations,
making stochastic simulations an enduring process.

9

1.3 Improving the Gillespie Algorithm
Since its creation in 1977, the Gillespie Algorithm has been the focus for improvements in efficiency. The most notable improvement for the Gillespie Algorithm comes
from the work of Gibson and Brack [34]. They were able to reduce the computational
complexity of the algorithm considerably, through the addition of a method for sorting
the reactions and reducing the dependence on random number generation. However,
the limitation associated with reaction network growth - number of molecules and
reactions - is still an issue.
A number of methods have now been proposed to combine differential equations
with the Gillespie Algorithm. These hybrid methods attempt to divide the reactions
into fast and slovj. We will not provide an exhaustive discussion on each method, but
we wish to mention two notable works below.
The work of Haseltine and Rawlings [43] has been well-cited. They provide the
theoretical background for dividing reactions into fast and slow subsets, allowing for
the fast reactions to be approximated either deterministically or as Langevin equations. Essentially, they are able to integrate the system over much larger time steps
than the original Gillespie Algorithm. For the original Gillespie Algorithm, increasing the number of molecules for a fast-reacting protein will significantly increase the
computational load; however, by using deterministic processes for fast reactions, the
computational load of their algorithm will not increase in this case.
Rao and Arkin [101] applied the quasi-steady state assumption to modify the
Gillespie Algorithm. Using the quasi-steady state assumption, they were able to
reduce model complexity by reducing the number of molecular species and reactions.
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Essentially, the assumption is that the net rate of formation is approximately zero for
highly reactive and transitory species - e.g., enzyme-substrate complexes. In their
paper, the authors provide some mathematical rigor behind the algorithm as well as
some results for example systems.

1.4

Our Work

In Chapter 1, we have provided an introduction to the concept of modeling biochemical reaction networks and a brief discussion on some of the most popular techniques. For the rest of this work, we will focus on biochemical modeling with our
algorithm., the Nondeterministic Waiting Time algorithm.
In Chapter 2, we will introduce the Nondeterministic Waiting Time algorithm.
We provide an in-depth look at the pseudocode; a discussion on the implementation;
and some results from example systems illustrating the concepts of the algorithmic
improvements is provided in the chapter. Chapter 3 illustrates the results of two popular models: the Lotka-Volterra predator-prey model and a circadian rhythm model.
The two models are used to emphasize the difference between our algorithm and the
solutions to systems of ordinary differential equations and the Gillespie Algorithm.
In Chapter 4, we provide simulation results for the Fas-mediated apoptotic pathway. We compare the results of our algorithm for the model with the solutions to the
systems of ordinary differential equations provided in [47]. Then, in Chapter 5, we
propose an extension of the Fas model discussed in Chapter 4. The extension revolves
around the addition of proteins encoded in the human immunodeficiency virus. The
model, which explores T cell latency, is the first reported of its kind.

Chapter 6
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provides the conclusion for the work. A discussion on possible research extensions is
also provided therein.

CHAPTER 2
T H E NONDETERMINISTIC WAITING
TIME ALGORITHM
In Chapter 1, we provide a survey - but in no way an exhaustive account - of
the numerous algorithms pertaining to the simulation of molecular interactions in a
biochemically reactive system. Each of the simulation techniques discussed have their
own particular strengths and weaknesses. For the stochastic techniques, the strengths
and weaknesses typically revolve around the accuracy with which the algorithm can
predict the chemical master equation and the computational efficiency with which
it functions. For the deterministic techniques, speed is one of the main strengths,
but at a loss of the randomness inherent in living biochemical systems. Predicting
the behavior of the minority populations is impossible with deterministic techniques,
since they display the average behavior of the system and, thus, favor the majority
behavior.
The focus of Chapter 2 will be the discussion of a different type of biochemical simulation algorithm. A technique designed in such a way that it is capable of
exhibiting behavior similar to continuous deterministic approaches for certain biochemical models, but it behaves similar to the discrete stochastic approaches - e.g.,
the Gillespie Algorithm - for certain other types of systems. We have chosen to call
12
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this technique the Nondeterministic Waiting Time (NWT) algorithm.
This work is an extension of previous modeling efforts initiated by the advisor
for this dissertation, Dr. Andrei Paun. In [17] the groundwork for a Deterministic
Waiting Time algorithm was laid out. Here, we provide an efficient, refined algorithm
with several important extensions from the previous algorithm. Notably, the algorithm now has a nondeterministic component and a memory enhancement, which
gives it a unique ability to simulate reaction competition over limited numbers of
reatants. Additionally, the implementation of a min-heap with special maintenance
functions improved the efficiency of the previous simulation algorithm.
In Chapter 2, we will introduce the concepts behind the Nondeterministic Waiting
Time algorithm. The entire source code is available in the Appendices (B and C)
near the end of this work. However, in Chapter 2, we will provide several blocks of
pseudocode as necessary to discuss the important aspects of the simulation technique.
After introducing the algorithm, we will provide a couple of small example systems
to illustrate the particular concepts and enhancements which we have implemented
in our N W T algorithm. We must begin, however, with a discussion on Membrane
Systems and why we have chosen this computing paradigm as the framework of our
biochemical reaction network simulator.

2.1 Introducing M e m b r a n e S y s t e m s
In Section 2.1, we will present the foundations for our discrete, nondeterministic
biochemical simulation techinque: the Nondeterministic Waiting Time algorithm. In
the design of this algorithm, our goal is to define a simulation technique between the
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realm of the Gillespie Algorithm and modeling with systems of ordinary differential
equations. Moreover, we wish to have a modeling technique which is less computationally intensive than the Gillespie Algorithm, yet maintains a level of nondeterminism
(or stochasticity) which set it apart from solutions to systems of ordinary differential
equations. To describe the foundations of the NWT algorithm, we must explore the
realm of a relatively new paradigm of computing: Membrane Systems (or P Systems).
The evolution of DNA, RNA, and proteins during life's tenure on Earth is the story
of the storage and application of information, similar in development to the field of
computer science. For these macromolecules of life, there is a classic debate between
life scientists surrounding which of them evolved first. Implicit to this debate is an
emphasis on the billions of years of information theory inherent in life and nature.
Let us assume, for the sake of argument, that RNA existed before the others. Then
we can imagine that the initial molecules of life had the ability to store information,
the way modern messenger RNA (mRNA) carries the genetic information from the
nucleus to the cytoplasm for translation into a protein. However, we can also imagine
some initial molecules of life possessing the ability to put the information to work,
the same way small nuclear RNA (snRNA) has responsibilities in the modern cells
pertaining to the transcription of a gene.

It is from the incredible achievements

in information storage and application, apparant in all living cells, that Membrane
Systems evolved as a way to view the molecular activity within a cell as a computation.
The concept of computing with membranes was first proposed in 1998 by Gheorghe
Paun [100]. As a model for computation, Membrane Systems have proven to be quite
useful; they take advantage of exponential space in order to solve computationally
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hard problems efficiently.

In their short history as a computational paradigm, a

multitude of Membrane Systems have been proposed. These Membrane Systems have
the ability to attack NP-Complete problems through the use of exponential space,
sharing some of the fundamental concepts of biological parallelism as DN A computing
[l]. For example, a Membrane System has been described which is capable of solving
the boolean SAT problem in linear time [133]. However, no one has yet been able to
build an actual Membrane Systems computer out of a cell. If we could harness the
computational power of a cell, we could break through the glass ceiling on efficient
solutions to computationally complex problems - i.e., NP-complete. Although the
majority of Membrane Systems research has been on abstract models and theory,
there are a few groups who wish to use Membrane Systems in a different way. Some
computer science groups are investigating the use of Membrane Systems to address
problems in computational biology. This is the direction of our interest.
For our purposes, we will define a Membrane System. IT. in the following way:
n = (E, L,fi, Mu. . , M m , Ru... ,Rm),

(2.1)

where
» The alphabet, E, is a list of all the proteins in the system.
does not contain information on the numbers of each protein.

The alphabet
That is, the

alphabet is initialized with only the number of different types of proteins with
no information on the total number of molecules in the system.
• A set of labels, L, representing all of the different compartments of the system.
» The membrane structure, ju, represents the hierarchical organization of the different compartments, L.
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• The multiplicity sets, M,: where 1 < i < m, contain the multiplicities of the
proteins within each compartment - i.e., the number of molecules per protein.
• The rule sets, R where 1 < i < m, contain the rules associated within each
compartment. The rules are the chemical reactions.
It is worth mentioning that for the remainder of this text, reaction/rule and
species/protein will be used interchangeable. One of the nice features of Membrane
Systems is that they can easily be comprehended using a graphical representation.
For an example, let us consider a Membrane System illustrated in Figure 2.1.
In mathematical terms, we describe the system below
• E = {a, b, c, d, e}

• L = {\h,[]2,[h}
• A* = [l [2[3 taWi

• Mi = {ac}, M2 = 0, M 3 = 0
• R1 = {e —>• eout}, R2 = {b —> d,d —> de, (cc —> c) > (c —> 5)},
i?3 = {a —> ab, a —>• b5,c —> cc}.
The Membrane System described above has eight rules and five distinct types of
proteins. N.B., the 5 in the rules denotes a "dissolve" rule whereby the membrane m
which the rule is executed disappears - all proteins present in the membrane at this
time are dumped into the parent membrane. Notice, the system begins with only one
protein of a and one protein of c, both of which are present in membrane 3.
The rules of the system govern the biochemical evolution of the system. The rules
act in a maximally parallel manner - i.e., for the system to evolve from one state to
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the next state, all rules which can be applied are applied. For abstract Membrane
Systems, the transition from one system state to the next is called a computation.
The computations of a Membrane System are similar to the transitions of a Turing
Machine. The system continues until it reaches a stopping configuration. For the
example system above, the first computation would yield cc from c and ab from a
(applying the only two possible rules).

3

ac
a -* ab
a -• b5
c -* cc

b -*d
d -* de
[cc => c) > (c -> 6)
e ->'e'out
Figure 2.1 Example of a Membrane System.

For our NWT algorithm, we would like to use Membrane Systems more as a
data structure. The simulation of a chemically reactive system - e.g., a living cell
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- is merely the evolution of the Membrane System according to the set of rules,
{Ri,..., Rm}- To do so, we will need a discussion on how/when rules will execute.
As the rules describe the interactions between proteins in the alphabet, the evolution
of the Membrane System tracks protein dynamics. While there are many types of
biochemical reactions, we will list a few of these to facilitate our understanding on
the design and implementation of the Membrane System proposed in Equation 2.1.
Some basic examples of biochemical reactions are listed in Table 2.1.
Table 2.1 Typical examples of biochemical reactions.
—

Ri: Monomolecular decay:

A —> 0

R2: Monomolecular reaction:

A —^-> B

k
k

Rs: Bimolecular reaction:

A + B —^ C

R4: Trimolecular reaction:

A + B + C —^ D

k

In order for the Membrane System to illustrate protein dynamics over time, we
need to discuss the temporal aspects of the rules of the system. To model the biochemistry of life, the individual chemical reactions described in the system occur must
over different lengths of time in an asynchronous manner. The rules of our Membrane
System obey the law of mass action, which was first formalized in 1864 [37, 38, 120].
The law of mass action states that a reaction rate is directly proportional to the number of reactants available in the system. In other words, the time a reaction takes to
occur is dependent on the number of its react ant molecules.
With the law of mass action, we have a way to associate time dynamics with the
evolution of the Membrane System as it jumps from one configuration to the next. We
also have a way to make the rules occur in an asynchronous manner. As previously
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mentioned, a Membrane System typically evolves by applying rules in a maximally
parallel manner. In other words, when the system jumps from one configuration
to the next, any and all rules which can be applied (given sufficient reactants) are
applied. But, when we use the law of mass action, the reactant concentrations govern
how much time must transpire before a particular reaction can take place. Therefore,
for any particular configuration of the Membrane System, the number of reactant
molecules for a given reaction determines when that reaction is next slotted to occur.
The values associated associated with the law of mass action are called kinetic rates.
These kinetics rates must be determined through biological experimentation. As
such, the kinetics of a chemically reactive system are often described as concentrationbased values. The reason for this is the fact that biological results are often generated
from enormous populations of cells. Often a biological experiment will consider a population of millions of cells. To determine the intracellular concentrations of proteins,
these cells are then lysed as a large population. The intracellular molecules are then
measured in terms of light intensity (radiological or photonic markers), which gives
data on general concentrations of particular molecules across the population. Finally,
the values are averaged to give the concentration per cell. Therein, lies a major problem, with biochemical modeling. We rely on the values generated in the biological lab,
and these values are often generated over entire cell populations instead of individual
cells. Hence, the interesting phenotypic, biochemical and physiological characteristics
of individual cells can be lost in lieu of the behavior of the majority of the cells in
the population.
There are techniques which can measure single cell dynamics, and this technology
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is very promising. For instance, important results on p53 have been reported [65]
from the results of measuring single cell dynamics instead of averaging over cellular populations. The authors of [65] were able to show individual cells undergo not
dampened oscillations, as previously reported [5], but each individual cell instead undergoes different numbers of oscillations. The average behavior for the cell population
appears dampened, but individual cells do not.
At the lab of Dr. Mark DeCoster of Louisiana Tech University, we now have the
capabilities to measure single cell dynamics via a high-speed imaging system. Towards
the end of the work of this dissertation, Chapter 6, there is discussion on the dynamics
of Fas involving Ca + signaling, which could be explored using the system at Louisiana,
Tech University. It is our hope that future collaborations between Dr. Andrei P aim's
computational group and Dr.

DeCoster's biomedical laboratory will help unlock

some of these secrets and provide new aspects to Fas signaling cascade. Regardless
of whether data comes from large cell populations or single cell dynamics, we, as
modelers, must remain vigilent and build the best models with the data available to
us. As is the case with the model discussion of Chapter 5, expanding the Fas model
with the effects of viral proteins, relying on biological data from a wide variety of
sources can result in difficulties when trying to set up a model.
The kinetic rates, kR for some reaction R, will often have units based on nMs, //Ms,
etc. Let's assume we have these kinetic rates for every reaction in our Membrane System. We have already stated that our technique is a discrete one. Therefore, in order
deal with multiplicities of proteins as opposed to concentrations, we must calculate a
discrete kinetic constant. This discrete kinetic constant will be based on numbers of
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molecules. When we initialize the Membrane System, we must calculate the discrete
kinetic constants from the concentration-based kinetic rates in the following way
const R =

^-r,

(2.2)

V'-' x Nl~l
where V is the volume of the system, NA is Avogadro's constant (6.0221415 x 1023)
and i is the number of reactants involved in the reaction.
With the law of mass action and the discrete kinetic constants, we have the means
to allow the rules of the Membrane System to occur at times dependent On reactant
multiplicities, which are subject to variation throughout the entire simulation run.
We can now define a reaction's Waiting Time (WT). The Waiting Time is a value
associated to each reaction, signifying when the next time a single instance of the
reaction will occur. As molecular multiplicities will change throughout a simulation,
so will the reaction Waiting Times (in accordance with the law of mass action).
As mentioned, we initialize the discrete kinetic constants at the beginnning of the
simulation. Once we have these constants (along with the initial multiplicities of the
proteins), we can initialize the Waiting Time for every reaction in the system. The
Waiting Time is the amount of time required for the execution of one instance of
a reaction. For a first order equation, like R] from Table 2.1, the WTaiting Time is
calculated with the following equation:

where A is the reactant required for reaction Ri, \A\ represents the number of
molecules present in the system at the moment of Waiting Time calculation, and
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kd is the discrete kinetic constant. N.B., Ri and R2 from Table 2.1 are calculated the
same way (if we assume kd = kx) because they both have reaction order one and use
the same reactant species, even though the products are different.
If one of the reactants for a reaction has no molecules present in the system, then
we set the Waiting Time equal to infinity; since we have chosen to implement the
algorithm in ANSI C, this is can be easily accomplished

For higher order

reactions, we need to incorporate the other reactants into the calculation of Waiting
Time. Following the examples in Table 2.1, a second order reaction (bimolecular)
would be calculated in the following way

WTK

R3

=
ky*\A\*\B\'

(2 4)
' ^

and a third order reaction (trimolecular) would be

where A, B, and C are the reactants required for reactions i? 3 and R4, \A\,

\B\,

and \C\ represent the number of molecules present in the system at the moment of
Waiting Time calculation, and ky and kz are the discrete kinetic constants.
In this way, the initial Waiting Time is calculated for every reaction in the entire
system. Now the question remains: how do we efficiently sort the reactions so that
we can easily determine which reaction is slotted to occur next? . To do this, we
will need to build a min-heap (based on reaction Waiting Times), where the top of
the heap is the reaction with the smallest Waiting Time - i.e., the next reaction to
occur. However, we will not be able to maintain the min-heap, as the Waiting Times
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change, in a standard manner.

When a rule is applied, multiple nodes can have

changes to their Waiting Time, since the multiplicities of the system are changed.
Thus, multiple Waiting Times can fail the min-heap property throughout the tree
simultaneously after each time step.

In order to efficiently evolve the Membrane

System, we will need to incorporate some special heap maintenance functions, similar
to those proposed by Gibson and Bruck [34] in their modification of the Gillespie
Algorithm. This will be discussed further in Section 2.3.
With constRt

and WTj^,

for each reaction Ri, we have all of the elements for

the initialization of our Membrane System. In Section 2.1, we will provide a full
description of the NWT algorithm. Then, we will discuss the specifics on our implementation of the Membrane System. The implementation discussion will lead us into
our description of the min-heap maintenance. Finally, we will discuss the concept of
reaction memory, in order to ensure the proper evolution of the Membrane System.
2.2 T h e N o n d e t e r m i n i s t i c W a i t i n g T i m e
Algorithm
Section 2.1 gave us the data structure for the N W T algorithm. We have a Membrane System, which describes all aspects of the system - e.g., rules, compartments,
protein types, numbers of molecules per protein, etc. We discussed the fact that our
Membrane System will not evolve in a typical (maximally parallel) manner, because
the reactions occur in an asynchronous manner over discrete time intervals of different
lengths according to the law of mass action.
Next, we provide a description of the NWT algorithm. The entire source code
can be viewed in Appendices B and C. The Membrane System evolves through the
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execution of reactions in a Waiting Time-dependent manner until a desired simulation
time has been reached. We will now list the Steps for the NWT algorithm.
1. Build Membrane System: Import data for Membrane System - alphabet, membrane hierarchy, etc. Convert protein concentrations to molecular multiplicities.
Convert kinetic rates to discrete kinetic constants. For each reaction R^, where
1 < i < m, we calculate the initial Waiting Time, WTRi. Choose the desired
amount of time for the simulation, r/ m . Set current simulation time to zero
(r = 0).
2. Build Heap: Using the reaction Waiting Times, we build a min-heap of all
reactions in the system.
3. Select Rule: Choose the reaction with the lowest Waiting Time - the top of the
min-heap. Upon selecting the top node, recursively check to see if there are an)'
children nodes sharing the minimum Waiting Time. If such a tie for minimum
Waiting Time exists, proceed to step 4. If no tie exists, then proceed to step 5.
4. Handle Tie: Check the multiplicities of the reactant species for all tied reactions.
If there are enough reactants to satisfy all of the reactions with the minimum
Waiting Time, implement all tied reactions. If there are not enough reactants
to accommodate all the reactions, use the nondeterministic logic to apply as
many rules as possible.
5. Apply Rule: Update the multiplicities of the reactant(s) and product(s) for the
reaction(s) from step 3. Aggregate the simulation time (r = T + WTappned).
6. Update Rules: Recalculate the Waiting Time for all reactions whose reactants
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include the products or reactants of the applied reaction(s). That is, we need to
see how the multiplicity changes from the applied reaction(s) have affected the
Waiting Times for all rules dependent on those proteins with changed multiplicity. For each such reaction compare the new Waiting Time with the existing
Waiting Time and keep the smallest of the two (unless the new time is infinity).
7. Memory Enhancement:

If the recalculation of a reaction's Waiting Time results

in a value of infinity, then we must store the amount of time waited as a percentage (Memperc).

If the recalculation of a reaction's Waiting Time results in

a real value and the previous value was infinite, then the Waiting Time will
need to be adjusted according to the stored memory percentage.
8. Heap Maintenance:

Adjust the min-heap, bubbling reaction nodes up or down in

order to satisfy the min-heap property, once reaction Waiting Times have been
recalculated according to the multiplicity changes. N.B., to accomodate the
multiple changes in Waiting Times, we employ nonstandard heap maintenance
methods.
9. Termination:

If r = Tfin, then terminate the simulation. Output the multiplity

information for entire simulation. Otherwise, go back to step 3.
The above pseudocode represents a simple explanation of the N W T algorithm;
however, we will use the rest of Chapter 2 to elaborate on each step, giving the
reader a clear understanding on how to efficiently implement the ideas described in
the algorithm. First, we will need to discuss the language and tool used to encode the
. model for step 1. For this work, we did not seek to develop our own esoteric method
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for encoding the information of a biochemical network. Instead, we have chosen to
use a standard language utilized by many systems biology labs across the world.
We feed our simulator with a file encoded in the Systems Biology Markup Language (SBML). SBML is one of the most popular methods to encode biochemical
models, developed through a broad international collaborative effort involving the
cooperation of many institutions [48]. We chose SBML for its visibility and availability. SBML has in place an extensive emailing group for quick discussions on coding
issues and future extensions/developments of the standard. For these reasons, the
choice to use SBML instead of similar methods - e.g., CellML - was an easy one.
To generate the SBML files, we use the CellDesigner software [32, 33] which is
also the result of a large international collaborative effort but maintained through
Keio University. The CellDesigner software provides an easy graphical interface with
which to program the models. CellDesigner has many functions, including simulation packages, but we are only concerned with its ability to generate SBML models
(pictures and code) through a simple, user-friendly graphical interface.
CellDesigner adds its own extra information to the SBML code, to define the
spatial aspects for the graphics - e.g., the locations of membranes and proteins,
sizes of proteins, etc. However, the program has the ability to export the model
as pure SBML code with none of the extraneous graphical information. There are
several different version of SBML code, but we used CellDesigner to generate SBML
Level 2 Version 1, the newest standardized SBML format. The SBML file is free
of any additions made by CellDesigner. In Figure 2.2, we provide an example of
CellDesigner's graphical representation and SBML code. The Figure represents the
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bimolecular reaction which is listed in Table 2.1, and gives us a chance to discuss the
various components of the SBML code important for the models in later Chapters.
Within the SBML code, we have everything we need to initialize the Membrane
System (step 1 of the NWT algorithm). SBML is a sort of one-size-fits-all language
for the description of a biochemical reaction network. As such, we are not interested
in using every part of the entire language, for the models present in this work. We
will highlight only the parts of the SBML code pertaining to our work, ignoring the
components that are of no concern for the models discussed in later Chapters.
The <listOfCompartments> is the first tag of interest to us. It marks the beginning of the model information for populating the compartments, L, and the membrane hierarchy, /z, of the Membrane System. We associate the compartment id flag
with L and the outside flag determines where that particular compartment is located
with respect to other compartments, fi. For instance, a nucleus would have outside
= u cytoplasm".
The tag <listOfSpecies> contains all of the information used to populate the
alphabet. E, of the Membrane System as well as the multiplicities of each protein
per compartment, the sets Mi,..., Mz from the Membrane System description in Section 2.1. The flags id and initialAmount describe the values to be stored in E and
the MjS, respectively. The ids of the proteins are unique, and we use those values
instead of name to associate reactants and products with a reaction. As you will
see later, we also keep track of name, but we store the name of the protein only to
ease the post-simulation analysis. We assume the initialAmount values are always
given as concentrations. Therefore, the NWT algorithm needs to convert the protein
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concentrations into the numbers of molecules using the basic equation

\P\ = [P]*NA,

(2.6)

where [P) is the concentration of protein P, \P\ is the number of molecules, and NA
is Avogadro's constant.

Cytoplasm

<?xml version="1.0" encoding= a UTF-8" ?>
<sbml > ; r n l n s = ' ' h t t p : / / w w w . s b m l . o r g / s b m l / l e v e l 2 " level="2* version ="!">
- <inodel id="untit)ed">
- <distOfConipartments>
<compartment id="default" s i z e - ' l " / >
ccompartment id="cl" name="Cytoplasm" size="l" outside="defaulr" / >
</listOfCompartments>
-- <listOfSpecies>
<species i d = " s l " nam5="A" c o m p a r t m e n t - ' c l " initialAmount="10" charge="0"
<species id="s2" name='!B" compartment="cl" initialAmount="20" charge--"0"
<species id="s3° name="C" ccmpartment="cl" initialAmount="0" charge="0" /
</lis t o f Species >
- <listOfReactions >
- <reac,tion i d = " r e l n reversible="false" fast="false">
- <listOfReactants>
<specissRe.ference spedes= B sl" / >
<specissReference species="s2" ./>
</listOfReactants>
- <listOfProducts>
<spedesReference sp«cies="s3" •>
</listOfProducts>
- <kineticLaw>
<math >;mlns="http://www. w 3 . o r g / 1 9 9 8 / M a t h / M a t h M L " / >
- <listOfParameters>
p a r a m e t e r id="ky ,! value="12" / >
<.'listOfParameters>
<j''kineticLa'/.'>
</reaction>
</listOfReactions>
</model>
</sbrnl>

Figure 2.2 Comparison of the graphical representation and SBML code for a
model generated using the CellDesigner software.
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Next, we need to populate the list of rules (Ri,..., Rt) of the Membrane System.
We find this information under the <listOfReactions> tag. Under this tag, we find all
of the reactions for the entire biochemical network. The description of each individual
reaction begins with the <reaction> tag. For each reaction, we read the reaction id
flag, which CellDesigner assigns as a unique value per reaction. Two important tags
per reaction are the <listOfReactants> and the <listOfProducts>,
In our example, we see s i and s2 are the two reactants for the bimolecular reaction.
Notice, the protein id is used instead of the name. Following our example, we seethere is only one product listed in the SBML code, s3. Finally, we find the kinetic
rate, which falls under the <parameter> tag. In our implementation, we are not
concerned with the rate id, so we ignore this value. We wish only to store the kinetic
rate value flag. Finishing our example reaction, we see the parameter, ky, has value
12.
Using the SBML code, we can populate every aspect of the Membrane System. We
have chosen to implement the algorithm in the C programming language. Initially, we
programmed the entire algorithm in Java for portability reasons. However, for, larger
models, like the one described in Chapter 5, we found the speed benefits of C to be
necessary in reducing simulation runtime. Also, C gave us the ability to parallelize
our simulations via MPI. We mention the fact that we switched from Java to C,
because we will begin using the word struct (to facilitate understanding of the source
code in the Appendices). However, a Java implementation could be understood by
substituting the word struct with object.
All of the elements of the Membrane System can be contained in two arrays of
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structs. We refer to one array as the "Alphabet" and the other array as "Reactions".
We represent these structs graphically below (Figure 2.3) and invite the interested
reader to look at Appendix C for the source code of the two structs. By explicitly
explaining these two arrays and the aspects of the structs, we can better understand
their relationships and how we have effectively and efficiently implemented the NWT
algorithm.
Alphabet Array

Reaction
Protein

(a) Id

(a) Compartment

(b) ConstR

(b) Id

(c)WT

fc) Multiplicity

(d) Memory_WT

(cl) ReactionList array

(e) Memory_Percent

(e) Multiplicity array

(f)Heap_lndex
(g) Reactants array
(h) Products array

Rules Array

Figure 2.3 The two structs: Protein and Reaction, nodes used to build the
Alphabet and Rule sets of the Membrane System.
With our discussion of the SBML code, it is already clear what is meant by (a)
through (c) of the Protein struct. These components consist of (a) a string, (b) a
string, and (c) an integer (the number of molecules must be a whole number). The
Compartment and Id components are fixed throughout the entire simulation run. The
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Multiplicity component is subject to change throughout the simulation, increasing or
decreasing by one whenever a given protein is the product or reactant of an applied
reaction.
Part (d) of the Protein node is the ReactionList array. The ReactionList array
contains the indices of all of the reactions for which the protein is a reactant. The
purpose of the ReactionList array is 0 ( 1 ) time access to all reactions which use the
protein as a reactant. This is convenient for quick recalculation of the Waiting Time
of a reaction, after a change in the multiplicity of at least one of its reactants has
occured as the result of the execution of a rule - that is, step 6 of the N W T algorithm.
Finally, component (e) is the Multiplicity array. At each second (easily modified
to handle minutes or hours as needed) throughout the entire simulation run, the
multiplicities of all proteins are saved to their Multiplicity array. This allows us to
circumvent read/write access of the slower memory (IDE/SATA haxddrives) in favor
of faster memory (RAM). It would be nice to store all the multiplicities in RAM until
the simulation has finished, however, the current implementation of the algorithm has
the harddrive access after every 40,000 seconds (simulation time). We wanted to take
advantage of the built-in declarations of C to ensure compatibility across different
systems, compilers, etc. For simulations longer than 40,000 seconds, the Multiplicity
array is dumped to a results file every time the array becomes full, then it begins
filling again, continuing until the desired simulation time is reached.
Next, we will consider the components of the Reaction structs. Component (a)
comes directly from the SBML code and is stored as a string. We discussed earlier
(Equations 2.2, 2.3, 2.4, and 2.5), the calculation of the (b) ConstR

and the (c)

WT.
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Both of these values need to be stored with double precision. This is due to the fact
that most biochemical reactions take less than one second to occur. Hence, we want
to use the largest standard type definition to ensure the largest possible number of
decimal places. Values (a) and (b) do not change after initialization. However, as
discussed, the Waiting Times are recalculated as the multiplicities of the reactants
change.
Components (d) and (e) deal with the memory enhancement of the NWT algorithm. These parts are better left unexplained until the discussion of memory
enhancement in Section 2.4. We would like to note that these values are stored with
double precision. The Heaplndex (f) is required to handle heap maintenance, which
will be explained in Section 2.3.
Finally, the Reactants array and the Products array (components (g) and (h))
contain the indices of the alphabet for the reactants and products of the rules. This
allows 0(1) time access when updating the multiplicities of the proteins affected by
the execution of a given rule, respectively. We allow our algorithm to handle reactions
of order no higher than three (trimolecular reactions). Any higher order reaction can
be broken down into subsequent smaller order reactions. Hence, the Reactants and
Products axrays are not larger than three. This is important for the discussion of
runtime later in the Chapter.
This concludes our discussion of step 1 of the NWT algorithm. The information
of the Membrane System is completely contained within two arrays of structs: the
Alphabet array and the Rules array. Step 2 involves building the min-heap of the
array. This step does not require much elaboration, but we will mention the min-heap
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property. For any two reactions, i?i and R2, in the heap, if R2 is a child of Ri, we
must have
WTRi < WTR2.

(2.7)

Steps 1 and 2 are each called only once during the simulation. Now we must
discuss step 3 of the NWT algorithm: Select Rule. We want to select the reaction
with the lowest Waiting Time. Since we have organized our reactions in a min-heap,
this step requires only 0(1) time to complete. However, we must check to see if any
other rules have the same Waiting Time - i.e., reactions attempting to execute at
the same exact instant. These competing reactions could potentially be trying to
use the same limited reactants. If there are multiple rules slotted to occur at the
same moment, then we must ensure there are enough molecules to satisfy all of the
reactions. Otherwise, we will need to choose reactions nondeterministically until all.
available reactants have been exhausted.
We want to create a temporary array to store all the reactions with the minimum
Waiting Time. The elements of this array are pointers to nodes in the heap. The first
node in the array is the top of the heap. We want to add all reactions to the array with
the minimum Waiting Time. To do so, we will recursively check children nodes until
we stop finding tied reactions - i.e., reactions attempting to occur simultaneously.
The recursive method is presented below:
1: CheckTie(VKT, parent)
2:
3:
4:

IF leftchild exists
I F \parent(WT) - leftchild(WT)\

<t

add leftchild pointer to ties array
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5:

CheckTie(WT,

6:

I F rightchild

7:

leftchild)

exists

I F \parent(WT)

- rightchild{WT)\

8:

add rightchild

9:

CheckTie(H/T,

< e

pointer to ties array
rightchild)

Consider lines 3 and 7. Ideally, we would like to check for equality between the
parent

and child.

However, due to the way the C programming language handles

double precision, we are not allowed to make exact comparison, e.g., parent(WT)
leftchild(WT).

=

Instead, we use an error tolerance, e, to declare two doubles are

'equal'. In our simulations, we have defined the error tolerance as 10~ 13 , as it worked
well during simulation testing.
If the two Waiting Times are within e of each other, then they are considered
to be equal. The child is added to the array of ties, and the CheckTie method is
recursively called with child as the passed parameter. This continues until no more
children have the minimum Waiting Time. Once the method (and any recusive calls
to the method) terminates, then we have a complete ties array. If there is only one
element in the ties array, then there is no tie, and we can move on to step 5 and
apply only the one rule. Otherwise, we must apply as many rules as possible in a
nondeterministic manner.
To nondeterministically apply rules, we define a random number generator using
the system clock as the random seed. We randomly generate numbers between 0 and
the end of the ties array. Using this randomly chosen index, we check if sufficient
reactants exist to implement the reaction. If there are sufficient reactants, we apply
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the reaction - i.e., we increase the multiplicity of the product(s) by one and decrease
the multiplicity of the reactant(s) by one. If there are insufficient reactants, we skip
the reaction, and no multiplicity changes occur for the reaction. In either case, the
reaction is removed from the ties array, and the process continues until the ties array
is empty. This completes step 4 and step 5. Recall, in the case of only one reaction,
we skip step 4 and apply just the one reaction in step 5. In either case, we are ready
to move on to step 6: Update Rules.
Step 6 of the algorithm requires access to component (g) and (h) of the Reaction
struct and component (d) of the Protein struct. For each reaction applied in step 5,
we must recalculate the Waiting Time of the applied reaction and the Waiting Time
of every reaction affected by the multiplicity changes. We must discuss step 6 within
the context of the heap maintenance. Hence, we will continue the discussion of step
6 in Section 2.3, which will also be a discussion of step 8, Heap Maintenance. As
you will see in the next two Sections, steps 6, 7, and 8 are all intertwined. But, the
discussion on step 7 is left for Section 2.4.

2.3 M a i n t a i n i n g t h e M i n - h e a p
As we stated earlier, we are building a min-heap from our Rules array with the
bottom-up method.

However, the maintenance of the heap is accomplished in a

nonstandard way. Standard methods for heap maintenance involve selecting the top
node and removing it from the heap entirely. Meanwhile, new nodes are added to
the bottom and bubbled up as necessary. There are a couple of reasons why we do
not want to remove the nodes of applied rules from the heap and add them to the
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bottom.
For one, the number of reactions will not grow or shrink during a simulation run.
Hence, we do not need to remove or add reactions to the heap once it has been
initialized. Second, it is most often the case that, once a reaction is applied, its new
Waiting Time is very close to the previous value. Therefore, the top node will most
likely be located near the top of the heap once the heap is resorted. Hence, popping
the top node and adding it to the bottom will often result in the node being bubbled
back up to near the top of the tree (a waste of computer clock cycles, especially for
a significantly large numbers of reactions).
As we said at the end of Section 2.1, step 6 and step 8 are must be handled
concurrently. We will provide the pseudocode for the two steps below, then we will
clarify their function with an example.
1: U p d a t e R u l e s Q
2:

F O R each applied Ri

3:

Recalculate WTRi

4:

FixHeap(i?j node)

5:

F O R each reactant X of Ri

6:

F O R each reaction Rx requiring X as a reactant

7:

Recalculate WTRx

8:

FixHeap(f? x node)

9:
10:
11:

F O R each product Y of R
F O R each reaction Ry requiring Y as a reactant
Recalculate WTR
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12:

FixHeap(i^ node)

13: FixHeap (node)
14:

IF (node has a parent)

15:

I F (parent(WT)

> node(WT))

16:

Swap the parent with node

17:

FixHeap(node)

18:

IF (node has leftchild or rightchild)

19:

I F (node(jyT) > leftchild(WT)

or node(W/T) >

rightchild(WT))

20:

Swap node with the c/w/d with that smallest WT

21:

FixHeap(node)
To understand the relationship between steps 6 and 8 of the NWT algorithm,

we will follow the maintenance of the heap with an example tree. In Figure 2.4, we
provide a tree with twelve reactions (A, B, C, D, E, F, G, H, I, J, K. and L). The
Waiting Times for each reaction are also provided (.1, .3, .4, .6, .7, .8, .9, and oc)
in the heap. We see the tree is indeed a min-heap. The reaction with the smallest
Waiting Time is reaction E (WTE = 0.1).

.1
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J:

H .9
/

B .6
\

/

c co D C O K .7

G CO
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A oo
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-f
CO

Figure 2.4 Heap example.
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There are a few important assumptions we must state for the example problem.
First, we assume the algorithm has just executed reaction E. In other words, reaction
E was selected in step 3, and the multiplicities of the reactants and products of
reaction E have been updated to accomodate the execution of the rule (step 5). But,
we have not yet recalculated the Waiting Time for reaction E. So, in our discussion of
the example, we will assume that we are starting from step 6 of the algorithm, which
begins at line 1 of the above pseudocode after a call to the UpdateRules method. We
have also marked in Figure 2.4 all of the nodes requiring a recalculation of Waiting
Time after the multiplicity changes have occured as a result of the execution of
reaction E. These affected rules are all marked in gray.
Besides recalculating the Waiting Time for the applied reaction E, we assume
that the multiplicity changes brought on by the execution of reaction E will affect
the Waiting Times of reactions J and I. Finally, we notice that before any Waiting
Time is recalculated, the tree satisfies the min-heap. This is an important property
for understanding the implementation of steps 6 and 8. It ensures that after each
Waiting Time recalculation, the min-heap property is fully satisftied, before moving
on to the next recalculation.
In this particular example, there is no tie for minimum Waiting Time. Hence, the
first FOR loop, line 2, runs only a single iteration. The Waiting Time of reaction
E is recalculated and the result is shown in Figure 2.5. We see that reaction E now
has a Waiting Time of oo. From this, we know that one of its reactant species was
completely exhausted by the execution of reaction E. Also, we see that the tree is
now in violation of the min-heap property. The FixHeap method is called.
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Figure 2.5 Recalculation of the Waiting Time for reaction E.

The FixHeap method is called on the node representing reaction E. Figure 2.6
illustrates the steps required to adjust the tree. First, the node (reaction E) checks
for a parent, line 14. It has none, so lines 15-17 are ignored. However, reaction E does
have a left child and a right child (line 18). Furthermore, we see that the Waiting
Times for the two children (reactions F and J) are both smaller than the Waiting
Time for reaction E, satisfying the IF statement on line 19. Then, according to line
20, we must swap reaction E with the child with the smallest Waiting Time (reaction
F). We see the change in Figure 2.6(i). After swapping the two nodes, we call the
FixHeap method again, passing reaction E (in its new position) as the parameter.
Continuing with Figure 2.6(i), we consider the FixHeap method on reaction E.
The reaction now has a parent (reaction F), satisfying line 14. However, the IF
statement on line 15 fails, since the Waiting Time of reaction E is greater than the
Waiting Time of reaction F. Once again, the left and right children of reaction E
both have smaller Waiting Times, so we swap reaction E with the smaller of the two
(reaction B). We see the result of this transition in Figure 2.6(h). With line 21, we
make another call to the FixHeap method with reaction E.
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Figure 2.6 Reheaping the applied reaction.
OB the next call to the FixHeap method, we see reaction E will move down one
more level. Reaction E is compared to reaction K and reaction A. The Waiting Time
of reaction E is larger than the Waiting Time of reaction K but not larger than the
Waiting Time of reaction A. Regardless, the IF statement on line 19 is satisfied, and
reaction E is swapped with reaction K according to line 20. A final call to the FixHeap
method is made on reaction E. However, with the final call, lines 15 and 19 cannot be
satisfied. Hence, the method terminates. We see in Figure 2.6(iii) that the min-heap
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property is satisfied for every node in the tree. However, we need to continue the
method UpdateRules, since we still must cope with the affected rules (reaction 1 and
reaction J).
Now that reaction E has been recalculated and we have a min-heap, we can continue the pseudocode at line 5. For lines 5-12, the NWT algorithm is able to recalculate each rule affected by the applied rule, and update the heap to accomodate
the changes made to the Waiting Times of the affected rules (I and J). Without loss
of generality, we can assume that reaction I is recalculated before reaction J. After
explaining the heap maintenance for reactions I and J, we will provide an explanation
on the irrelevance of choosing I before J. For now, we continue by assuming that the
recalculation of the Waiting Time for reaction I is smaller than the previous value.
Hence, the WT is changed and the heap now violates the min-heap property at node
I. We see the the violation of the min-heap property in Figure 2.7.
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Figure 2.7 Recalculating the Waiting Time for reaction I.

After the Waiting Time for reaction I is recalculated (line 11), we call the FixHeap
method for node I (line 12). We see reaction I has a parent, and its parent node (reaction G) has a Waiting Time greater than the Waiting Time of reaction I. Therefore,
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the two nodes are swapped (line 16). The FixHeap method is called on reaction I
(line 17) from its new position (see Figure 2.8(i)). With this call to FixHeap, we have
yet to complete lines 18-21 in the original FixHeap call. For this first call to FixHeap,
this will result in no changes, since everything below reaction I (in its new position)
satisfies the min-heap property.
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Figure 2.8 Reheaping reaction I.
It is clear from Figure 2.8(i) that reaction I will need to move up one more position,
switching places with reaction J. Once this happens, the min-heap property is satisfied
and all of the calls to FixHeap will result in no additional changes before terminating.
We note that in Figure 2.8(h), we indeed have a min-heap. Now we have just one
final reaction to handle (reaction J). We recalculate the Waiting Time of reaction J
and find that it is now smaller than the previous value (see Figure 2.9(i)).
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Figure 2.9 Reheaping reaction J.
Following the pseudocode, we see that reaction J will be compared to its parent
node, reaction I. Since the Waiting Time of reaction J is lower than the Waiting Time
of reaction I, the two nodes are swapped (Figure 2.9(h)) and FixHeap is called on
reaction J (in its new position). Additionally, the Waiting Time of reaction J is lower
than the Waiting Time of reaction F. The two nodes are swapped and the result is
a tree that fully satisfies the min-heap property (Figure 2.9(iii)). This concludes the
example problem. Each node was recalculated and adjusted before the algorithm
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continues on to the next affected reaction.
Now, we must comment on the irrelevance of checking reaction I before reaction
J. The way we have implemented steps 6 and 8 allows us to ignore the order to check
the affected reactions. Prior to each Waiting Time calculation, the tree satisfies the
min-heap structure. Consider the recalculation of a reaction's Waiting Time. One of
three things can happen: (a) Waiting Time increase (to infinity), (b) Waiting Time
decrease, or (c) Waiting Time does not change. In the case of (c), the reaction will
fail for lines 15 and 19. In other words, if there are no changes to the Waiting Time,
then there need be no changes to the heap. For (a), the reaction may need to move
down in the tree, but it will certainly not move up. Therefore, only lines 18-21 are
required for (a). Finally, if the Waiting Time decreases, then only lines 14-17 are
relevant - i . e . , the smaller Waiting Time may cause the reaction to move up the tree.
Regardless, once the FixHeap method has been called (along with subsequent
recursive calls) on a node satisfying one of the three properties above (a) through (c).
the tree will satisfy the min-heap property. We do this for each reaction affected by
the execution of the reaction with the minimal Waiting Time (step 3), and we see
our algorithm efficiently sorts the reactions.
The implementation of our heap yielded a massive performance increase over the
previous algorithm from [17]. While incorporating the heap structure we not only
increased the sorting performance, we were able to eliminate an extraneous FOR loop
(running for every reaction in the tree) used to put Waiting Times in the context of
simulation times. Our previous simulator had a runtime of 0(n2 logn). To be able to
give the complexity of the algorithm proposed and show that it is indeed efficient, we
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need to make several assumptions which are (usually) valid for the signaling cascades:
1. each reaction involves at most 5 different species of molecules;
2. there are a bounded number of reactions having the same reactant (usually 3,
at most 5);
3. there are not many reactions happening at the same time (due to the differences
in molecule multiplicities and reaction rates).
From 1, 2 and 3 we can now state that our new algorithm has a runtime of 0(n log n)
with respect to the number of reactions simulated.
This concludes our discussion of steps 6 and 8. We skipped step 7, but we will
now explain it in Section 2.4. Technically, steps 6, 7 and 8 all happen at the same
time. We see the interplay with steps 6 and 8 above, and step 7 merely factors into
the recalculations of the Waiting Times (lines 3, 7, and 11 of the above pseudocode).

2.4 M e m o r y E n h a n c e m e n t
There are often situations in biochemical networks, where one (or more) protein(s)
(pi E £ ) is a reactant for two or more reactions of different kinetic rates (fast vs. slow).
In order to explain our memory

enhancement,

we will consider an example system

involving only three reactions (Ri, R2 and R^) acting on four proteins (A, B, C, and
D). The model is described in Table 2.2.
When described as a system of ordinary differential equations, the biochemical
network is given in Equation 2.8.
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Table 2.2 An example system to illustrate memory enhancement.

Reaction
i? i :
A^C
R2: A^ B
R3: D -^ D + A

Rate Constant
hi (slow)
k2 (fast)

d[A]

h

— - Mk^-UA
I^IJ
dt
d[B]
= k2 * [A]
dt
d[C]
=
Jfei * [A]
dt
d[D]

dt

- n

Initial Molecules
A= 1
B =0
C = 0
D =• 1

+ UD]

(2.8)

We specifically designed the system above to highlight the effects of the memory
enhancement, and we will compare our refined algorithm with solutions to the system
of ordinary differential equations described in Equation 2.8. A model similar to this
one could be used to investigate the dynamics of human immunodeficiencey type 1
(HIV-1) Tat protein, since it is initially transcribed at very low numbers [57]. Once
Tat is assembled in the cytosol, it can be exocytised or translocated to the nucleus
[109]. When Tat is translocated to the nucleus it can begin upregulating HIV-1
proteins (including itself). Since the downstream effects of Tat translocation to the
nucleus has profound impacts on the cell (causing upregulation of the HIV-1 proteins),
a discrete and nondeterministic approach is necessary to follow the dynamics of the
low levels of Tat proteins [124].
In the system, molecules of A are formed from molecules of D. This reaction can
basically be viewed as a combined transcription and translation rule with D being the
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gene and A being the protein encoded by the gene. Once a molecule of A is formed,
it has the option doing one of two things: (i) turning into a molecule of B at rate k2
or (ii) turning into a molecule of C at a rate hi. If we consider the species A as being
analogous to HIV-1 Tat protein, then A —> B could be translocation to the nucleus
and A —> C could be translocation to the extracellular environment.
Next, we will look at two cases for the model described in Table 2.2 and discuss
the memory enhancement. The cases vary by choices of the kinetic rates. The first
case shows that the memory enhancement can produce the same results as the deterministic differential equations approach. For the second case, we will show how
the technique can produce different results, illustrating that the ability of the NVv'T
algorithm to explore nondeterminism of molecular signaling cascades. There are no
modifications to the N W T algorithm between the two cases. The only difference is
the kinetic constants for initialization of the model.

2.5

Case 1: Deterministic M e m o r y
Enhancement

For the first case, we let k\ = 10, k2 — 4, and fc3 = 5. The results of a simulation
using the NWT algorithm plotted against the solution of the system of ordinary
differential equations is shown in Figure 2.10. The graph shows the accumulation
of C molecules throughout a 10 second run. The bars of the graph are the discrete
simulation results using the N W T algorithm, and the black line is the solution to the
system of ordinary differential equations. With the choices of the kinetic values, there
are no nondeterministic decisions for the entire length of the NWT simulation. So,
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there is no surprise that the N W T algorithm shows the same increase in C molecules
as the solution to the system of ordinary differential equations.
At initialization (t = 0), there is exactly one molecule of D and one molecule of A.
Therefore, from Equation 2.3, we see t h a t all three reactions have real (finite) waiting
times when the simulation begins. Furthermore, we have WTR, = 0.25, WTR/2 = 0.1
and WTR.3 = 0.2. Using these WTs, we are able to build a min-heap where the top
node is R2, since it has the smallest Waiting Time.
The first reaction to occur is R2, which immediately exhausts the system's supply
of A molecules, yields one molecule of B and a simulation time of t = 0.1. The
rules affected by the applied rule must be recalculated; the Waiting Times are now
WTRl

= WTR2

== 00. Since R3 does not require a molecule of A, WTRs

is left-

unchanged after the first reaction is executed. Also, upon readjusting the min-heap),
R3 is now at the top since it has the smallest value for WT.
The next reaction to be applied is i? 3 , which gives us a new molecule of A and
a simulation time of t = 0.2. This is where the memory enhancement plays a role.
In the first step, reaction R2 used up all of the molecules of A. However, when this
happened, Ri had already waited for 0.1 seconds - the amount of time a molecule of
A. was in the system. The memory enhancement allows the simulator to keep track
of the percentage of time waited. In other words, Ri waited for 0.1 seconds out of
its required 0.25 seconds, which means it has waited 40% of its Waiting Time. If we
allow the algorithm to keep track of this percentage, then, when a new molecule of A
is formed, we can recalculate the WT for reaction Ri, using the percentage to adjust
its Waiting Time accordingly. That is, after R3 is applied in step two and we have a
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new molecule of A, we recalculate WTRl using Equation 2.3, but we take 60% of this
number - the percentage of time left to wait.
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Figure 2.10 The number of C molecules for a simulation of t = 10. The NWT
algorithm results are represented with bars while the solution to
the system of ordinary differential equations is the solid line.

To recap, the first reaction applied is R2. The Waiting Times for reaction R2 and
Ri are both recalculated as infinity, since R2 used all the molecules of A present in
the system. The memory enhancement allows Ri to store the percentage of time it
has left to wait (60%) when A is exhausted. Next, R3 is the second reaction to be
applied. When this occurs, there is a new molecule of A in the system, which means
R2 and R\ need to be recalculated. The Waiting Time of R2 is calculated as 0.1, but
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the Waiting Time of R\ is recalculated as 0.15. This number stems from the equation

WT

- = Memk^x\

(29)

where Mem is the percentage of time left to wait (60% in the example above). We
will reiterate the memory enhancement calculations in the second case study with
different kinetics.
In this case, the solutions to the system of ordinary differential equations and the
results from the N W T algorithm agree. In the next case, we will explain how the
nondeterminism of the N W T algorithm can lead to results different than continuous,
deterministic solutions to system of ordinary differential equations.

2.6 Case 2: N o n d e t e r m i n i s t i c M e m o r y
Enhancement
We will now modify the kinetic constants to highlight the effects of the nondeterministic component of the N W T algorithm in conjunction with the memory
enhancement. Although the kinetics of our sample system have been deliberatly chosen to highlight the nondeterministic effects, we will later show, in Chapter 3, how
our nondeterministic logic can have similar implications in a known model, comparable to the Gillespie Algorithm - deviating from deterministic simulations - but at a
considerably reduced computational cost.
For our next simulations, we assume k\ = 0.1, k2 — 1.0, and k% = 0.5. The initial
Waiting Times are initialized as WTRl

— 10, WTR2 = 1, and WTRs = 2. In Figure

2.11, we see the accumulation of B and C molecules. The results of the ODE-based
simulation are visibly different than the results of the N W T algorithm. The reasons
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for the differences are the nondeterministic decisions on reaction competition for A
molecules.

500

(a)

400

(b)

600

Time

Figure 2.11 Results of the memory enhancement simulation for the ordinary
differential equations and the NWT algorithm, (a) molecules of B
and (b) molecules of C.

In both graphs we see the results of the solution to the system of ordinary differential equations (straight black line) shown with many runs with the NWT algorithm.
In the two graphs, we have (a) the number of molecules of B and (b) the number of
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molecules of C are shown. Molecules of B and C both come from A molecules. However, the reaction for B is faster than the reaction for C. In the solution to the system
of ordinary differential equations, a molecule of A can be used to partially satisfy B
and C. Since our NWT algorithm is discrete, the molecules are nondeterministically
chosen to satisfy one or the other - similar to cellular processes. The reaction changing A into C 'remembers' how long it has waited, and uses this information the next
time a molecule of A is ready.
Based on the initialized Waiting Times, the first reaction to be applied is R2.
After i?2 is applied, the simulation time is aggregated (t = 1) and there are no
more molecules of A present in the system. Similar to the previous case study, the
Waiting Times for R2 and R± are both set to infinity (no reactant molecules available).
However, we store the percentage of time waited (Mem)
in this case, Mem^

for the slow reaction JRI -

= 90%. Since R% is unaffected by the execution of the first

reaction, it now has the minimum waiting time. The next rule to be applied is i? 3 .
The simulation time is adjusted (t = 2), and we now have a new molecule of A. With
our new A molecule available, we must recalculate the Waiting Times for Rt and R2.
Using the Mem^,

we can recalculate the Waiting Time for reaction Rj and use

the fact that it has already waited 10% of its Waiting Time. Therefore, when a new
molecule of A is formed two seconds into the run, we recalculate the WT^

using

Equation 2.9. In our case, we have WTR^ = 9 and WTRi = 1.
In a strictly deterministic sense, our algorithm is capable of generating equivalent
results to an ordinary differential equations model (see case 1 above).

But, with

the nondeterminism of our algorithm, the memory enhancement can lead to different
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results. Continuing the calculations for the simulation, we skip ahead to a future
event (t = 18). Up until this point, we have been creating molecules of A, and every
single one of them has been deterministically chosen to change into molecule B via
reaction R2. But, at t = 18, a molecule of A has been created, and the Waiting Times
of reaction Ri and R2 are equal WTRl
have MemRi

= WTR2 = 1. The reason for this is that we

= 10%. In other words, Ri and R2 are competing to use the same

single molecule of A to form a C and B molecule, resp. The solution to the sj^stem
of ordinary differential equations has no issue at this timepoint, because, whereas our
simulator represents molecules of A discretely and has only allowed reaction R2 to
occur so far, the differential equations simulation is sending a fraction of each A to
form a fraction of B and C. This is merely a consequence to the way solutions to
systems ordinary systems of differential equations behave.
Our algorithm faces the question: a,t t — 18 should the A molecule be allowed to
satisfy R\ or R2? The algorithm answers the question by making a nondeterministic
choice between R\ and R2 (step 3 of the N W T algorithm). If Rx is chosen, then it
is applied, and our results stay with the ordinary differential equations results (up
to t = 19). Remember, the ordinary differential equations have been slowly and
continuously aggregating the C molecules throughout to reach one full molecule of C
at time t = 19. However, if R2 is chosen, then our solution diverges from the previous
solution. When the effects of the nondeterministic decisions are aggregated over 1000
seconds, we see the different results obtained from the NWT algorithm (Figure 2.11).
With this example system, we show how reaction memory can affect results. The
memory enhancement is designed to give the NWT algorithm results more like solu-
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tions to ordinary differential equations in a strictly deterministic sense. However, as
a consequence to the reaction memory, we have possible divergence in situations of
very low molecular multiplicity, due to the nondeterministic component of the NWT
algorithm.

2.7

Summary

In Chapter 2, we have provided all of the information necessary to understand and
implement the Nondeterministic Waiting Time algorithm. We introduced Membrane
Systems along with a discussion on why this particular paradigm is useful to apply
to modeling biochemical reaction networks. We provided pseudocode for the NWT
algorithm, and the interested reader can look at the Appendices (B and C) for our C
encoding. We also offered an explanation on the specific improvements over previous
work from the modeling group of the advisor for this dissertation, Dr. Andrei Paun.
For the rest of this dissertation, we will be exploring models reported in the literature. Then, in Chapter 5, we provide the framework for a new model, investigating the
effects of the human immunodeficiency virus on T cells. But first, in Chapter 3 will
explore two popular models, to emphasize the N W T algorithm's unique perspective
on biochemical network simulation.

CHAPTER 3
EXPLORING SOME COMMON MODELS
In Chapter 2, we provided the pseudocode for the NWT algorithm, as well as an
in-depth look at its implementation, some results of example systems, and a discussion
on efficiency. Now we will use the N W T algorithm to explore some popular models in
computational and systems biology. We will compare the results obtained from the
NWT algorithm with results obtained from systems of ordinary differential equations
and the Gillespie Algorithm. The primary goal of Chapter 3 is to illustrate the ability
of the NWT algorithm to utilize deterministic and nondeterministic decision-making
to produce results similar to ordinary differential equations for some models and
results similar to the Gillespie Algorithm for other systems.

3.1 Lotka-Volterra P r e d a t o r - P r e y M o d e l
The Lotka-Volterra predator-prey model depicts the interactions of two species.
It was developed independently by both individuals [94]. We will briefly discuss
the motivation behind the model. First, we assume a prey population, P\(t),

and

predator population, i ^ W , which represents the number of each species at time t.
We can think of these two populations as lion and zebra, shark and fish food (the
particular study of interest to Volterra), etc. In order to model population dynamics,
we need to associate to each species a reproductive rate (rPl and rP2).
55
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We assume that without any predators, the prey population will follow the Malthusian model [94]. However, predators will negatively affect the reproduction rate.
Hence, we have rPl = a — b * P2. We also assume that without any prey, the predator will follow the Malthusian model (but with a negative reproductive rate). Furthermore, the prey will increase the production rate of the predators. So, we have
rP2 = -c + d* P^.
Now we can formalize the predator-prey model as a pair of first-order, nonlinear,
differential equations
^2
at
HP
?-l

=

P^(a-b*P2)

= -P2*(c-d*P1)

(3.1)

at
In Figure 3.1, we see a picture of the predator-prey model. The picture (as well
as the SBML code for the model) was generated using CellDesigner [32, 33:. T h e
Lotka-Volterra model involves two interacting species. Prey species are born at a
rate a and are consumed at a rate b by the predator species. The predator species are
born at a rate of d if there is available food (prey). The way the system is designed,
an increase in prey leads to an increase in predator, and an increase in predator leads
to a decrease in prey. Total annihilation of prey leads to total extinction of predator,
since the food supply of the predator will be exhausted.
We used three different simulation techniques to model the reactions described in
the Lotka-Volterra model: a system of ordinary differential equations (Equation 3.1),
the Gillespie Algorithm, and our NWT algorithm. The system of ordinary differential
equations was solved in MATLAB, while the other two algorithms were both coded
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in C. Below we see the results of the three simulations in Figure 3.2 for one hundred
seconds.

d

Figure 3.1 The Lotka-Volterra model.

The solution to the ordinary differential equations in Equation 3.1 shows consistent oscillations throughout the entire simulation run. The N W T shows dampened
oscillations over time. The Gillespie Algorithm has difficulties producing the oscillations, due to the stochasticity of the algorithm. In this case, our N W T algorithm
runs deterministically. The system is small enough and the dynamics are such that
the N W T makes no nondeterministic decisions due to reaction competition. If we
expand the results of the solution to system of ordinary differential equations and the
N W T algorithm, we see further decline in the amplitude for the N W T algorithm. In
Figure 3.3, we expand the simulation run for a total of five hundred seconds. The
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results for the solution to the system of ordinary differential equations and the NWT
algorithm simulation are provided.

Loika-volterra (ODE)

(a)

Lotka-Voherra (NWT)

Time

Time

(b)

Lolka-Volterra (Gillespie)
•Prey
-Pred

80

(c)

100

Time

Figure 3.2 Results of three simulation techniques for the Lotka-Volterra model
(up to 100 seconds), (a) solution to ordinary differential equations,
(b) the N W T algorithm, and (c) the Gillespie Algorithm.

We modeled this classic system to illustrate the differences in the results of our
simulation technique compared to the solution of the system of ordinary differential
equations, the NWT algorithm, and the Gillespie Algorithm simulations. Our system
was able to exhibit oscillatory behavior, albeit the oscillations are damped. However,
as you can see in Figure 3.3, the oscillations persist with the N W T algorithm (and
the ordinary differential equations). Yet, the Gillespie Algorithm will always reach
a steady state, whereby the predator and prey species will eventually completely
disappear. Since there are no nondeterministic decisions made during the run, we
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can only attribute the dampened oscillations to the fact that the system is discrete.
We will next discuss a circadian rhythm model, which will illustrate how our algorithm
can produce Gillespie-like results, even though we have a reduced complexity.
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Figure 3.3 Results of the two simulation techniques for the Lotka-Volterra
model (up to 500 seconds), (a) solution to ordinary differential
equations and (b) the NWT algorithm.
3.2 Circadian Rhythm
Circadian rhythm models are often explored in nature. These act as internal
clocks which allow organisms to anticipate daily changes in the environment [6] for instance, when to hunt for food, when to rest, etc. Yet, at the level of cellular
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biochemistry, circadian rhythms have also been reported [25]. Biological systems run
by internal clocks - that is, certain proteins are created at certain parts of the day.
Therefore, simulating circadian rhythm models is important in understanding the
way DNA is interpreted and pre-existing proteins waiting to be activated are used by
the body for daily survival [6].
We have chosen to model the circadian rhythm model described in [118]. The
system descibes an activator and a repressor gene (A and R). These genes are transcribed into mRNA, which leads into the translation of the proteins. The activator A
binds to the promoters for A and R and increases the transcription rate. The system
of ordinary differential equations described in [118] showed that intrinsic biochemical noise enhanced the oscillations. In Equation 3.2, we see the system of ordinary
differential equations for the model.
dDA
dt

=

9A * D'AA — 7/i * DA * A

"" •

dDR
dt
dD\A
dt
dD'R
dt

=

9R * D'R - -yR * DR * A

-=
-

-

J?A

= CLA * D'A + aA* DA - 5Ma * MA

-=

*D' *A-6A*D'
±s/

- "RlA
*s±-uAR*

A

7R*DR*A-6R*D'R

dA
—dt = pA*MA+9A*D'A+9R*D'R-A*('yA*DA+'YR*DR
dMR
,
,
—— = aR * DR + OR * DR - 6MR * MR
at
dR
— = PR * MR — 'yc*A*R
+ 5A*C — 5R*R
dt
—

= 'yc*A*R-8A*C

+ 'yc*R + i)A)

(3.2)
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where A and R represent the number of activator and repressor proteins, D'A and DA
represent the number of activator genes with or without binding to A, D'R and DR
represent the number of repressor genes with or without binding to R, MA and MR
represent mRNA molecules of A and R, and C represent the corresponding inactivated
complex formed by A and R.

Figure 3.4 Picture of the circadian rhythm model.

Deterministic modeling techinques, like the solution to the systems of ordinary
differential equations, for biochemical interactions fail to produce the oscillations
of a circadian rhythm model. However, the stochastic noise from a Gillespie-based
approach leads to repeated oscillations throughout an entire run. Our NWT algorithm
can produce results similar to the Gillespie algorithm - genetic oscillations - but at
a considerably reduced computational cost.
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The results for the simulation of the circadian rhythm model are shown in Figure
3.5. We present the results from Gillespie's Algorithm, the solution of the system of
ordinary differential equations (Equation 3.2), and our NWT algorithm. The N W T
algorithm is able to reproduce the oscillations for the perturbed model, as is the
case with the Gillespie approach [118]. Similar to Gillespie, the NWT shows some
variability in both the amplitude - numbers of molecules - and the periodicity of
oscillations.
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Figure 3.5 The results for the circadian rhythm model: (a) the NWT algorithm and (b) the Gillespie Algorithm. Both algorithms are plotted
against the solution to the system of ordinary differential equations.
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The authors in [118] showed that parameter values can have a profound impact
on oscillations. By reduction of the kinetic rate governing R degradation, the deterministic results produce a single peak followed by a steady state, while a stochastic
simulation remains oscillating. Our NWT algorithm also produces oscillations instead
of a steady state, but at a reduced computational cost from the Gillespie Algorithm
approach. This is the benefit of modeling with the NWT algorithm instead of the
Gillespie Algorithm.
For our simulation to produce oscillations comparable to the Gillespie Algorithm,
we require only 50 random numbers to be generated. This stems from the fact that
the NWT algorithm relies on deterministic kinetics for the majority of reactions, but
when reactants are limited and competition for reactants exists, nondetermimstic
decisions drive a variable reponse from the competing reactions.

3.3 Summary
In Chaper 3, we have provided two popular models. The models were used to
illustrate how our technique compares to the Gillespie Algorithm in situations of
low molecular multiplicity. For the circadian rhythm model, we were able to show
oscillations where the ordinary differential equations failed to do so. In modeling
the Lotka-Volterra model, we showed (dampened) oscillations where the Gillespie
Algorithm failed (see Figures 3.2 and 3.3). This aligns with our claim in Chapter 2
that the NWT algorithm lies between the Gillespie Algorithm and solutions to systems
of ordinary differential equations. In the Chapter 4, we will apply our algorithm to a
model for Fas-mediated apoptosis.

CHAPTER 4
MODELING FAS-INDUCED
APOPTOSIS
The term apoptosis was coined in the classic work of Kerr, Wyllie and Currie [58].
Within that paper, the authors described apoptosis as a form of cell death distinct
from necrosis, citing a lack of inflammation of the tissue among other differences.
Apoptosis is often used synonomously with -programmed cell death, emphasizing a
cell's inherent genetic predisposition for death. In other words, the cell's genome
contains the instructions for the cell's self-destruction. However, we note that there
are other accepted forms of programmed cell death described in the literature [24,
31, 112]. These types of cell death - for example, aponecrosis - are characterized as
sharing some of the characteristics of necrosis and/or apoptosis. Essentially, apoptosis
is a clean and effective method for the elimination of unwanted or damaged cells within
the organism. It is sometimes called cellular suicide; the cell receives a message to die
and, based on its biochemical composition at the time the death message is received,
the cell 'decides' whether to live or die. Furthermore, there are additional situations
where apoptosis is not a programmed cell death, such as the case with some cancers
and other disorders [42, 72, 82, 84].
Thus, cellular apoptosis is an important process in biological systems. Through64
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out the entire lifespan of an organism, death by apoptosis is essential for maintaining
cellular homeostasis. Indeed, in [103], the authors estimate that a typical human
being will produce ten billion cells daily from stem cells to replace the ones dying
from apoptosis. There are some especially vital roles for apoptosis in early embryonic
development. For example, a developing human initially overproduces the cells of the
nervous and immune systems; however, those cells lacking synaptic connections (neurons) or functional antibodies (B cells and T cells) are subject to death via apoptosis
(reviewed in [84] and [98], respectively). Aside from a critical early developmental
role, apoptosis has also been related to aging effects.

For instance, one theory on

aging, involving the oxidative stresses on the mitochondria induced by harmful free
radicals, illustrates age-related apoptotic cell death [45, 99].
Under the microscope, apoptosis manifests through a series of physiological changes.
The cell shrinks and condenses, while the cytoskeleton collapses and the nuclear envelop disassembles. Pyknosis (the condensation of the chromatin) occurs, which is
followed by cell surface blebbing, leading to the formation of apoptotic bodies containing all the intracellular material. These self-contained, apoptotic bodies can then
be phagocytised by macrophages, parenchymal cells, or neoplastic cells. In this way,
organelle integrity is maintained - keeping the potentially harmful biochemical elements, which the cell is harboring, from leaking into the extracellular environment
and negatively affecting healthy bystander cells, causing inflammation, etc. Hence,
the organism is able to recycle the materials from the now defunct cell for future
generations of cells. In contrast, oncosis, the process through which a cell undergoes necrotic cell death, is characterized by karyolysis and cell swelling. Necrotic cell
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death leads to an explostion of intracellular matter into the extracellular environment.
Hence, necrotic cell death can lead to negative effects, like inflammation.
The idea that apoptosis is "programmed" into a cell yields the possibility, by
analogy, t h a t we may have the means to reprogram a cell to live or die as needed. In
other words, if a cell has cancer, then we can reprogram it to die. If a cell has a virus
- e.g., the human immunodeficiency virus or the human papillomavirus - then we can
reprogram it to die. In contrast, we may reprogram cells in very close proximity to
HIV-infected cells - the so-called bystander cells - to live. These examples may be
over-simplified, but they illustrate the importance of understanding genetic manipulation on an in silico effort. If you change one gene, you need to be able to predict
the consequences of that change. That is at the heart of computational biology. However, we are not ready to begin manipulating genes involved in apoptosis, because the
signaling cascades are too complex. There are too many interacting elements with
multiple responsibilities. The only way to gain a deep understanding of the molecular
interactions involved in apoptotic signaling is through the development of extensive
computer models.

4.1 A p o p t o t i c Signaling Cascades
The study of apoptotic signaling cascades is especially interesting to the fields
of biology and medicine since defects in these pathways have been linked to various
autoimmune disorders [72], neurological disorders [84], and cancers [42, 82]. Indeed,
a recent study [130] implciates Fas-mediated apoptosis in patients with spinal cord
injury. Therefore, understanding the molecular mechanisms underlying the apoptosis
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pathways can offer new therapeutic approaches to combating a wide range of dieases
and disorders.
There are two signaling pathways for apoptosis described in the literature: the
extrinsic and the intrinsic (or mitochondrial) pathway. The physiological response
induced by each pathway is the same - DNA fragmentation, degradation of cytoskeletal and nuclear proteins, formation of apoptotic bodies, etc. However, albeit the two
pathways have distinct beginnings, the molecular mechanisms in the final steps of the
signaling cascades are the same. The two pathways converge with particular members
of a family of cysteinyl-aspartate-specific proteases, caspases, which are produced
as zymogens - i.e., they require a biochemical change to become active [69].
The intrinsic apoptotic pathway is initiated in response to some type of intracellular event - e.g., DNA damage from radiation. Typically, this pathway leads to the
induction of the p53 pathway - a DNA repair pathway. If the DNA cannot be sufficiently repaired, a signaling cascade involving p53 leads to reduced mitochondrial
permeability, formation of the apoptosome complex, and activation of the effector
caspases.

The activation of the effector caspases - for example, Caspase 3 - are

important for the morphological changes associated with apoptosis [95].
For the extrinsic pathway, cells can receive apoptotic signaling via autocrinic and
paracrinic messaging. That is, the cell can receive a death signal from a neighboring
cell, or it can send itself a death signal.

These death signals come in the form

of apoptotic stimuli which bind to transmembrane receptors - the so-called death
receptors - on the cell surface. The known ligand/receptor combinations are TNFa / T N F R l , FasL/FasR, Apo3L/DR3, Apo2L/DR4, Apo2/DR5 [26]. Depending on
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the biochemical composition of the cell, these death-inducing stimuli can lead to a
proteolytic cascade, whereby the inactive proenzyme caspase are activated and cell
death can occur. . For instance, Cytotoxic T lymphocytes can send death-inducing
ligands (specifically, the Fas ligand) to cells as a method for fighting disease or viral
infection. This is the main method through which the body fits disease.
For the rest of this Chapter, we concern ourselves with the molecular mechanisms
underlying the Fas-mediated apoptotic signaling cascade - extrinsic and intrinsic
pathways.

4.2 Fas-mediated Apoptosis
In the past decade, there has been a wealth of information discovered on the
Fas-mediated apoptotic pathway. For instance, in [56] they were able to show that
Fas/FasL interactions are required for apoptosis of activated T-cells.
One of the troublesome characteristics of some cancerous cells is the upregulation
of Fas ligand. This so-called counterattack, is a method the tumor cells can use
to delete (by apoptosis) antitumor lymphocytes [96]. There are a variety of tumor
types - e.g., colon cancer, esophageal cancer, melanoma, astrocytoma - showing high
expression levels of Fas ligand [97].
In order to test the effectiveness of our technique, we decided to simulate the Fasmediated signaling cascade, as it was reported in [47]. A graphical representation of
the model can be found in Figure 4.1. The rules are found in Appendix D. Next, we
will walk you through the Fas-induced apoptotic signaling cascade. The Fas pathway
is most accurately described as two different pathways [107] - type I and type II -
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sharing an initial phase and an ending phase but unique in the molecular mechanisms
in between.

Type I Pathway

(_Casp8pj"

( Casp3pJ
__JProcasp3
f Apoptosis j
\
Type II Pathway

\

/
Casp9 \-^*

( Apaf .)
( ProcaspS \ Cyto.c* )
( ATP )

Cell Membrane

Figure 4.1 Picture of the Fas-mediated apoptotic signaling cascade. Both the
type I and type II pathways are illustrated.

Both the type I and type II pathways begin the same way: the Fas ligand (FasL)
binds to a transmembrane receptor, Fas (CD95/APO-1). This receptor is a member
of the tumor necrosis factor-receptor super family - a family consisting of over 30
proteins interacting with 19 different ligands. It is expressed on a variety of cells
including activated T and B cells. The binding of ligand to receptor is known as
receptor cross-linking. When this cross-linking occurs, a conformational change takes
place in the receptor producing the complex Fasc. The crosslinking between ligand and receptor, along with recruitment of Fas-associated death domain, form the
components of the Death-Inducing Signaling Complex (DISC) [62]. The cytoplasmic
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domain of this complex recruits Fas-associated death domain (FADD), with a maximum of three FADD per binding site (trimer). While FADD is bound to the complex
Fasc, Caspase-8 and FLIP are recruited competitively. Once at least two molecules of
Caspase-8 have been recruited to a binding site, a dimer, Caspas-8^ 41 , is released into
the cytoplasm, where it can then be phosphorylated into active form (Caspase-8*).
The binding of FLIP to the Fasc complex is considered to be an inhibitor of apoptosis,
because it decreases the number of sites available for Caspase-8 recruitment.
Unless sufficiently inhibited, the signaling cascade can continue in two different
ways - the type I or type II pathway. If the initial concentration of Caspase-8 is
large enough, Caspase-3 will be directly phosphorylated by the Caspase-8* (the type
I pathway). Otherwise, Caspase-8* can truncate molecules of Bid (tBid). Each tBid
molecule binds with two Bax molecules, which leads to the release of Cytochrome
c from the mitochondria (type II pathway). Once released, Cytochrome c binds to
Apaf and ATP, forming a complex that can recruit and phosphorylate Caspase-9
(Caspase-9*). The active Caspase-9* molecules can continue the cascade by direct
phosphorylation of Caspase-3. We consider the activation of Caspase-3 to be the end
of the signaling cascade. Hence, from our perspective, the cell is dead once all of the
Caspase-3 molecules are activated.
Besides FLIP, there are other inhibiting factors at play: Bel-2 hinders the release
of Cytochrome c from the mitochondria and XIAP blocks Caspase-9* from binding
with Caspase-3. In other words, if sufficient levels of FLIP, Bcl-2, and/or XIAP exist,
the apoptotic pathway can be blocked, and the cell lives.
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4.3 R e s u l t s of Discrete M e t h o d
We modeled the pathway described above using 101 different rules working on 53
distinct proteins and protein complexes. Fei Hua et al., in [47], provided the results
for the system of ordinary differential equations, as well as some experimental data
(from the Jurkat cell line) which they used to fit their model. We compared our results
with the results from [47], simulating the same 101 rules and same initial conditions
as the system of ordinary differential equations.
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Figure 4.2 The decline of full length Caspase-3 for different concentrations of
Bcl-2: (i) baseline, (ii) 10-fold increase, and (iii) 100-fold increase,
(a) The results of the solution to the system of ordinary differential
equations and (b) the results of the NWT algorithm.

Similar to [47], we simulated three different initial concentrations for Bcl-2: the
baseline value (75nMs), an increase by 10-fold (750nMs), and an increase by 100fold (7500nMs).

Assuming a cell volume of 10~ 12 liters, we converted the con-

centrations into molecular multiplicities: baseline value (45166 molecules), 10-fold
(451660 molecules), and 100-fold (4516606 molecules). We expected to see a decline
in Caspase-3 activation as Bcl-2 concentration was increased by 10-fold and 100-fold;
we provide the results of our simulations in (Figure 4.2). We also provide the results
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of simulations with a decrease of 10-fold and 100-fold in comparison to the baseline
Bcl-2 multiplicity (Figure 4.3). Notice, the graph based on the N W T algorithm is
comparable to the ODE-based results from [47].
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Figure 4.3 The decline of full length Caspase-3 for decreased concentrations of
Bcl-2: (i) 10-fold and (iii) 100-fold, (a) The results of the solution
to the system of ordinary differential equations and (b) the results
of the N W T algorithm.

4.4 Bcl-2's Effects on t h e T y p e II P a t h w a y
Next, we analyzed the Caspase-3 activation kinetics by considering the different
mechanisms through which it has been suggested that Bcl-2 blocks the type II pathway. In [16], [87], and [123] the authors suggested that Bcl-2 might bind with (a)
Bax, (b) Bid, (c) tBid, or (d) both Bax and tBid to block the mitochondrial pathway.
We implemented four different sets of rules to test each Bcl-2 binding mechanisms.
We refer the interested reader Appendix D for the details of the rules.
The dynamics of Caspase-3 activation were studied by increasing the baseline Bcl2 concentration by 10-fold and 100-fold. The conclusion of [47] is that Bcl-2 binding
to both Bax and tBid (d) is the most efficient mechanism for inhibiting apoptosis.
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Our Membrane System agrees with the observations from [47]. The results of (d)
are illustrated in Figure 4.2, and (a) - (c) can be seen in Figure 4.4 - Figure 4.6. A
comparison of (a) - (d) at baseline Bcl-2 concentration is shown in Figure 4.7.
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Figure 4.4 The effects of Bcl-2 binding to Bax only, (a) The results of the
solution to the system of ordinary differential equations and (b)
the results of the N W T algorithm.
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Figure 4.5 The effects of Bcl-2 binding to tBid only, (a) The results of the
solution to the system of ordinary differential equations and (b)
the results of the N W T algorithm.

4.5 M o d e l i n g t h e Behavior of t h e T y p e I P a t h w a y
Algorithm
Some cells are not sensitive to Bcl-2 over expression, as described in [107]. In
these cells, Caspase-3 is activated through the type I pathway, bypassing the role of
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the mitochondria and Bcl-2. Scaffidi et al. have suggested in [107] that the type of
pathway is chosen based on the concentration of Caspase-8 generated in active form
following the binding of Fas ligand to its receptor site. High concentration of active
Caspase-8 allows for direct activation of Caspase-3 (type I), but if the concentration of
Caspase-8 is sufficiently low, amplification of the death signal through the mitochondria is required to induce cell death (type II). We tested this hypothesis by increasing
the initial concentration of Caspase-8 by 20-fold (from 33.33nMs to 666.6nMs), which
was expected to lead to increased active Caspase-8* throughout the simulation run.
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Figure 4.6 The effects of Bcl-2 is binding to Bid only, (a) The results of the
solution to the system of ordinary differential equations and (b) the
results of the N W T algorithm.
We ran two different version of the increased Caspase-8 model, using the baseline
concentration of Bcl-2 and an increase of Bcl-2 by 100-fold, in order to gauge the
sensitivity of the type I pathway to Bcl-2 upregulation. Figure 4.8 shows that Caspase3 activation was not sensitive to the increase in Bcl-2 concentration, which is the
hallmark for type I pathway dominant behavior. N.B., for these simulations Bcl-2
was allowed to bind to both Bax and tBid, which was shown above to be the most
efficient mechanism for Bcl-2 inhibition of apoptosis.
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Figure 4.7 The results of baseline Bel-2 concentration with each of the four
mechanisms for Bcl-2 inhibition (binding with Bax only, Bid only,
tBid only, or Bax and tBid). (a) The results of the solution to the
system of ordinary differential equations and (b) the results of the
N W T algorithm.
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Figure 4.8 Investigation of the effects of Bcl-2 increase (100-fold) for the type
I pathway, (a) The results of the solution to the system of ordinary
differential equations and (b) the results of the N W T algorithm.

Our Membrane System has yielded results comparable to the solutions to the
system of ordinary differential equations. The sixteen distinct simulations show similar apoptotic behavior to the determinstic results (Figure 4.2 through Figure 4.8).
However, albeit the activation of Caspase-3 is similar between the two techniques,
the molecular interactions throughout are different. We have compared the results of
our simulator with the experimental results in [47], the determinstic results from the
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same paper, and the stochastic approach described in [17]. The Caspase-3 results are
as expected, but the activation of Caspase-8 raises our interest. See Figure 4.9 for a
comparison between the techniques.
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Figure 4.9 Results of the three simulation techniques and experimental data
provided by [47], showing decline of (a) full length Caspase-3 and
(b) full length Caspase-8.
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The experimental data and determinstic results were obtained from Fei Hua et
al. We see that the decrease of full length Caspase-3 is similar in all three simulation
results. Interestingly, the decline of full length Caspase-8 is less prominent in the two
Membrane System simulations. The contrast could be the result of the discrete nature
of the Membrane Systems. As for both results being different than the experimental
data, we believe that further investigation of kinetic rates of the reactions will allow
for better agreement between simulation and experimentation.

4.6

Summary

We have chosen to simulate Fas-induced apoptosis because it has one of the most
detailed descriptions/characterization in the literature (due in large part to its role in
cancer and HIV research). In the interest of comparing our Membrane System with
the solutions to the system of ordinary differential equations, we have implemented
101 different rules working on 53 distinct proteins and protein complexes. The pathway begins with the stimulation of FASL and ends with the activation of the effector
Caspase-3. Fei Hua et al., in [47], provide the determinstic results, as well as some
experimental data (from the Jurkat cell line), which they used to fit their model.
The consistency between the framework and the experimental results of [47] validates our model. Our NWT algorithm shows that Membrane Systems are an intriguing alternative to ordinary differential equations methods. We have argued that
the discrete nature of our technique might be better for simulating the evolution of
systems involving low numbers of molecules.
In Chapter 5, we will build on the rules for Fas-mediated apoptosis discussed in
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this Chapter. There are a few proteins encoded in the HIV genome, which seem
to have severe consequences on Fas-induced apoptosis [109]. The so-called 'latently'
infected T cells are especially interesting in the potential strategies for the eradication
of the AIDS epidemic [41].

CHAPTER 5
HIV-1 EFFECTS ON THE FAS
PATHWAY
In Chapter 5 we will explore the qualities of the human immunodeficiency virus
(HIV) which help it remain remarkably difficult to cure. Our goal is to model the
effects of HIV-1 proteins on the Fas-induced apoptotic pathway. This is the first effort
of its kind, and we hope it will provide insight into future HIV research and modeling.
The virus has several remarkable qualities: (1) it predominantly infects the cells
of the i m m u n e system; (2) it shows a high genetic variation throughout the infection in a single individual due to the high error rate in the reverse transcription; (3) it
induces apoptosis in the so-called bystander immune cells; and (4) normal immune
system function can cause some HIV-infected T cells to become latent, entering a
reversibly nonproductive state of infection. Since the latent cells are transcriptionally
silent, they are virtually indistinguishable from the uninfected cells. Also, the number of latently infected cells is relatively small, which makes the experimental study
of these cells difficult - current technology in biochemistry requires large numbers
of the molecules/cells to be studied. It is widely believed that the latently infected
CD4+ T cells represent the last barrier to an HIV cure. This Chapter is based on
our publication in WMC09, presenting a first modeling effort for the Fas-mediated
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apoptosis (or programmed cell death) of latently infected T cells [51].
We will focus on the apoptotic modeling (reason 3), since it is the avenue through
which the virus destroys the effectiveness of the host's immune system.

We will

base our model on the work described in Chapter 4, using the Nondeterministic
Waiting Time algorithm discussed in Chapter 2.

Furthermore, in order to make

the modeling effort easier and due to the high genetic variability (reason 2) of the
viral genome, we will combine several similar processes together into single reactions.
The kinetic constants for the new reactions, modeling the biochemical interactions
involving viral proteins with the host cell, will be obtained by fitting the model to
reported experiments on the infected, nonlatent cells. Finally, we will simulate the
reactivation of latently infect T cells by making some adjustments to the appropriate
initial conditions of the system.

5.1 A Brief H i s t o r y of H I V
HIV, which is responsible for the onset of acquired immune deficiency syndrome
(AIDS), has lead to more deaths than nearly any other virus in human history. Indeed,
AIDS is called a global pandemic by the World Health Organization (WHO), and is
"undoubtedly the defmining public-health crisis of our time" [111]. According to
statistics from the WHO, there were 33.2 million people living with HIV in 2007, 2.5
million newly infected individuals, and 2.1 million AIDS deaths [126].
When AIDS was first labeled as a diseases in 1981, there was an initial debate over
what was causing the immune syndrome. It was suggested that a retrovirus could
be the cause. However, retroviruses were a relatively new field of study and only a
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few had yet been identified. Two labs, Gallo's in the United States and Montagnier's
in France, are both credited with the discovery of HIV [7, 78]. Although political
tensions surrounded the discovery, the two groups essentially agree that it was a
combined effort to discover the virus behind AIDS.
Upon discovery of the virus causing AIDS, there was an explosion of subsequent
breakthroughs. A bloodtest was developed within a couple of years [77], securing the
world's blood transfusion supply. In 1985, a group succesfully sequenced the viral
genome [122]. And, the first anti-HIV drug, AZT, was developed by 1987 [77]. With
such quick discoveries, some believed the race for a cure would be a short one.
However, this task quickly became quite daunting, for reasons we will elaborate
in the rest of Section 5.1, and the race for the cure has turned into an everlasting
marathon. Even though there are a variety of drugs now available to combat the
effects of HIV, reducing it to a sort of chronic illness, the complete eradication of
the viral infection is still yet an unattained achievement for science. There are two
important qualities of HIV which makes it difficult to find a cure: (a) a high genetic
variability and (b) an ability to go silent (so-called HIV latency).
One of the reasons the cure for HIV remains elusive is the high genetic variability
of the virus. There are two strains of HIV: type 1 and type 2. HIV-1 is the virus whose
discovery was discussed above. HIV-2 was specifically isolated [21] in West Africa in
1986. Unlike HIV-1, the type 2 strain remains confined to West Africa [106]. Since
HIV-1 is more virulent and transmissive [106], the disussion and modeling efforts of
this Chapter will be concerned with the type 1 variant.
HIV-1 can be broken down into multiple subtypes (see Figure 5.1). Infected indi-
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victuals are susceptible to co-infections and superinfections [111]; this can lead to new
recombinant forms of the virus. For instance, in Southeast Asia an estimated twenty
percent of infections come from recombinant forms [111]. Lack of immunization and
continuous evolution of the viral genome makes vaccine development a considerable
challenge. The modeling community must remain aware of the different subtypes,
to avoid illfit models based on these genetically distinct subtypes, resulting in poor
approximation of reality.
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Figure 5.1 Estimated number of HIV-1-infected individuals in 2007 [126] as
well as the various HIV-1 subtypes per region [111].

5.2 A I D S P a t h o g e n e s i s
The pathogenesis of AIDS is attributed to the depletion of the host's CD4+ T cells,
the loss of which results in a dysfunctional immune system. Finkel and colleagues
in [28] concluded that HIV-1 infection causes death predominantly in the so-called
bystander T cells. These healthy, uninfected cells are marked for destruction by the
neighboring HIV-1-infected cells. The mechanism of the bystander cell death was
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shown to be apoptosis. Proteins encoded by the HIV-1 genome exhibit anti- and proapoptotic behavior on infected and bystander cells, enhancing or inhibiting a cell's
ability to undergo apoptosis.
There are numerous drugs available for limiting the impact of HIV-1 on the immune system; the most successful approach, highly active anti-retroviral therapy
(HAART), is a combination of several types of drugs, targeting different mechanisms
of HIV-1 infection and proliferation. Although HAART has proven to be effective in
the reduction or elimination of viremia [89], it is ineffective in the complete eradication of the viral infection. The HIV-1 infection is able to persist in a dormant state
throughout the entire time a patience is on HAART. The way this is accomplished is
one of the most remarkable qualities of HIV - i.e., latency.
Latent reservoirs of HIV-1 have been detected in HIV-1-infected patients [18, 19].
Latently infected cells are relatively rare - about 1 in 106 resting T cells [19]. However,
they are considered to be the largest obstacle in combating HIV-1 infection [29, 110,
114]. Understanding the mechanisms behind HIV-1 latency is a focal point for current
AIDS-related research (for a recent review on latency see [41]).
There are two types of latency described in the literature. The first, preintegration
latency, refers to resting T cells containing unintegrated HIV-1 DNA. If a T cell is in
a resting state, the HIV-1 DNA is not able to quickly integrate into the host's viral
genome. Since the unintegrated HIV-1 DNA is labile and reverse transcription of HIV1 RNA is slow (on the order of days) [90, 131, 132, 135], it is believed that patients
with reduced viremia after several months of HAART therapy do not have resting T
cells with unintegrated HIV-1 DNA [11]. Hence, we will not concern ourselves with
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modeling preintegration latency. We will instead discuss the second form of latency postintegration latency. It is this alternative form of latency which will be the focus
of the rest of the Chapter.
Postintegration latency refers to resting T cells with stably integrated HIV-1 DNA.
These cells can provide a reservoir for viral reproduction for years [29]. The cells
exist as a natural consequence to normal healthy immune function. When the body
is invaded by an organism, T cells are activated to destroy the invading pathogen.
Once the pathogen is destroyed, many of the T cells commit apoptosis or else they
would persist in killing other cells at the inevitable detriment of the host organism.
However, a few of these active T cells return to a quiescent state. This return to a
nonactive status is the basis for so-called memory T cells.
When an activated HIV-1-infected T cell turns into a memory T cell, this is very
troublesome for the infected individual. The individual now has a T cell which is virtually indistinguishable from all of the other resting T cells, and yet it is infected with
the HIV-1 genome. The cell can persist almost indefinitely in this state. Hence, when
the individual goes off HAART and the resting HIV-1-infected T cell is reactivated,
viraemia is quickly restored and the individual will succumb to AIDS.
It is because of their long lifespan and ability to restore viraemia that we have
chosen to model the reactivation of a postintegration latently infected CD4+ T cell.
We chose to model the Fas-induced apoptosis of these cells because the effects are
well characterized in the literature and no one has made an attempt to do so before.
As far as we know, this paper reports the first attempt at modeling the Fasmediated apoptotic signaling pathway in reactivated latently infected CD4+ T cells.
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We will draw upon the system we laid out in Chapter 4, which is based on information
for the Jurkat T cell line from [47] (and references therein). We have extended the
model from Chapter 4 in order to better understand the reactivation of latently
infected T cells.

5.3 HIV-1 Infection
There is still some debate about the effects of HIV-1 proteins on cellular signaling
networks; however, we have pooled the collective knowledge of the biological community in order to categorize and model the described functions of various HIV proteins.
For an illustration of the Fas pathway and the involvement of the HIV proteins we
refer the reader to Figure 5.2. We will explain the inspiration for the model below.
The mechanisms behind HIV-1 infection of CD4+ T cells are well understood. A
spike on the virus, the gpl20 envelope glycoprotein, binds to the CD4 receptor of
the target cell and, in conjunction with subsequent binding to a coreceptor (CCR5 or
CXCR4), a path is opened for the virus to inject its contents into the cell [15, 128].
Reverse transcriptase creates cDNA from the HIV-1 RNA and the genome of the
virus is implanted into the cell's own DNA for future production. During this time,
the immune system fails to detect and destroy the infected cell.
Upon infection, the contents of the virion (e.g., Vpr, HIV protease (HIVpr), reverse
transcriptase (RT), and HIV RNA

(HIV#AM))

are released into the cytoplasm [14],

In the newly infected and active CD4+ T cells, the

HYVRNA

is converted to cDNA

(RIVCDNA)

by the reverse transcriptase about five hours post-infection [60]. The

HIVC£>/SM

is then integrated into the host's genome with the help of the viral integrase
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approximately one hour later [27]. We will formalize these rules as we discuss the
inspiration from the literature behind their creation. For our convenience, we have
labeled the integrated HIV genome as

HJVLTR

in our rules. HIVLTR is the basis for

interactions involving the HIV long terminal repeat; in our model, it is a necessary
component for all reactions pertaining to HIV-1 protein production.

Cell Surface

Figure 5.2 HIV-1 protein effects on the Fas-mediated signaling cascade.

After integration of the viral DNA, gene expression of HIV proteins becomes
possible. The nuclear factor of activated T cells (NFAT) and

NF-KB

have been shown
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to play important roles in HIV gene expression [61, 80]. In a resting CD4+ T cell, NFKB is sequestered in the cytoplasm by its inhibitor, I/tB. Following cellular activation,
NF-/d3 is released by its inhibitor, which allows it to relocate to the nucleus where
it can bind to the

HWLTR-

Also following T cell activation, NFAT, located in the

cytoplasm of resting CD4+ T cells, undergoes dephosphorylation and translocation
to the nucleus where it can bind to the HTVLTR [61]. Once
translocated to the nucleus, they can bind to the

HYVLTR,

NF-KB

and NFAT are

combining their efforts to

synergistically enhance the promoter activity. Moreover, [61] shows that the combined
effects of Tat, NF-«B and NFAT is much stronger than the pairings of Tat and
or Tat and NFAT. In our model, we have combined the roles of
The translocation and binding rules for NFAT (and

NF-KB)

NF-ACB

NF-KB

and NFAT.

are shown in Table 5.2.

Table 5.1 Reactions involving translocation of the HIV genome and integration into the host's genome.
Reaction
1: mVRNA
2: BIVCDNA
3 : BIVCDNA

Reaction Rate
+ R T -> H I V c D N ^ + R T
—> HIV C £>T\M (nuclear i m p o r t )
—> H I V L r f t

k^
k22
/L22

Multiply spliced (MS) HIV-1 m R N A s - responsible for T a t / R e v protein creation
- are d e t e c t a b l e in resting C D 4 + T cells [68]. However, d u e t o t h e inefficient e x p o r t

of the mRNA transcripts to the cytosol, Tat and Rev proteins are undetectable in the
latent cells. Activation of these latent cells leads to production of Tat and Rev, and
subsequent upregulation of all HIV-1 proteins. In order for the infected cells to create
HIV proteins other than Tat and Rev, the transcriptional elongation induced by Tat
and the efficient nuclear export of MS HIV-1 RNAs by Rev are required. Our latent

cell model, beginning with cellular activation, initially allows for inefficient creation
of Tat proteins. We chose not to model Rev, since it has no known Fas apoptotic
function; its exporting functions are incorporated into the kinetic constants governing
mRNA translocation. Once Tat is located in the nucleus, it requires the help of two
other proteins provided by the host cell: CyclinTl and CDK9.

Table 5.2 Reactions involving HIV long terminal repeat (LTR) and HIV
mRNA production.
Reaction
4: NFAT -> NFAT (nuclear import)
5: CDK9 -» CDK9 (nuclear import)
6: CyclinTl + CDK9 -> P T E F b
7: NFAT + EWLTR -> HIV L T R :NFAT
8: H I V i r ^ N F A T + Tat - • HIV L T *:NFAT:Tat
9: HIV L T i J :NFAT:Tat + P T E F b -* HIV L T / J :NFAT:Tat:PTEFb
10: mVLTR - • }iWLTR + mRNA T a t
11: mVLTR -+ }HVLTR + mRNA V p ,
12: HIV L T * - • mVLTR + mRNA H /y p r
13: HIV L T i ? - 11WLTR + mRNA W e /
14:
mVLTR NFAT -)• HIV L r i ? :NFAT + mRNA T a t
15: EWLTR NFAT -> HIV L r i ? :NFAT + mRNA V p r
16: EIVLTR NFAT - • HIV L r R :NFAT + m R N A H / V
17: EWLTR NFAT - • HIV L r H :NFAT + m R N A N e /
18:
mVLTR NFAT:Tat - • BWLTR NFAT:Tat + mRNA T a t
19: H I V L T H NFAT:Tat - • EWLTR NFAT:Tat + mRNAy p r
20: EIVLTR NFAT:Tat - • HIV L T H NFAT:Tat + mRNA„ / V p r
21: R1VLTR NFAT:Tat - • HIV L T i ? NFAT:Tat + mRNA W e /
22: EWLTR NFAT:Tat:PTEFb -»
HIV L T f i :NFAT:Tat:PTEFb + m R N A r a t
23: HIV L T i ? :NFAT:Tat:PTEFb ->
HIV L r H :NFAT:Tat:PTEFb + mRNA V p r
24: HIV L T i ? :NFAT:Tat:PTEFb ->
HIV L T H :NFAT:Tat:PTEFb + mRNA H 7v pr
25: H I V L T i ? : N F A T : T a t : P T E F b ->
HIVLrK:NFAT:Tat:PTEFb + mRNAWe/

Reaction Rate
hs
hi
hb
hp
hi

h&
hg
hg
hg
hg
ho
ho
ho
ho
hi
hi
hi
hi
&32
k32
fc32
fc32
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In an inactivated cell, CyclinTl and CDK9 are sequestered in the cytoplasm [81].
Upon T cell activation, they are relocated to the nucleus. CyclinTl and CDK9
combine to make up the positive-acting transcription elongation factor (P-TEFb)
complex. The binding of P-TEFb and Tat at the

HWLTR

allows the hyperphos-

phorylation of RNA polymerase II (RNAPII), resulting in increased transcriptional
elongation. The translocation and binding rules for CyclinTl, CDK9 and Tat are formalized in Table 5.2. The transcription, translocation, and translation rules involving
HIV-1 mRNA molecules are also summarized in Table 5.3.

Table 5.3 Translation and degradation rules for HIV mRNA.
Reaction
Reaction Rate
26: mRNA Tat —> mRNA Tat (nuclear export)
fc33
27: mRNAjVe/ —> mRNAwe/ (nuclear export)
A;33
28: mRNAy pr —> mRNAypr (nuclear export)
fc33
29: mKNAHIVp7. —> m R N A ^ / ^ (nuclear export)
A;33
30: mRNA Tat -> mRNA Tat + Tat
k34
31: mRNAjve/ -* mRNA Ne/ + Nef
kM
32: mRNAypT. - • mRNAVpr. + Vpr
ku
33: mRNAH/ypr -> mRNAHiVpr + HIVpr
fc34
34: mRNA Tat —> degraded
k35
35: mRNAjve/ -^ degraded
A:35
36: mRNAy pr —>• degraded
A;35
37: mRNAH/vpr -^ degraded
^5

5.4 HIV-1-Related Effects on the Fas Pathway
Aside from its role in transcriptional elongation, the Tat protein is responsible
for both pro- and anti-apoptotic behavior. In [8], the authors demonstrated that
increased Tat expression causes upregulation of inactive Caspase-8, which is a proapoptotic molecule. Also, Tat has been associated with the downregulation of Bcl-2
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[109], which is an anti-apoptotic molecule. Given the pro- and anti-apoptotic duties
of Caspase-8 and Bcl-2, respectively, it would appear that a cell with high levels of Tat
has increased susceptibility to apoptosis. Conversely, [28] claims t h a t Tat upregulates
Bcl-2, resulting in decreased apoptotic rates of cells. Tat has also been implicated in
the upregulation of Fas ligand on the cell surface [8, 129], which may effect the cell
through autocrine signaling. The anti- and pro-apoptotic rules for Tat are found in
Table 5.4.

Table 5.4 Reactions involving Tat protein.
Reaction

38
39
40
41
42

Tat
Tat
Tat
Tat
Tat

;=± Tat (nuclear import/export)
-» Tat + Casp8
-> Tat + Bcl2
—>- FasL + Tat
+ Bcl2 -» Tat

Reaction Rate
^ 3 6 / , ^35r

hr
hs
k39
kio

The HIV-1 Vpr has been shown to both enhance and inhibit the Fas signaling
cascade. Upon infection, the ~700 molecules of Vpr in the virion are injected into
the cytoplasm of the cell [14]. At low levels, Vpr has been shown to prohibit apoptosis
by upregulating Bcl-2 and downregulating Bax [22]. However, higher concentrations
of Vpr affect the mitochondrial membrane permeability via interactions with the
permeability transition pore complex (PTPC), resulting in the release of Cytochrome
c into the cytoplasm [53]. In the same paper, the authors also demonstrated that
Bcl-2 can inhibit the effects of Vpr on the P T P C . The various apoptotic roles of Vpr
we define in Table 5.5.
Another protein packaged in HIV-1 virions, HIV p r , plays an important role in the
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Fas pathway. The HIVpr has been shown to cleave Bcl-2 into a deactivated state [113],
while it also cleaves Caspase-8 [83] into active form. Both rules are pro-apoptotic and
are in Table 5.6.
Table 5.5 Reactions involving Vpr protein.
Reaction
43: Vpr + Bax —> Vpr
44: Vpr + Bcl2 -> Vpr:Bcl2
45: Vpr:Bcl2 -> Vpr + Bcl2
46: Vpr + PTPC - • Vpr:PTPC
47: Vpr:PTPC + Cyto.c -> Cyto.c*+ Vpr:PTPC

Reaction Rate
k^
k43
k44
k45
k46

Table 5.6 Reactions involving HIV protease.
Reaction
Reaction Rate
48: HIVpr + Casp8 -> HIVpr + Casp8*
k^
49: HIV pr + Bcl2 -» HIVpr
k^

Finally, we define two pro-apoptotic rules for the Nef protein. Zauli et al. discovered in [134] that Nef can play a role in cell death by upregulating Fas receptor
and Fas ligand on the cell surface. Upregulating the receptor sites of Fas on the cell
surface prepares the cell for ligand binding, and can initiate the Fas-induced apoptotic signaling cascade. The upregulation of Fas ligand may protect the infected cell
from cytotoxic T cells, or it could be part of autocrinic signaling. The four rules for
upregulation and translocation of Fas and Fas ligand are in Table 5.7.

5.5 Modeling Results
We added all of the rules from Tables 5.1-5.7 to the Fas model described in Chapter
4 - see Appendix D for the complete list. From this, we are able to simulate two types
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of cells: nonlatent and latent. The differences between the two models are the initial
protein multiplicities. The nonlatent cell is an activated T cell which has just been
infected with the contents of the HIV-1 virion. The HIV-1 RNA and other viral
proteins are in the cytoplasm. The HIV-1 RNA must be incorporated into the host's
genome before the viral protein production can begin. The latent model is a newly
activated T cell with no HIV-1 proteins present. However, the HIV-1 genome is
already integrated into the host's DNA.

Table 5.7 Reactions involing Nef protein.
Reaction
Reaction Rate
50: Nef -* Nef + Fas
k^9
51: Nef - • Nef + FasL
fc50
52: FasL —> FasL (to cell surface)
k^

As we have discussed earlier, the nonlatent cell is used for the model fitting,
since the majority of information about HIV-1 proteins pertains to these types of
cells. The reason for this lies in the fact that latent cells are transciptionally silent
(virtually undetectable) and relatively rare. For instance, in Figure 5.3(a), the results
from the nonlatent simulation show the activity of Tat in that full length (inactive)
Caspase-8 increases by a factor of three. Our simulation agrees with the observations
of [8]. Also, in Figure 5.3(b), our model shows Vpr-induced upregulation of Bcl2 and downregulation of Bax by 30% and 20%, resp. Our results agree with the
experimental results on Vpr described in [22].
We will next consider the activation of Caspase-3. In Figure 5.4, both the nonlatent and latent models are shown to exhibit the onset of apoptosis - total activation
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of Caspase-3 - after approximately two days. Our results indicate that reactivated
latently infected CD4+ T cells activate all of the Caspase-3 molecules earlier than
the nonlatent model. Also, in Figure 5.4, we show the truncation of Bid, which is a
necessary step in the induction of the type II pathway. Active Caspase-8 is responsible for the truncation of Bid, so we are seeing the downstream effects of Caspase-8
activation.
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Figure 5.3 (a) Tat protein upregulates Caspase-8 levels by three-fold, (b) Vpr
upregulates Bcl-2 and downregulates Bax by 30% and 20%, respectively.

Next, let us consider the mechanisms behind Caspase-3 activation in the latent
and nonlatent models. According to the rules in Appendix A, an interaction between
full length Caspase-3 and active Caspase-8 or Caspase-9 can have two outcomes:
the activation of Caspase-3 or not. Both of our models show cooperation between
the two pathways, which is not explicitly stated in the literature. The nonlatent
results (Figure 5.5) show the first interactions between Caspase-3 and Caspase-8*
molecules occur just after 18 hours into the run. It isn't until ~ 10 hours later (26
hours into the run) that we begin to see Caspase-3 interactions with Caspase-9*,
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after signal amplification through the mitochondria. As discussed in [47, 50], given a
sufficiently high initial concentration of Caspase-8 in the cell, signal amplification is
not necessary to induce apoptosis. For this model, we set the initial level of Caspase-8
to be insufficient for apoptosis by the type I pathway.

12 16 20 24 28 32 36 40 44
Time (Hour)
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12 16 20 24 28 32 36 40 44 48 52 56

(b)

Time (Hour)

Figure 5.4 (a)Total reduction of full length Caspase-3 is seen after ~ 40 hours
in the latent model, whereas the nonlatent model takes ~ 47 hours,
(b) The decline of Bid through interactions with Caspase-8, leading
to a rise in tBid.
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Figure 5.5 Interactions involved in the type I and type II pathways for the nonlatent simulation, (a) The results for the three days of simulation
and (b) An excerpt of one minute from the three day simulation
(from 32 hours to 32 hours and 1 minute).
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The results of the latent simulation are similar to the nonlatent, where both pathways appear to govern Caspase-3 activation. In the latent run (Fig. 5.6), we see type
I interactions first occur about 12 hours into the simulation, while type II molecular
binding occurs after 21 hours.
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Figure 5.6 Interactions involved in the type I and type II pathways for the nonlatent simulation, (a) The results for the three days of simulation
and (b) An excerpt of one minute from the three day simulation
(from 32 hours to 32 hours and 1 minute).

Although Figure 5.5(b) and Figure 5.6(b) imply type I interactions occur more
frequently than type II, it must be noted that, due to the kinetics governing these
binding rules, Caspase-8* can remain bound to Caspase-3 for a longer period of time
than Caspase-9*. Therefore, although it seems that Caspase-8* binds to Caspase-3
more frequently, the reactions are merely slower. In fact, both models exhibit more
interactions between Caspase-9* and Caspase-3.
5.6 Summary
Based on the biological evidence in the literature, we constructed a model for
the effects of HIV-1 proteins on the Fas-mediated apoptosis pathway. This work is
the first of its kind, simulating Fas-induced apoptosis in reactivated latently infected
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CD4+ T cells. We have provided some preliminary results in an effort to understand
CD4+ T cell latency. Interestingly, our results show a cooperation between the type
I and type II pathways. We have not been able to verify an explanation for this in
the available literature.
Finally, we would like to note that the experimental information on the latent HIV1-infected CD4+ T cells is scarce, due to the fact that these cells are found in such
small numbers in vivo. Therefore, our model relies heavily on applying the knowledge
of activated HIV-1-infected CD4+ T cells. We look forward to new experimental
results about these enigmatic cells, which we will use to refine the model.

CHAPTER 6
CONCLUSIONS A N D FUTURE
WORK
The focus of this entire dissertation has been the modeling of biochemical reaction
networks. We introduced various aspects of modeling algorithms and tools from the
literature pertaining to signal transduction simulation.

The original ideas in this

paper pertain to the Nondeterministic Waiting Time (NWT) algorithm and the effects
of HIV-1 proteins on the Fas-mediated apoptotic signaling cascade.
We have provided an exhaustive explanation on the design and implementation
of the N W T algorithm.

We discussed important improvements over the previous

modeling efforts by Dr. Paun's group - specifically, reaction memory, efficient sorting
of reaction Waiting Times, and nondeterminism. The algorithm is designed to be
faster than the Gillespie Algorithm. And yet, we are able to simulate biochemical
systems discretely with a degree of nondeterminism, differentiating our technique
from the solutions to systems of ordinary differential equations.
Using our NWT algorithm, we have shown results for modeling some popular networks - e.g., the Lotka-Volterra predator-prey model and a circadian rhythm model.
With these two models, we have shown our algorithm can exhibit Gillespie-like results
with the latter, while NWT simulations of the former model show similarities to the
97
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results of the solution to the system of ordinary differential equations. However, the
computational load of the nondeterminstic decisions in our NWT algorithm is far less
than the Gillespie Algorithm, as is the case in the noise-induced oscillations for the
circadian rhythm model.
We have used our N W T algorithm to explore Fas-induced apoptosis. We started
by simulating a model developed by the Lauffenberger lab at M.I.T. [47]. Our simulator is capable of showing comparable results to the solution of the system of ordinary
differential equations from that group. However, when compared with the experimental results, we did notice some differences between our discrete, nondeterminstic
technique, the ordinary differential equations, and experimental results provided by
the M.I.T. lab. Activation of Caspase 3 was very close, but Caspase 8 was a bit
different. In other words, the end of the signaling cascade occured at the same time,
but a critical earlier component showed different activity. We concluded t h a t this was
due to the discrete nature of our simulation.
After an extensive literature review, we were able to extend the Fas model of
[47] to incorporate HIV-1 activity. This was the first attempt someone has made in
modeling Fas-induced apoptosis in HIV-1-infected cells. We made a special effort to
model the so-called latently infected T cells, which are considered the last barrier in
the eradication of HIV-1-infection. There are some interesting directions to go with
this research.

6.1 E x t e n s i o n s on t h e H I V M o d e l
There are several avenues to explore in extending the HIV model from Chapter
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5. For instance, we would like to model the effects of HIV-1 proteins on bystander
cell apoptosis. As mentioned in the introduction, HIV-1 appears to primarily kill
uninfected bystander T cells [28]. Various mechanisms have been reported for the
destruction of the bystander cells. Along with Fas-induced apoptosis, other possible mechanisms for bystander cell death are reviewed in [3, 105, 109]. Upon being
exocytosed by an infected cell, several of the proteins encoded in HIV-1 can exhibit
destructive qualities when interacting with neighboring bystander cells - either on the
surface or through endocytosis. In Figure 6.1, we see a proposed model for bystander
cell apoptosis.

Mitochondria
Bystander Cell

Figure 6.1 The effects of an HIV-1-infected T cell on its neighboring healthy,
bystander cells.

There are a few HIV-1 proteins we have ignored in this model, because they affect
T cells in ways not within the scope of our current efforts. For example, soluble and
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membrane-bound Env can bind to the CD4 receptor of bystander cells. In [20] and
[9], the authors have shown that ligation of the CD4 receptor by Env. is sufficient to
increase apoptosis in bystander cells. The reasons for the increased apoptotic rates
following Env-CD4 binding can be attributed to Bel-2 down-regulation [44], increased
Caspase 8 activation [2], and upregulation of Fas [88], FasL and Bax [109].
Extracellular Tat can enter bystander cells through endocytosis, which leads to
pro-apoptotic activity. The addition of Tat to a culture of uninfected cells has been
shown to increase apoptosis [74]. Endocytosed Tat can upregulate levels of Caspase 8
[8] and increase expression of the Fas ligand [109], interfering in the same manner as
in the infected cells. Also, extracellular Vpr can disrupt the mitochondrial membrane,
leading to increased translocation of Cytochrome c* [109].
Modeling a cluster of cells would be a possible extension of this model. Using
MPI, we can have each node of a cluster model a distinct cell. One (or more) of the
nodes can be an HIV-1-infected cell, while many of the nodes can represent bystander
cells. We can simulate the effects of the HIV-infected cell on the healthy, bystander
cells. Besides HIV-1-related effects on the Fas-mediated apoptotic pathway, there are
other directions to go with Fas modeling.

6.2 Calcium's Role in A p o p t o s i s
In recent years, calcium's role in apoptosis has received increased attention. For a
recent review, we refer the reader to [93]. It seems that calcium is capable of exhibiting
both pro- and anti-apoptotic characteristics. While a large portion of the literature
illustrates calcium's role in the intrinisic (sometimes referred to as the mitochondrial)
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pathway, there is also evidence showing its role in the extrinisic pathway.
We propose an exploration into the role of calcium as an apoptotic signaling
molecule.

The effort will combine experimental and computational techniques to

derive new kinetic rates and extrapolate apoptotic signaling behavior for a variety
of cell types - besides Jurkat T cells, the lab of Dr. DeCoster is also investigating
neurons and astrocytes.
There are several studies showing cytosolic increases of calcium at early and late
stages of apoptosis [64, 70, 117]. In the lab of Dr. DeCoster, we have just begun to
explore the calcium dynamics in multiple cell types with treatments of staurosporine,
glutamate, potassium chloride (KC1), and ionomycin. We are working with several
different cell lines - astrocytes, glioblastoma and Jurkat T cells. Additionally, the
DeCoster lab is establishing its own primary astrocyte cell line of an adult rat brain.
Using multiple cell types will grant us a deeper understanding into the underlying
mechanisms. Preliminary data generated in the lab is very interesting, as glutamate
appears to delay apoptosis in astrocytes, yet has no effect in T cells. It is unsurprising
t h a t the Jurkat T cells show no response to glutamate stimulation, since they lack
both glutamate transporters and receptors. However, it would be beneficial to explore
the reasons why glutamate delays apoptosis in astrocytes.
It seems, calcium is able to exhibit both pro- and anti-apoptotic tendencies. In
Figure 6.2, we provide an overall picture of possible reactions that we can add to the
model described in Chapter 4 (Figure 4.1). We can attempt to derive the reaction
kinetics using the existing literature, and use experimental results from the lab of
Dr. DeCoster to decipher the unknowns. Below, we elaborate on the details from the
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literature for the inspiration behind Figure 6.2.
Ca 2+ has a unique ability to establish local concentrations in the cytoplasm. The
physical and chemical aspects of Ca 2+ , which enable localization, allow different functionality based on the spatiotemporal dynamics of this signaling molecule. Moreover,
due to its low diffusion rate - 100-fold lower than other typical second messengers,
cyclic AMP and inositol 3-phosphate (IP3) - and tendency to become sequestered
by different organelles in the cell, intracellular Ca 2+ is tightly controlled during the
cell's lifespan [93].

Type I pathway

h

\Staurosponne/

Figure 6.2 The picture represents how calcium relates to the proteins of the
Fas-mediated apoptotic signaling cascade.

Calcium release from the Endoplasmic Reticulum (ER) can have profound impact
on the mitochondria and, thus, the intrinsic apoptotic pathway. The "cross-talk"
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between the ER and the mitochondria is responsible for mediating signaling, ATP
production and apoptosis [119]. The functional significance of the physical and physiological link between the ER and mitochondria is profound [39, 104]. For instance,
in many apoptotic models the release of Ca 2+ from the ER is directly responsible for
mitochondrial calcium overload [40, 92]. Although Ca 2+ has a low affinity for the
mitochondrial Ca 2+ transporters, it is the close proximity between the mitochondria
and the ER which allows for the rapid accumulation of calcium in the mitochondrial
matrix [91]. The interactions between Ca 2+ and the mitochrondria, can lead to a
variety of mitochondrial activity. For instance, Ca 2+ overload can result in a loss of
mitochondrial membrane potential, which can lead to increased release of Cytochrome
c into the cytosol.
Specifically, we are very interested in the dynamics of Ca 2+ , IP3R and IP 3 , and
their interactions in a negative feedback loop proposed in [12]. In the aforementioned
paper, the authors were able to show a reduction in apoptotic behavior in Fas ligandstimulated cells, where the Cytochrome c/IP 3 R binding was inhibited. Alternatively,
cells lacking IP3R activity (knockout models and genetic deletions) show resistance
to apoptosis [10, 54, 59, 115]. Other models have been suggested in which Bcl2 family members interact with the type 1 version of IP3R to control Ca 2+

flow

from the ER - e.g., Bax, Bad, and Bcl-XL [85, 125]. Investigation into the role of
IP3R in calcium signaling may reveal a new pharmacological target in apoptosis [93].
Although calcium-related oscillations have been previously investigated (first in [76]),
they have not yet been explored computationally within the context of Fas-mediated
apoptosis.
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Anti-apoptotic molecules in the cell have been shown to reduce cytosolic calcium
levels when they are upregulated. For instance, Bcl-2 and Ca 2+ have been shown to
relate to each other. In [4] the authors observed Bcl-2 overexpression prevents Ca 2+
release from the ER. The authors of [66] were able to show a reduction in the release
of Ca 2+ from the ER in relation to Bcl-2 levels.
Pro-apoptotic molecules in relation to calcium release from the ER have also been
studied. The double knockout embryonic fibroblasts in [23], where pro-apoptotic
molecules Bax and Bak were deleted, had a major reduction in levels of calcium in
the ER. The double knockout models were resistant to a variety of apoptotic stimuli
[108]. In addition, silencing Bcl-2 in the double knockout models partially restored
the ER calcium levels. Finally, the green tea compound epigallocatechin gallate
reduced the leakage of calcium from the ER and restored ER calcium levels in Bcl-2
overexpressing cells - N.B., the compound is known to bind to Bcl-2 and deactivate
the protein. Hence, it interplay between elements in Figure 4.1 and Figure 6.2 is
clear, and investigation into these phenomena can lead to new insight into cancers,
autoimmune and neurodegenrative disorders.
Finally, as a tertiary research direction, we have the option of investigating calcium
oscillations in relation to HIV latency. There is recent evidence supporting the idea
that calpains may play a critical role in apoptosis. These cysteine proteases are
activated in a Ca 2+ -dependent manner, and they may be effective in inhibiting the
activation of latent HIV-infected cells [116]. Hence, as we establish our models of
Ca 2+ -mediated apoptotic signaling, we can also work the new dynamics from the lab
of Dr. DeCoster into the HIV apoptotic model we proposed in 5.
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6.3 Modifying N W T
The NWT algorithm could be improved by parallelizing the algorithm. To date,
the use of MPI has been restricted to running multiple simulations at the same time.
We have used MPI to initialize the same system on multiple nodes, to generate multiple simulation results faster. There is another way to consider using parallel computing facilities to speed up the algorithm and increase the number of nondeterminstic
decisions made throughout a simulation run. The idea would involve partitioning
the system into multiple subsystems, and having these subsystems interact through
diffusion-like reactions. Consider the very simple system illustrated in Figure 6.3.
N.B., there is a lot of whitespace in Figure 6.3, because we will require more space in
Figure 6.4.

[T>.

T
(Tp>M

Nucleus
Cytoplasm

Figure 6.3 A proposed reaction network for the partitioned system.
The system in Figure 6.3 describes a few reactions working on a few proteins.
Now, let us assume that all of the molecules of the system are accounted for in Figure
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6.4. If we ignore the lines for a moment, then we see the system will initialize with
six molecules of A, nine molecules of B, eight molecules of C, and five molecules
of D.

Now, looking at the lines, we can consider dividing the system into four

Membrane Systems, each one simulating on its own node, but communicating by
allowing molecules to float from one system to the next.
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Figure 6.4 Partition the cell into subcompartments for parallel simulation.

In Figure 6.4 we can see four different, groups. Each group would be initialized
as a Membrane System. We would need to develop communication laws to send a
protein from one Membrane System to the next. Therein lies the difficulty. We would
need to develop the mathematical framework behind when to send a protein from one
Membrane System to the next - some sort of diffusion law. By breaking the system
up into smaller subsystems, we can utilize the benefits of multiple processors, but we
can also open opportunities for more nondeterministic decisions.
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Our nondeterminism comes in the form of reaction competition, so it would be
beneficial (nondeterminstically speaking) for us to divide the system up in this manner. With less molecules in each Membrane System, the possibility for nondetermism
increases. The reaction memory would also play a larger role, since we would expect
reactions per subsystem to have infinite Waiting Times more often, given less reactant
molecules per subsystem. From Figure 6.4 it appears that subsystem III is the only
system with a nucleus. If we are dividing the system to deal with the spatio characteristics of proteins, then this would make sense. Perhaps a more appropriate way to
divide the system, would be to give each subsystem a piece of every compartment.
See Figure 6.5.
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Figure 6.5 A different view at breaking the system into subcompartments.

In Figure 6.5 we see a way to break up the system such that every rule has a
chance to be implemented. Now every rule has a chance to execute each subsystem.
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Some systems will come to lack certain reactants while other systems will have an
abundance of those reactants. Hence, nondeterminism may play a greater role, as
there will be a greater chance for reaction competition per subsystem. To implement
this type of extenstion to the N W T algorithm we need to be concerned with the
following:
1. How many subsystems do we define? What would be the logic behind defining
the total number of subsystems?
2. How do we decide to initialize the protein multiplicities per subsystem? Do we
merely divide the total number of molecules of each protein by the number of
subsystems?
3. How do we send proteins between compartments? A simple rule to send one to
another would suffice, but what sort of kinetics do we associate to these rules?
One would think sending one protein to a new subsystem should be governed
by more than mere random number generation.
There are some questions to be answered on this sort of implementation.

As

stated, this sort of setup would give more weight to the nondeterminism and memory
enhancement described in this work. If a mathematical framework could be developed
for breaking the system into subsystems, the logic should also be transferable to
applying a similar partitioning scheme to the Gillespie Algorithm.

6.4 T h e Future of S y s t e m s B i o l o g y
It is interesting to consider the future of computational and systems biology. The
field(s) are contingent upon the growth and production of so many areas of science.
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At the heart of this new wave of collaborative efforts sweeping the Earth is the
field of Systems Biology. The types of scientists involved in the field - biologists,
chemists, physicists, computer scientists, mathematicians, biochemists, biophysicists,
neuroscientists, and so on - is evergrowing, as humanity plunges deeper into solving
the mysteries of ourselves.
Not to overshadow the events surrounding the discovery of the structure of DNA,
the sequencing methods of Sanger, and other great biological or chemical discoveries,
but the twentieth century seemed dominated by what physics could accomplish. We
are leaving the era where humankind attempted to destroy itself with two great wars.
We are entering an era filled with incredible biological possibilities. We see discoveries
on genes which astound us - the obese gene, the gay gene, etc. These discoveries are
a bit short-sighted, in the sense that there are probably more factors than one gene
which governs behavior. Nevertheless, we are beginning to understand the possibilities
of our manipulation of genetic factors.
My interest in the future of this field lies in defining the specifics of the interaction
networks. Whole cell simulation, while a very nice notion, seems quite far away. We
are not equipped with the proper biochemical knowledge. We have exact methods
for biochemical simulation, but these are essentially intractable for large reaction
networks.
Current estimates put the number of possible interactions in a whole cell in the
100,000 range. Indeed, many of the simulations in this work had millions of interactions occur. To simulate an entire cell with realistic (stochastic) results, the amount
of computational power required would be extraordinairy. I look forward to the fu-
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ture of computer science and systems biology, as computers grow ever faster a,nd our
knowledge of the biochemistry of life continues to develop.

APPENDIX A
MATLAB CODE FOR
CIRCADIAN R H Y T H M MODEL

ill

•/.

-/„=======================================================
7»sol = ode23(function,tspan,initial)
sol = ode23«3simpp53) [0 400],[1 1 0 0 0 0 0 0 0]);
figure
yplot=sol.y;
plot(sol.x,yplot(8,:),'LineWidth',3);
h = legend('ODE Results',15);
xlabel('Time','fontsize',18);
ylabel('Molecules','fontsize',18);
axis([0 400 0 3000]);
%========================================================

function dydt = simpp53(t,y,Z);
Aa=50;
Aaa=500;
Ar=0.01;
Arr=50;
Ba=50;
Br=5;
dMa=10;
dMr=0.5;
da=l;
dr=0.05;
ga=l;
gr=l;
gc=2;
0a=50;
0r=100;
•/,=«==============================================

dydt = [
0a*y(3)-ga*y(l)*y(6)
0r*y(4)-gr*y(2)*y(6)
ga*y(l)*y(6)-0a*y(3)
gr*y(2)*y(6)-0r*y(4)
Aaa*y(3)+Aa*y(l)-dMa*y(5)
Ba*y(5)+0a*y(3)+0r*y(4)-y(6)*(ga*y(1)+gr*y(2)+gc*y(8)+da)
Arr*y(4)+Ar*y(2)-dMr*y(7)
Br*y(7)-gc*y(6)*y(8)+da*y(9)-dr*y(8)
gc*y(6)*y(8)-da*y(9)
];

APPENDIX B
SOURCE CODE N W T . C
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/*
* Cascader.c vl.7
* by John Jack
*

* Synopsis: A discrete nondeterministic simulation technique based
* on Membrane Systems, developed by John Jack and Andrei Paun
*/
#include <stdio.h>
#include <stdlib.h>
#include <string.h>
#include <math.h>
#include <time.h>
#include <pthread.h>
#include "cascader.h"
//BEGIN MPI BLOCK
#ifdef USE_MPI
#include "mpi.h"
#endif
//END MPI BLOCK
//********** GLOBAL VARIABLE DECLARATIONS *************************//
//Alphabet tail and head
int alphabet_tail;
int rules_tail;
//Create the heap (which points to the reaction list)
struct reaction *heap[RULES];
//An array to keep track of Lagged WTs
#ifdef USE_LAGS
double taullags[MAXLAGS] ;
double tau21ags[MAXLAGS] ;
int taulhead,tau2head;
int taultail,tau2tail;
#endif
//Debugging variable used to stop the program if there is an error
int stop; //Used in program
//************************* MAIN METHOD *********#*****************//
/**
* The mainO method has several features:
* (i) calls function importSBML to read information and build
*
membrane system (protein alphabet[] , reaction rules[])

* (ii) Initialize the Membrane System ( evolution sim[])
* (iii) Initializes the heap (BuildMinHeap)
* (iv) Launch User Interface Menu
**/

int main(int argc, char *argv[])
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
int numprocs, rank, namelen;
char processor_name[MPI_MAX_PROCESSOR_NAME];
//Initialize the stuff
MPI_Init(&argc, feargv);
//Report number of processes in communicator comm
MPI_Comm_size(MPI_COMM_WORLD, fenumprocs);
//Report rank, a number between 0 and count-1,
//identifying the calling process
MPI_Comm_rank (MPI_C0MM_W0RLD, ferank);
//Useful for debugging — returns name of processor
//on which it was called
MPI_Get_processor_name(processor_name, fenamelen);
#endif
//END MPI BLOCK
//Variables for building the MEMBRANE SYSTEM
//Struct for maintaining all the information on the alphabet
// or proteins of the system
struct protein alphabet[ALPHABET];
//There are no proteins in the system yet (to be read
//from the xml file)
alphabet_tail = 0;
//Struct for maintaining all the information on the
//reaction/rules of the system
struct reaction rules[RULES];
//There are no rules in the system yet (to be read from the
//xml file)
rules_tail = 0;
//Set it true
stop = ISFALSE;
//Test and read the file (given as cmdline parameter) to
//initialize the simulator (populate alphabet[] and rules[])
importSBML(rules,alphabet,argv [1]);
//Initialize the simulator
initializeMembraneSystem(rules,alphabet);

//Initially build the minheap
buildMinHeap(heap);
/*
* Below is the UI, a simple user interface for launching the
* simulation run
*/
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
int choice;
do{
printf("******************* MAIN MENU *****************\n");
printf(" 1: Begin Simulation (NWT Algorithm) \n");
printf(" 2: Begin Simulation (Gillespie)\n");
printf(" 3: Print Initial WTs\n");
printf(" 4: Print Rules (reactions)\n");
printf(" 5: Print Kinetics\n");
printf(" 6: Print Alphabet (proteins)\n");
printf(" 7: Print Reactionlist for each protein\n");
printf(" 8: Find Max Reaction List\n");
printf(" 9: Quit\n");
printf("Command me: " ) ;
scanf("7„d",fechoice);
switch(choice) //CHANGES FIX MENU
{
case 1:
//NWT Algorithm
evolver(rules, alphabet, heap);
break;
case 2:
//Gillespie SSA
gillesp(rules,alphabet);
break;
case 3:
//Print the initialWTs
printWTs(heap);
break;
case 4:
//Print the list of rules
printRules(rules,alphabet);
break;
case 5:
//Print the discrete rate constants for all rules
printKinetics(rules,alphabet);
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break;
case 6:
//Print the initial multiplicities
printAlphabet(alphabet);
break;
case 7:
//Print the reaction dependences (reactants and products)
printReactionlist(rules,alphabet, heap);
break;
case 8:
findMaxReactionlist(rules,alphabet);
break;
case 9:
break;
default:
printfO'NOT VALID ENTRY!\n");
}
}while(choice != 9);
printf("Cascader has been terminated by user\n");
#endif
//END NDNMPI BLOCK
//BEGIN MPI BLOCK
#ifdef USE_MPI
#ifndef GA
//Run simulator
evolver(rules, alphabet, heap,rank);
#endif
#ifdef GA
gillesp(rules.alphabet,rank);
#endif
MPI_Finalize();
#endif
//END MPI BLOCK
//return 0;
}//end method main()

/*
* Method importSBMLO reads in all of the information to initialize
* the membrane system from the file, which was passed to the program
* as a cmdline parameter. All of the information is read into the
* alphabet[] and rules[] arrays. Also, the array of pointers to rules
* *heap[] array is built having the array of pointers to elements of
* rules[] allows us to build and maintain a heap without destroying

* the original order of rules []. This is necessary because each
* element of alphaebt[] has indexes pointing to nodes in the rules[]
* array.
*/
void importSBML(struct reaction *rules, struct protein *alphabet,
char *sbml_file)
{
//Needed for XML parser
FILE *fp;
//Read String
char str[READBUFF];
char xmlcase[10] = "NOTHING";
//Temp str
char *strtemppoint; //Used in XML
char *strpos;
//Position of the substring
char strtempClOO]; //Used for XML
char strtemp2[100]; //Used to interpret the double for kinetic XML
double concentration; //Used to convert cone, into multiplicity
int temp; //A temp (used for reaction XML parsing
//Debugging for XML read DEBUG
int numOfCompartments;
int numOfReactions;
int numOfProteins;
char *tag = NULL;
//Counter
int c;
//******************* READ IN XML FILE *************************//
//Check cmdline arg for filename and attempt to open with read privs
if((fp = fopen(sbml_file, "r")) == NULL)
{
printf("ERROR: You must provide the SBML code to initialize "+
"the simulator\n");
printf("*****************************************************\n")•
printf("USAGE: ./a.out <FILENAME>.xml.\n");
printf("e.g., ./a.out sample.xml.\n");
exit(l);
}
while(!feof(fp))
{
//READ STRING
if(fgets(str, READBUFF, fp))
{
//**********CHECKING XML TAGS******************//
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//Check title
if (strstr(str,"<model id=") != NULL)
{
strtok(str,"\"");
printf ("Successfully opened file °/„s\n" ,sbml_f ile);
printf ("Reading from project V7.s\"\n" ,strtok(NULL, "\"")) ;
}
//Find Compartments
if (strstr(str,"<compartment id=") != NULL)
{
numOfCompartments++;
strtok(str,"\"");
printf ("Compartment V7„s\"\n" ,strtok(NULL, "\"") ) ;
}
//**************** READ ALPHABET ************************//
//Start reading proteins
if (strstr(str,"<listOfSpecies>") != NULL)
•c

strcpy(xmlcase,"proteins");
}
//Stop reading in Proteins
if (strstr(str)"</listOfSpecies>") != NULL)
{
strcpy(xmlcase,"NOTHING") ;
}
//Find Information on Each Protein
if ((strcmp(xmlcase,"proteins") == 0) &&
(strstr(str,"<species ") != NULL))
{
//Read in a protein
//Increment tail to read in a new protein
alphabet_tail++;
//Get id for current reaction
//Create temp of string so strtok does not cut original to pieces
strcpy(strtemp,str);
strpos = strstr(strtemp,"id=");
//Store location of first character for id string
strtok(strpos,"\"");
//Must copy strtok to temp pointer then copy to string
//Else SegFaul
strtemppoint = strtok(NULL,"\"");
//Save ID

strcpy(alphabet[alphabet_tail] . i d , s t r t e m p p o i n t ) ;
//Get Name for current reaction

//Create temp of string so strtok does not cut original to pieces
strcpy(strtemp,str);
strpos = strstr(strtemp,"name=");
strtok(strpos,"\"");
strtemppoint = strtok(NULL,"\"");
//strcpy(strtemp,strtemppoint);
//Save Name
strcpy(alphabet[alphabet_tail].name,strtemppoint);
//Get compartment for current reaction
//Create temp of string so strtok does not cut original to pieces
strcpy(strtemp,str);
strpos = strstr(strtemp,"compartment=");
strtok(strpos,"\"");
strtemppoint = strtok(NULL,"\"");
//Save Compartment
strcpy(alphabet[alphabet_tail].compartment,strtemppoint);
//Get concentration for current reaction
//Create temp of string so strtok does not cut original to pieces
strcpy(strtemp,str);
strpos = strstr(strtemp,"initialAmount=");
strtok(strpos,"\"");
strtemppoint = strtok(NULL,"\"");
//Save Concentration
concentration = atof(strtemppoint); //Store concentration temp
//Convert Initial Concentration into Initial # of Molecules
alphabet[alphabet_tail].multiplicity = concentration * AVO;
//Initialize the reactionlist_tail
alphabet[alphabet_tail].reactionlist_tail = 0;
}
//Start reading proteins
if (strstr(str,"<listOfReactions>") != NULL)
{
strcpy(xmlcase,"reactions");
}
//Stop reading proteins
if (strstr(str,"</listOfReactions>") != NULL)
{
strcpy(xmlcase,"NOTHING");
}
//#*************#******* READ REACTIONS *******************//
//Find the reaction, put it in the array
if ((strcmp(xmlcase,"reactions") == 0) &&
(strstr(str,"<reaction ") != NULL))

{
//Read in a reaction
//Increment tail to read in a new reaction
rules_tail++;
strtok(str,"\"");
strtemppoint = strtok(NULL,"\"");
//Save ID of reaction
strcpy(rules[rules_tail].id,strtemppoint);
//Initialize fields in struct

r u l e s [ r u l e s _ t a i l ] . r e a c t a n t s _ t a i l = 0;
r u l e s [ r u l e s _ t a i l ] . p r o d u c t s _ t a i l = 0;
/ / I n i a l i z e the nondeterministic counters
r u l e s [rules_tail].nondetermin = 0;
r u l e s [rules_tail].no_nondetermin = 0;
//Make heap element point to reaction
heap[rules_tail] =
ferules[rules_tail];
(*heap[rules_tail]).heap_index = r u l e s _ t a i l ;
}
//Find the reactants for current reaction
if (strstr(str,"<listOfReactants>") != NULL)

i
strcpy(xmlcase,"reactants");
}
//Store reactant information
if ((strcmp(xmlcase,"reactants") == 0) &&
(strstr(str,"<speciesReference") != NULL))
{
//Read in a reactant
//Get reactant Id
strtok(str,"\"");
strtemppoint = strtok(NULL,"\"");
strcpy(strtemp, strtemppoint);
//Find the reactant in alphabet and store its alphabet index
for (c = 1; c <= alphabet_tail; C++)
if (strcmp(strtemp,alphabet[c].id) == 0)
{

/ / S t o r e index in alphabet array for the reactant
rules [rules_tail].reactants_tail++;
temp = r u l e s [ r u l e s _ t a i l ] . r e a c t a n t s _ t a i l ;
r u l e s [ r u l e s _ t a i l ] . r e a c t a n t s [ t e m p ] = c;
/ / S t o r e reaction index
alphabet[c].reactionlist_tail++;
alphabet[c].reactionlist[alphabet[c].reactionlist_tail]
}
}

= rules_tail;
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//End the reactantlist
if (strstr(str,"</listOfReactants>") != NULL)
{
strcpy(xmlcase,"reactions");
}
//Find the products for current reaction
if (strstr(str,"<listOfProducts>") != MULL)
{
strcpy(xmlcase,"products");
}
//Store reactant information
if ((strcmp(xmlcase,"products") == 0) &&
(strstr(str,"<speciesReference") != NULL))
•c

//Get reactant Id
strtok(str,"\"");
strtemppoint = strtok(NULL,"\"");
strcpy(strtemp, strtemppoint);
//Find the reactant in alphabet and store its alphabet index
for (c = 1; c <= alphabet_tail; C++)

if (strcmp(strtemp,alphabet[c] .id) == 0)
{
//Store index in alphabet array for the product
rules[rules_tail].products_tail++;
temp = rules[rules_tail].products_tail;
rules[rules_tail].products[temp] = c;
}
}
//End the productlist
if (strstr(str,"</listOfProducts>") != NULL)
{
strcpy(xmlcase,"reactions");
}
//Read in kinetics
if (strstr(str,"<listOfParameters>") != NULL)

•C
strcpy(xmlcase,"parameters");
}
if ((strcmp(xmlcase,"parameters") == 0) &&
(strstr(str,"<parameter") != NULL))
{
strtok(str,"\"");
strtok(NULL,"\"");
strtok(NULL,"\"");
strtemppoint = strtok(NULL,"\"");

strcpy(strtemp, strtemppoint);
r u l e s [ r u l e s _ t a i l ] . k i n e t i c = atof(strtemp);
}
//End kinetics
if (strstr(str,"</listOfParameters>") != NULL)

•C
strcpy(xmlcase,"reactions");
}
}
}//END XML PARSING WHILE LOOP
//Close file read
fclose(fp);
printf("Finished reading XML file\n");
}//end method importSBML
/*
* The method initializeMembraneSystemO launches three methods
* (i) Constrs must be calculate before WTs as they are used in WT
*
calculation
* (ii) Initialize lag merely ensures all lags are set to 0 until
*
user can identify the lags (if any)
*/
void initializeMembraneSystem(struct reaction *rules,
struct protein *alphabet)
{
initializeConstr(rules);
initializeWTs(rules, alphabet);
#ifdef USE_LAGS
initializeLag(rules);
#endif
}//end method initializeMembraneSystem
//**** PRINTING METHODS **********//
/*
* The method printAlphabet() does just that. It the entire
* alphabet (proteins) to the screen
* Output: Protein <name>, <id>, <compartment>, <current_multiplicity>
*/
void printAlphabet(struct protein *alphabet)
{
printf("****************************\nPrinting Alphabet...\n");
int c;
for (c = 1; c <= alphabet_tail; c++)
{
printf ("70d: Protein %s (7„s), 70s, %d molecules\n",
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c,alphabet[c].name,alphabet[c].id,
alphabet[c].compartment,alphabet [c].multiplicity);
}
}//end method printAlphabet
/*
* The method printRulesO does just that. It the entire set of rules
* (reactions) to the screen
* NOTE: The rules are read from rules [], wheih means they are always
*
printed in the same order as they were read in from SBML
*
So, the current WT does not affect the order (unlike *heap[])
* Output: <rules_index>: Reaction <name>, <constr>, <kinetic_rate>,
* <current_WT>, <lag>
*/
void printRules(struct reaction *rules, struct protein *alphabet)
{
printf("***************************\nPrinting Rules...\n");
int c,i;
for (c = 1; c <= rules_tail; C++)
{
#ifdef USE_LAGS
printf('7,d:Reaction 7.s: constr = '/.If, k = '/.If, WT = '/.If, " +
"Lag = %lf\nREACTANTS: ",c,rules [c].id,rules[c].constr,
rules[c].kinetic,rules[c].waitingtime,rules[c].lag);
#endif
#ifndef USE_LAGS
printf("'/.d:Reaction 7,s: constr = '/.If, k = '/.If, WT = '/.If, " +
Lag = %lf\nREACTANTS: ",c,rules[c].id,rules[c].constr,
rules[c].kinetic,rules[c].waitingtime);
#endif
for ( i = 1; i <= r u l e s [ c ] . r e a c t a n t s _ t a i l ; i++)
p r i n t f ("°/0s ",alphabet [rules [c] . r e a c t a n t s [ i ] ] .name) ;
printf("\nPRODUCTS: " ) ;
for ( i = 1; i <= r u l e s [ c ] . p r o d u c t s _ t a i l ; i++)
p r i n t f ("°/0s " .alphabet [rules [c] .products [ i ] ] .name);
p r i n t f ("\nThere are 70d r e a c t a n t s and 7od products\n",
rules[c].reactants_tail,rules[c].products_tail);
}
}//end method printRules
/*
* The method printKineticsO does just that. It the kinetics per rule
* (or reaction) to the screen (mostly for debugging and make sure
* Membrane System is initialized properly.

*/
void printKinetics(struct reaction *rules, struct protein *alphabet)
•c

printf("***************************\nPrinting Rules...\n");
int c,i;
for (c = 1; c <= rules_tail; C++)
{
#ifdef USE_LAGS
printf("%d:Reaction %s: constr = */.lf, k = 7.1f, WT = %lf, "+
"Lag = % l f \ n " , c , r u l e s [ c ] . i d , r u l e s [ c ] . c o n s t r ,
rules [c].kinetic,rules[c].waitingtime,rules[c].lag);
#endif
#ifndef USE_LAGS
printf("7.d:Reaction °/0s: constr = '/.If, k = '/.If, WT = '/.If, " +
"Lag = % l f \ n " , c , r u l e s [ c ] . i d , r u l e s [ c ] . c o n s t r ,
rules [c].kinetic,rules[c].waitingtime);
#endif
}
}//end method printKinetics
/*
* The method printReactionlistO does just that.
* Print the list of reactions of which each protein is a part.
*/
void printReactionlist(struct reaction *rules,
struct protein *alphabet, struct reaction **local_heap)
{
printf("****************************\nPrinting Reactionlists. . A n " ) ;
int c,i; //counters
int tempindex; //store reactionlist tail for each protein
int temp2;
for (c = 1; c <= alphabet_tail; C++)
{
//For simplicity
tempindex = alphabet[c].reactionlist_tail;
printf("Protein '/,s C/.s) : ",
alphabet[c].name,alphabet[c].id);
for (i = 1; i <= tempindex; i++)
{
//Get index in heap of r e a c t i o n
temp2 = r u l e s [ a l p h a b e t [ c ] . r e a c t i o n l i s t [ i ] ] . h e a p _ i n d e x ;
p r i n t f ("°/„s ", (*local_heap[temp2]) . i d ) ;
}
printf ( ' ' V ) ;
}
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}//end method printReactionlist
/*
* The method printWTsO does just that.
* Prints the Reactions and WTs in the order of the minHeap
*/
void printWTs(struct reaction **local_heap)
•C
printf(n***************************\nPrinting WTs. . .\n");
int c, i;
for (c = 1; c <= rules_tail; C++)
-C
p r i n t f ("Reaction %s: WT=°/0lf and Mem=7Jf\n", ( * l o c a l _ h e a p [ c ] ) . i d ,
(*local_heap[c]).waitingtime,(*local_heaptc]).memory_perc);
}
}//end method printWTs
//***#************* SIMULATOR ******************************//
/*
* The method method evolver is called when the user choosing
* to start the simulator. The initializeSimO method is called
* to prompt user for number of cycles (seconds) to run the
* simulation. And, evolver carries out the simulation until
* desired simulation time is reached, or terminates if ALL
* molecules are exhausted — i.e., all WTs are infprintWTs()
* does just that. It prints the Reactions and WTs in the
* order of the minHeap
*/
//BEGIN MPI BLOCK
#ifdef USE_MPI
void evolver(struct reaction *rules, struct protein *alphabet,
struct reaction **local_heap, int rank)
//END MPI BLOCK
#endif
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void evolver(struct reaction *rules, struct protein *alphabet,
struct reaction **local_heap)
#endif
//END NONMPI BLOCK
•C

//Struct for maintaining all the information regarding
//an actual simulation run (simtimes, exporting times, etc.)
struct evolution sim;

//Initialize the values of sim
//BEGIN MPI BLOCK
#ifdef USE_MPI
initializeSim(&sim,rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
initializeSim(&sim);
#endif
//END NONMPI BLOCK
//The tie
int ties_tail = 0;
//The multiplicities
int multiplicities_tail = 0;
//Information counters — keep track of simulator workings
int nondeterministic_count = 0;
int random_count = 0;
int ties_count = 0;
//Create a tie heap, (check for multiple reactions with minWT)
int ties[MAXREACTI0NS] ;
//Create a 2D array to store the previous
//multiplicities per cycle of proteins
int multiplicities[ALPHABET][PREVIOUSMULT];
//BEGIN MPI BLOCK
#ifdef USE.MPI
//Export the initial conditions (multiplicities at time t=0)
exportlnitialMultiplicity(alphabet, &multiplicities_tail,rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
//Export the initial conditions (multiplicities at time t=0)
exportlnitialMultiplicity(alphabet, &multiplicities_tail);
#endif
//END NONMPI BLOCK
//Time the program
time_t start, finish;
//Start timer
time(festart);
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//BEGIN MPI BLOCK
#ifdef USE_MPI
printInitialStepToFile(local_heap,sim.simulation_time, rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
printInitialStepToFile(local_heap,sim.simulation_time);
#endif
//END NONMPI BLOCK
while ((sim.completed_cycles < sim.goal_cycles) && (stop == ISFALSE))
{
//Check to see if ALL rules are beyond the goal time
//(i.e., no rule can be applied)
if ((*local_heap[l]).waitingtime > sim.goal_cycles + 1)
•c

printfC'ALL RULES EXCEED THE GOAL CYCLES\n");
printf ("min WT = '/.If and °/„d\nsimtime = 7,lf \n",
(*local_heap[1]).waitingtime, sim.goal_cycles, sim.simulation_time);
storeMultiplicity(alphabet, &multiplicities_tail, multiplicities);
printf ("Exporting at time t=°/„lf \n", sim.simulation_time);
//BEGIN MPI BLOCK
#ifdef USE_MPI
exportMultiplicity(alphabet, &multiplicities_tail,
multiplicities,rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
exportMultiplicity(alphabet, &multiplicities_tail, multiplicities);
#endif
//END NONMPI BLOCK
/*CHECK FOR INFINITY*/
if ((*local_heap[l]).waitingtime == (1.0/0.0))
printf("ERROR: MODEL OUT OF MOLECULES (MIN WT IS INFINITY)\n");
break;
}
//Simulator can apply rule
else
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
applyRule(rules, alphabet, local_heap, &sim, &ties_tail, ties,

&nondeterministic_count, &random_count, &ties_count, rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
applyRule(rules, alphabet, local_heap, &sim, &ties_tail, ties,
&nondeterministic_count, &random_count, &ties_count);
#endif
//END NONMPI BLOCK
//A second has completed
if (sim.simulation_time / (sim.completed_cycles + 1) > 1)

-C
//Aggregate completecycles
sim.completed_cycles++;
//Print current second on screen
printf ("°/0d\n" ,sim.completed_cycles);
storeMultiplicity(alphabet, &multiplicities_tail, multiplicities);
//See if multiplicity arrays are full
if (multiplicities_tail == PREVIOUSMULT)
•c

printf ("Exporting at time t=°/„lf\n", sim. simulation_time) ;
//BEGIN MPI BLOCK
#ifdef USE_MPI
exportMultiplicity(alphabet, &multiplicities_tail,
multiplicities, rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
exportMultiplicity(alphabet, &multiplicities_tail, multiplicities);
#endif
//END NONMPI BLOCK
}
>

}
//BEGIN MPI BLOCK
#ifdef USE_MPI
printStepToFile(local_heap,sim.simulation_time, rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
printStepToFile(local_heap,sim.simulation_time);
#endif

//END NONMPI BLOCK
}
printf ("Storing final multiplicity at time = °/„lf \n",
sim.simulation_time);

//BEGIN MPI BLOCK
#ifdef USE_MPI
//Export the final multiplicity
exportMultiplicity(alphabet, &multiplicities_tail,
multiplicities, rank);
//Extraneous information for analysis and debugging postrun
printFinallnfo(rules,alphabet, nondeterministic_count,
random_count, ties_count,rank);
//Finish counting the time of the program
time(&finish);
P£*ij^~tf ("******************************************************\j^") *

printf ("* Simulator for rank %d finished in °/».2f seconds *\n",
rank,difftime(finish, start));
printf("******************************************************\n");
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
//Export the final multiplicity
exportMultiplicity(alphabet, &multiplicities_tail, multiplicities);
//Extraneous information for analysis and debugging postrun
printFinallnfo(rules,alphabet, nondeterministic_count, random_count,
ties_count);
//Finish counting the time of the program
time(&finish);
printf("******************************************************\n")•
printf("* Simulator finished in °/0.2f seconds *\n",
difftime(finish, start));
#endif
//END NONMPI BLOCK
}//end method evolver
/*

* The method initializeSim prepares the evolution struct
* [created in method evolverO] for simulation
*/

//BEGIN MPI BLOCK
#ifdef USE MPI
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void initializeSim(struct evolution *sim, int rank)
#endif
//END MPI BLOCK
//BEGIN MPI BLOCK
#ifndef USE_MPI
void initializeSim(struct evolution *sim)
#endif
//END MPI BLOCK
{
//Initialize the timing for the simulator
sim->completed_cycles = 0 ;
sim->rules_applied = 0;
sim->simulation_time =0.0;
sim->export_counter = 0;
//BEGIN MPI BLOCK
#ifdef USE_MPI
sim->goal_cycles = 1000;
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
//Read in the desired simulation runtime
printf("Enter desired simulation time (seconds): " ) ;
scanf ("°/0d", &sim->goal_cycles);
printf ("Simulating for °/0d seconds\n" ,sim->goal_cycles) ;
#endif
//END NONMPI BLOCK
//Initialize random Number Generator
#ifdef USE_MPI
unsigned int iseed = (unsigned int)time(NULL)*rank;
#endif
#ifndef USE_MPI
unsigned int iseed = (unsigned int)time(NULL);
#endif
srand(iseed);
}//end method initializeSim

/*
* The method applyRuleO does just that.
* The rule with the min WT is rules[0]. We refer to it as the
* applied rule. Rules must be passed to method so it can be
* passed to updateRules for referencing the "pointers" in struct
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* protein of the reactionlist. The method method evolver is
* envoked when the user choosing to start the simulator.
*/
//BEGIN MPI BLOCK
ttifdef USE_MPI
void applyRule(struct reaction *rules, struct protein *alphabet,
struct reaction **local_heap, struct evolution *local_sim,
int *ties_tail, int ties[MAXREACTIONS], int *nondeterministic_count,
int *random_count, int *ties_count, int rank)
//END MPI BLOCK
#endif
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void applyRule(struct reaction *rules, struct protein ^alphabet,
struct reaction **local_heap, struct evolution *local_sim,
int *ties_tail, int ties[MAXREACTIONS], int *nondeterministic_count,
int *random_count, int *ties_count)
#endif
//END NONMPI BLOCK
{
//Temp so we can recalculate heap[l], but keep track of reactants
struct reaction applied = (*local_heap[l]);
//Replace simulation time with the applied rule WT. Aggregate simtime
local_sim->simulation_time = applied.waitingtime;
//Store the head node in the reaction ties list
ties[0] = 1;
*ties_tail = 1;
//Recursively check for ties
checkTied, local_heap, ties_tail, ties);
//Counters
int i,c;
//There is no tie apply the rule at the top of the heap
if (*ties_tail == 1)
{
//Update multiplicities of reactants and products for applied rule
//Reactants multiplicity
for (i = 1; i <= (*local_heap[l]).reactants_tail; i++)
{

alphabet[(*local_heap[l]).reactants[i]].multiplicity—;
}
//Products m u l t i p l i c i t y
for ( i = 1; i <= (*local_heap[l]).products_tail; i++)
•C

alphabet[(*local_heap[l]).products[i]].multiplicity++;

}
//For statistical purposes, aggrate total # of rules applied
local_sim->rules_applied++;
//and # of times particular rule is applied
(*local_heap[1]).times_applied++;
//Recalculate the WT for the Applied rule
recalcAppliedWT(alphabet, local_heap, local_sim);
//Heap maintenance after recalculating the WT of the top node
fixHeap(l, local_heap);
//Update all the rules affected by the applied rule
updateRules(applied,rules,alphabet, local_heap, local_sim);
}
//Test are at least two ties slotted to occur at the same moment
else
{
printf("there is a tie");
int enoughReactants = checkReactants(alphabet, local_heap,
ties_tail, ties);
ties_count++;
//Build an array of pointers to the reactions
//So that we can update all the reactions affected by the tied
//reactions. This is necessary to allow the heap to update
//after each waiting time calculation. Otherwise stuff moves
//ties no longer points to the reactions.
struct reaction *tieptrs[MAXREACTIONS];
for (i = 0; i < *ties_tail; i++)
{
t i e p t r s [ i ] = &(*local_heap[ties[i]] ) ;
}
//Apply all tied reactions
if (enoughReactants == ISTRUE)
{
//Apply all the rules in the tie
for (i = 0; i < *ties_tail; i++)
•C

//Update m u l t i p l i c i t i e s of r e a c t a n t s and products for applied rule
//Reactants m u l t i p l i c i t y
for (c = 1; c <= ( * l o c a l _ h e a p [ t i e s [ i ] ] ) . r e a c t a n t s _ t a i l ; c++)
{
alphabet[(*local_heap[ties[i]]).reactants[c]].multiplicity—;
}
//Products m u l t i p l i c i t y
for (c = 1; c <= ( * l o c a l _ h e a p [ t i e s [ i ] ] ) . p r o d u c t s _ t a i l ; C++)
{
alphabet[(*local_heap[ties[i]]).products [c]].multiplicity++;

}
//For statistical purposes, aggrate total # of rules applied
local_sim->rules_applied++;
//and # of times particular rule is applied
Olocal_heap[ties[i]]).times_applied++;
}
//Update all rules affected by the tie
for (i = 0; i < *ties_tail; i++)
{
//Recalculate the wt for the Applied rule must point to ruleslist
//because stuff has possibly moved
recalcTiedWT((*tieptrs[i]).heap_index,alphabet, local_heap,
local_sim);
//Heap maintenance after recalculating the WT of the top node
fixHeap((*tieptrs[i]).heap_index, local_heap);
//Update all the rules affected by the applied rule
updateRules((*tieptrs[i]).rules,alphabet, local_heap, local_sim);
}
}
//Nondeterministically apply as many tied reactions as possible
else
{
//Build an array of pointers to the applied rules, so that we
//can properly update the heap later
struct reaction *applied_rules[MAXREACTIONS];
int applied_rules_tail = 0;
int random = 0; //Used to pick the rule for application
int temp_tail = *ties_tail;
int apply_rule = ISFALSE;
//A temporary variable to be used in swapping elements of the array
struct reaction *temp;
//Apply all the rules before updating the WTs of everything. We
//update the WT for the applied rules, but only to help sort the heap
for (i = 0; i < *ties_tail; i++)
{
//Check if there is only one option
if (i == *ties_tail - 1)
{
random = 0;
}
//If more than one, generate random choice for array
else
{
//Generate random int from 0 to ties_tail-l

random = rand() °/0 temp_tail;
}
random_count++;
//See if enough reactants exist to apply rule
apply_rule = checkRule(random.alphabet, local_heap, ties);
//Enough reactants available
if (apply_rule == ISTRUE)
{

nondeterministic_count++;
(*heap[(*tieptrs[random]).heap_index]).nondetermin++;
(*heap[(*tieptrs[random]).heap_index]).times_applied++;
//Update m u l t i p l i c i t i e s of reactants and products for applied r u l e
//Reactants m u l t i p l i c i t y
for (c = 1; c <= ( * t i e p t r s [ r a n d o m ] ) . r e a c t a n t s _ t a i l ; C++)
{
alphabet [ O t i e p t r s [random]) . r e a c t a n t s [c]] . m u l t i p l i c i t y — ;
}
//Products m u l t i p l i c i t y
for (c = 1; c <= (*tieptrs[random]).products_tail; C++)
{
alphabet[Otieptrs[random]).products[c]].multiplicity++;
}
applied_rules[applied_rules_tail] = tieptrs[random];
//Move to next p o s i t i o n in the applied_rules array
applied_rules_tail++;
//Eliminate applied r u l e from the t i e array
temp = tieptrs[random];
tieptrs[random] = t i e p t r s [ t e m p _ t a i l - l ] ;
t i e p t r s [ t e m p _ t a i l - l ] = temp;
//Decrease the number of r u l e s s t i l l need applying
temp_tail—;
}
//Not enough reactants available (remove node, but do not apply)
else
{

(*heap[(*tieptrs[random]).heap_index]).no_nondetermin++;
temp = tieptrs[random];
tieptrs[random] = t i e p t r s [ t e m p _ t a i l - l ] ;
t i e p t r s [ t e m p _ t a i l - l ] = temp;
temp_tail—;
}
}

//Now fix the WT for each tied rule and ALL affected rules
for (i = 0; i < *ties_tail; i++)
{
//Recalculate the wt for the Applied rule must point to ruleslist
//because stuff has possibly moved
recalcTiedWT((*tieptrs[i]).heap_index,alphabet, local_heap,
local_sim);
//Heap maintenance after recalculating the WT of the top node
fixHeap((*tieptrs[i]).heap_index, local_heap);
//Update all the rules affected by the applied rule
updateRules((*tieptrs[i]),rules,alphabet, local_heap, local_sim);
}
}
}
*ties_tail = 0;
}//end method applyRule
/*
* The method checkTieO checks to see if multiple reactions have
* the minimum waitingtime in the heap. It stores the index
* (from *heap[]) of all of the reactions with a tie
*/
void checkTie(int parent, struct reaction **local_heap,
int *ties_tail, int ties[MAXREACTIONS])
•c

//Check left child exists
if (2 * parent <= rules_tail)
{
if (fabs((*local_heap[l]).waitingtime (*local_heap[2 * parent]).waitingtime) < TDL)
•c

//Store index for tie
ties [*ties_tail] = (2 * parent);
//Increase the tail index (so sim knows tie)
(*ties_tail)++;
//Call checkTie (check children of the tied node)
checkTie(2 * parent, local_heap, ties_tail, ties);
}
}
//Check right child exists
if (2 * parent + 1 <= rules_tail)

i
if (fabs((*local_heap[l]).waitingtime (*local_heap[2 * parent + 1]).waitingtime) < TOL)
•C
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//Store index for tie
ties [*ties_tail] = (2 * parent + 1);
//Increase the tail index (so sim knows tie)
(*ties_tail)++;
//Call checkTie (check children of the tied node
checkTie(2 * parent + 1, local_heap, ties_tail, ties);
}
}
}//end method checkTie
/*
* The method checkRuleO checks to see if the tied rule
* (at *heap[index]) can be applied
* MOTE: it is only needed if there are any reactions trying
* to apply at the same exact time as the reaction
* with min WT (top of heap)
*/
int checkRule(int index, struct protein *alphabet,
struct reaction **local_heap, int ties[MAXREACTIONS])
{
//Counter
int c;
//For each reactant of the tying reaction
for (c = 1; c <= (*local_heap[ties[index]]).reactants_tail; C++)
{
if (alphabet[(*local_heap[ties[index]]).reactants[c]].multiplicity < 1)
return ISFALSE;
}
return ISTRUE;
}//end method checkRule
/*
* The method checkReactants checks all of the reactants
* for all of the tied reactions to see if they can all be applied.
* If they can't it returns ISFALSE, otherwise it returns ISTRUE
*/
int checkReactants(struct protein *alphabet,
struct reaction **local_heap, int *ties_tail, int ties [MAXREACTIONS])
{
//Temp for the reactants list
int reactantmult[ALPHABET];
//Counters
int i,c;
int temp;

//Initialize array
for (i = 1; i <= alphabet_tail; i++)
reactantmult[i] = 0;
//Keep track of how many reactants are needed to
//satisfy ALL reactions in tie
//For each reaction in the tie
for (i = 0; i < *ties_tail; i++)
{

//For each r e a c t a n t of the tying r e a c t i o n
for (c = 1; c <= ( * l o c a l _ h e a p [ t i e s [ i ] ] ) . r e a c t a n t s _ t a i l ;
{
r e a c t a n t m u l t [ ( * l o c a l _ h e a p [ t i e s [ i ] ] ) . r e a c t a n t s [ c ] J ++;
}
>

C++)

//Mow we see if there are enough reactants for the equations
//For each protein in the alphabet
for (i = 1; i <= alphabet_tail; i++)
{
if (alphabet[i].multiplicity - reactantmult[i] < 0)
{
return ISFALSE;
}
}
return ISTRUE;
}//end method checkReactants
/*
* The method updateRulesO is called by the applied rule method
* when there was no ties for WT. All rules affected by the
* multiplicities changes from the applied rule must be recalculated.
*/
void updateRules(struct reaction applied, struct reaction *rules,
struct protein ^alphabet, struct reaction **local_heap,
struct evolution *local_sim)
{
//N.B., the elements in k = alphabet[i].reactionlist[j] is the
//index of the associated reactions in the original list rules[k].
//The reaction is found in the heap by accessing
//(*heap[rules[k].heap_index]). To save time and space, I do not
//simplify these accesses with temp variables.
//Counters
int i,c;
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/ / R e c a l c u l a t e a l l r e a c t i o n s involving each r e a c t a n t of the applied
//rule
for (i = 1; i <= applied.reactants_tail; i++)
•C

for (c = 1; c <= alphabet[applied.reactants[i]].reactionlist_tail; C++)

•C
/ / R e c a l c u l a t e WT of the affected r u l e
recalcAffectedWT(
rules[alphabet[applied.reactants[i]].reactionlist[c]].heap_index,
alphabet, local_heap, local_sim);
//Heap maintenance a f t e r changing a WT
fixHeap(
rules[alphabet[applied.reactants[i]].reactionlist[c]].heap_index,
local_heap);
}
}
//Recalculate all reactions involving each product of the applied rule
for (i = 1; i <= applied.products_tail; i++)
{
for (c = 1; c <= alphabet[applied.products[i]].reactionlist_tail; C++)
{
//Recalculate WT of the affected rule
recalcAffectedWT(
rules[alphabet[applied.products[i]].reactionlist[c]].heap_index,
alphabet, local_heap, local_sim);
//Heap maintenance after changing a WT
fixHeap(
rules[alphabet[applied.products[i]].reactionlist[c]].heap_index,
local_heap);
}
}
}//end method updateRules
/*
* After a cycle (second) is completed, we need to store the
* multiplicity of each protein. The array is
* multiplicities[proteinindex][time].
*/
void storeMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int multiplicities[ALPHABET][PREVIOUSMULT])
•C

//Counter
int i;
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for (i = 1; i <= a l p h a b e t _ t a i l ; i++)
•C

/ / S t o r e the m u l t i p l i c i t y at the time
multiplicities[i][*multiplicities_tail]
}

= alphabet[i].multiplicity;

(*multiplicities_tail)++;
}//end method storeMultiplicity
/*
* The method exportMultiplicityO is used to export the
* multiplicities of all proteins for all of the simulation
* timepoints (usually seconds). It is not to be confused
* with the method exportlnitialMultiplicity which is called
* only once to output the multiplicities at time t=0.
* This method can be called multiple times in a simulation run,
* because the multiplicities array (for each protein) has a
* max = MAXMULT, which is defined in the cascader.h file.
*/
//BEGIN MPI BLOCK
#ifdef USE_MPI
void exportMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int multiplicities[ALPHABET][PREVIOUSMULT],
int rank)
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void exportMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int multiplicities[ALPHABET][PREVIOUSMULT])
#endif
//END NONMPI BLOCK
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Convert the rank to a string so we can create appropriate output
//file
char srank[100] ;
sprintf(srank, "results%o.csv", rank+1);
FILE *ofp;
printf("Begin exporting Values for thread %d...\n",rank);
printf ("Opening existing file ('results0/^, csv') \n", rank);
//File output
//Open file with write prives
ofp = fopen(srank,"a");

141
if (ofp == NULL)
•c

fprintf(stderr, "Can't open output file results.csv!\n");
exit (1) ;
}
#endif
//END MPI BLOCK
//END NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
printf("Begin exporting Values..An");
printf("Opening existing file ('results.csv')\n");
//File output
//Open file with write prives
ofp = fopen("results.csv","a") ;
//END NONMPI BLOCK
if (ofp == NULL)

•C
fprintf(stderr, "Can't open output file results.csv!\n");
exit(1);
}
#endif

int i,c; //counters
for (c = 0; c < *multiplicities_tail; C++)
•C

for (i = 1; i <= alphabet_tail; i++)

{
if (i == alphabet_tail)
fprintf (ofp, "°/0d\n" m u l t i p l i c i t i e s [i] [c] ) ;
else
fprintf(ofp, "%d,".multiplicities[i][c]);
}
}
fclose(ofp);
*multiplicities_tail = 0;
}
/*
* The method exportlnitialMultiplicityO is used to export
* the multiplicities of all proteins for the time t=0.
* It is called only once. All other exporting of multiplicities
* is handled by the method exportMultiplicityO

*/
//BEGIN MPI BLOCK
#ifdef USE_MPI
void exportInitialMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int rank)
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void exportInitialMultiplicity(struct protein ^alphabet,
int *multiplicities_tail)
#endif
//END NONMPI BLOCK
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Convert the rank to a string so we can create appropriate output
//file
char srank[100];
sprintf(srank,"results%o.csv",rank+l);
FILE *ofp;
printf ("Begin exporting Values for thread °/„d. . . \n" ,rank) ;
printf ("Opening existing file ('results°/0d. csv') \n", rank) ;
//File output
ofp = fopen(srank,"w"); //Open file with write prives
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
printf("Begin exporting Values ...\n");
printf("Opening new file\n");
//File output
//Open file with write prives
ofp = fopen("results.csv","w");
#endif
//END NONMPI BLOCK
if (ofp == NULL)
•c

fprintf (stderr, "Can't open output file °/0s!\n", "results.csv");
exit(1);
}

//Counters
int i,c;
for (i = 1; i <= alphabet_tail; i++)
{
if (i == alphabet_tail)
fprintf(ofp, "7od\n" , alphabet [i] .multiplicity);
else
fprintf (ofp, "°/0d," .alphabet [i] .multiplicity);
}
fclose(ofp);
*multiplicities_tail = 0;
}
//BEGIN MPI BLOCK
#ifdef USE_MPI
void printlnitialStepToFile(struct reaction **local_heap,
double simulation_time, int rank)
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void printlnitialStepToFile(struct reaction **local_heap,
double simulation_time)
#endif
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//convert the rank to a string so we can create appropriate
//file

char srank[100] ;
sprintf(srank, "simulation°/„o. csv" ,rank+l) ;
FILE *ofp;
//File output
//Open file with write prives
ofp = fopen(srank,"w");
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
//Open file with write prives
ofp = fopen("simulation.csv","w");
#endif
//END NONMPI BLOCK

if (ofp == NULL)
{
fprintf(stderr, "Can't open output file %s!\n","info.csv");
exit(l);
}
//Print the nondeterminism information
//Counters
int c,i ;
fprintf (ofp, "Simulation Time = ,°/0lf \n" ,simulation_time);
fprintf(ofp,"Reaction ID,WT,Memory,Nondeterministic Applied,"+
Mondeterministic Not Applied,Total Applied\n");
for (c = 1; c <= rules_tail; C++)
{
//Print Information on each Rule
fprintf (of p,"°/os,7,lf,%lf,%d,70d,°/0d\n",(*local_heap[c]). id,

(*local_heap[c]).waitingtime,(*local_heap[c]).memory_perc,
(*local_heap[c]).nondetermin,(*local_heap[c]).no_nondetermin,
(*local_heap[c]).times_applied);
}
//Close file output
fclose(ofp);
}//end method printlnitialStepToFile
//BEGIN MPI BLOCK
#ifdef USE_MPI
void printStepToFile(struct reaction **local_heap,
double simulation_time, int rank)
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void printStepToFile(struct reaction **local_heap,
double simulation_time)
#endif
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Convert the rank to a string so we can create appropriate output
//file
char srank[100];
sprintf(srank,"simulation%o.csv",rank+l);
FILE *ofp;
//File output
//Open file with write prives
ofp = fopen(srank,"a");

#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
//Open file with write prives
ofp = fopenC'simulation.csv", "a");
#endif
//END NONMPI BLOCK
if (ofp == NULL)
{
fprintf(stderr, "Can't open output file %s!\n","info.csv");
exit(l);
}
//Print the nondeterminism information
int c,i;
//printf("What the Crap?");
fprintf(ofp,"Simulation Time =,Zlf\n",simulation_time);
fprintf(ofp,"Reaction ID,WT,Memory,Nondeterministic Applied,"+
Nondeterministic Not Applied,Total Applied\n");
for (c = 1; c <= rules_tail; C++)
{
/ / P r i n t Information on each Rule
f p r i n t f (ofp, "7„s,70lf / / I f ,7od,%d,70d\n", (*local_heap[c]) . i d ,
(*local_heap[c]).waitingtime,(*local_heap[c]).memory_perc,
(*local_heap[c]).nondetermin,(*local_heap[c]).no_nondetermin,
(*local_heap [ c ] ) . t i m e s _ a p p l i e d ) ;
}
//Close file output
fclose(ofp);
}//end method printStepToFile
/*
* The method printFinallnfo() is used to gain information on
* the simulator. Mostly, it targets the nondeterministic aspects
* of the simulator.
*/
//BEGIN MPI BLOCK
#ifdef USE_MPI
void printFinallnfo(struct reaction *rules, struct protein *alphabet,
int nondeterministic_count, int random_count, int ties_count,
int rank)
#endif
//END MPI BLOCK
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//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void printFinallnfo(struct reaction *rules, struct protein *alphabet,
int nondeterministic_count, int random_count, int ties_count)
#endif
//END NONMPI BLOCK
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Convert the rank to a string so we can create appropriate output
//file

char srank[100];
s p r i n t f (srank, "inf o°/„o . csv" ,rank+l) ;
FILE *ofp;
printf ("Exporting final information for °/0d. . .\n" ,rank) ;
//File output
//Open file with write prives
ofp = fopen(srank,"a");
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
printf("Exporting Final Information..An");
//Open file with write prives
ofp = fopen("info.csv","w");
#endif
//END NONMPI BLOCK
if (ofp == NULL)
{
fprintf(stderr, "Can't open output file °/0s!\n", "info.csv");
exit(l);
}
fprintf(ofp, "# of ties = %d\n" ,ties_count);
fprintf(ofp, "# of random variables generated = °/„d\n" ,random_count);
f printf (ofp, "# of nondeterministically applied rules = 7od\n",
nondeterministic_count);
//Print the nondeterminism information
//Counters
int c,i;
fprintf(ofp,"Index , ID , Nondeterministic Applied ,
"Nondeterministic Not Applied, Total Applied, Reactant 1, "+

"Reactant 2, Reactant 3, Product 1, Product 2, Product 3\n");
for (c = 1; c <= rules_tail; C++)
{
//Print information on the number of times rule was applied
//at the end of run
fprintf (ofp, "%d,%s,°/„d,°/0d,0/0d, " , c,rules [c] . id,rules [c] .nondetermin,
rules [c].no_nondetermin,rules [c].times_applied);
//Print the Reactants for the reaction
for (i = 1; i <= 3; i++)
{

if (i <= r u l e s [ c ] . r e a c t a n t s _ t a i l )
f p r i n t f ( o f p , " % s , " . a l p h a b e t [ r u l e s [c] . r e a c t a n t s [ i ] ] .name);
else
fprintf(ofp,",",alphabet[rules [c].reactants[i]].name);
}
//Print the products for the reaction
for (i = 1; i <= 3; i++)

•c
if ( i <= r u l e s [ c ] . p r o d u c t s _ t a i l )
fprintf (ofp, "°/0s,", alphabet [rules [c] .products [ i ] ] .name);
else
fprintf(ofp,",",alphabet[rules[c].products[i]].name);
}
//End the line for the next reaction information
fprintf(ofp,"\n");
}
//Close the file 10
fclose(ofp);
}//end method printFinallnfo
//******************** REACTION METHODS *************************//
/*
* The method initializeConstrO is run once before the user is
* prompted with the initial menu. The Constrs are needed to
* calculate the WTs for each reaction. Constr is based on the
* kinetic rate, Avogadro's number, and the order of the reaction
* Currently the simulator has a max order of three. If necessary,
* all higher order reactions can be divided into subreactions of
* lower order in the SBML file
*/
void initializeConstr(struct reaction *rules)
•C

//Counter
int i;
for (i = 1: i <= rules_tail; i++)

{
if ( r u l e s [ i ] . r e a c t a n t s _ t a i l == 2)
r u l e s [ i ] . c o n s t r = r u l e s [ i ] . k i n e t i c / AVO;
e l s e if ( r u l e s [ i ] . r e a c t a n t s _ t a i l == 3)
r u l e s [ i ] . c o n s t r = r u l e s [ i ] . k i n e t i c / (AVD * AVO);
else
rules[i].constr = rules[i].kinetic;
}
}//end method initializeConstrstruct reaction **local_heap
/*
* The method initializeLagO is run once before the user is prompted
* with the initial menu. All lags are set to 0, and remain this way
* unless the user specificies the lags.
*/
#ifdef USE_LAGS
void initializeLag(struct reaction *rules)
{
//Counter
int i;
//Initialize lag values for all rules
for (i = 1; i <= rules_tail; i++)

i
rules[i] -lag = 0;
rules[i].lagmultiplicity = 0;
rules[i] .tau = 0;
}
//Initialize the two lag arrays — set all values to inf
for (i = 0; i < MAXLAGS; i++)
{
taullags[i] = (1.0/0.0);
tau21ags[i] = ( 1 . 0 / 0 . 0 ) ;
}
//Initialize the heads and tails for the queues
taulhead = 0;
tau2head = 0;
taultail = 0;
tau2tail = 0;
}//end method initializeLag
#endif
/*
* The method initializeWTsO calculates the WT for each reaction
* at t=0. It is run only once, which is before the user is prompted
* with the menu.

*/
void initializeWTs(struct reaction *rules, struct protein, ^alphabet)
{
printf("Initializing the WTs...\n");
int i;
//rule_WT is a pointer to a reactions WT
double *rule_WT;
double *rule_Mem;
double constr;
#ifdef USE_LAGS
double lag;
#endif
for (i = 1; i <= rules_tail; i++)
{
rule_WT =
ferules[i].waitingtime;
rule_Mem = ferules[i].memory_WT;
rules[i].memory_perc = 1.0;
constr = r u l e s [ i ] . c o n s t r ;
#ifdef USE_LAGS
lag = r u l e s [ i ] . l a g ; //CHANGES
calclnitialWTs(rule_WT,rule_Mem,constr,rules[i].reactants,
rules[i].reactants_tail,alphabet,lag);
#endif
#ifndef USE_LAGS
calcInitialWTs(rule_WT,rule_Mem,constr,rules[i].reactants,
rules[i].reactants_tail,alphabet);
#endif
}
}//end method initializeWTs
/*
* The method changeLagO is only executed if the user selects
* to do so in the menu. The method prompts the user for two lag
* rules. If the user only wants one lag, then for the second lag,
* just pick on outside the boundaries of the rules list, but within
* the boundaries of the array (i.e., <= MAXREACTIONS)
*/
#ifdef USE_LAGS
void changeLag(struct reaction *rules, struct protein *alphabet)
{
/**************SETUP TAU1************************************/
//Print the rules so user can choose the two lag rules from list
printRules(rules,alphabet);
//Counters
int c,i;

double templag;
printf("Which rule is taul?");
scanf ("7.d", &c) ;
//Confirm Choice
printf ("You have chosen °/0d\n",c);
//Print data for chosen rule
printf("70d:Reaction %s: constr = lit,
k = 7„lf, WT = 7.1f," +
" Lag = 7.1f\nREACTANTS: ",c,rules[c].id,rules[c].constr,
rules[c].kinetic,rules[c].waitingtime,rules[c] .lag);
for (i = 1; i <= rules[c].reactants_tail; i++)
printf ("7oS ", alphabet [rules [c] . reactants [i] ] . name);
printf("\nPRODUCTS: " ) ;
for ( i = 1; i <= r u l e s [ c ] . p r o d u c t s _ t a i l ; i++)
p r i n t f ("7oS ",alphabet [rules [c] .products [ i ] ] .name) ;
p r i n t f ("\nThere are 7od r e a c t a n t s and 7.d p r o d u c t s \ n " ,
rules[c].reactants_tail,rules[c].products_tail);
templag = 0;
printf("What is the value of lag taul?\n");
scanf ('"/.If", fetemplag);
rules[c].lag = templag;
printf("Lag taul has been changed to %lf\n".rules[c].lag);
//Tell the rule that it is taul
//—> so it points to the right array, taullags[]
rules[c].tau = 1;
/*****#****=tc***SEXUP TAU2***********************************/
printf("Which rule is tau2?");
scanf("%d", &c);
//Confirm Choice
printf ("You have chosen 7»d\n",c);
//Print data for chosen rule
printf ("7.d: Reaction 7.s: constr = 7.1f, k = 7.1f, WT = 7.1f," +
" Lag = %lf\nREACTANTS: ",c.rules[c].id,rules[c].constr,
rules[c].kinetic,rules[c].waitingtime,rules[c].lag);
for (i = 1; i <= rules[c].reactants_tail; i++)
printf ("70s ", alphabet [rules [c] . reactants [i] ] . name);
printf("\nPRDDUCTS: " ) ;
for ( i = 1; i <= r u l e s [ c ] . p r o d u c t s _ t a i l ; i++)
p r i n t f ("7oS ", alphabet [rules [c] . products [i] ] . name) ;
p r i n t f ("\nThere are 7od r e a c t a n t s and 7»d products\n",
rules[c].reactants_tail,rules[c].products_tail);
templag = 0;
printf("What is the value of lag tau2?\n");
scanf ("7.1f" , fetemplag);
rules[c].lag = templag;

printf ("Lag tau2 has been changed to °/„lf\n", rules [c] .lag);
//Tell the rule that it is taul
//—> so it points to the right array, taullagsG
rules[c].tau = 2;
//Reinitialize WTs and heap
buildMinHeap(heap);
}//end method changeLag
#endif
/*
* The method caldnitialWTsO calculates the WT time t=0.
* It is run only once, which is before the user is prompted
* with the menu
*/
#ifdef USE_LAGS
void calcInitialWTs(double *rule_WT, double *rule_Mem,
double constr, int reactants[], int reactants_tail,
struct protein alphabet[], double lag)
#endif
#ifndef USE_LAGS
void calcInitialWTs(double *rule_WT, double *rule_Mem,
double constr, int reactantsD, int reactants_tail,
struct protein alphabet[])
#endif
{
//Counter
int i;
//Calculate the velocity based on kinetics
double velocity = 1;

for (i = 1; i <= r e a c t a n t s _ t a i l ; i++)
{
velocity = velocity * alphabet[reactants[i]].multiplicity;
}
velocity = velocity * constr;
*rule_WT = (1 / velocity);
*rule_Mem = (1 / velocity);
}//end method calcInitialWTs
/*
* The method recalcAppliedWT is called after the applied rule
* been executed by simulator and the WT must be recalculated.
*/
void recalcAppliedWT(struct protein *alphabet,
struct reaction **local_heap, struct evolution *local_sim)
{

//Check if it is a lagging rule
#ifdef USE_LAGS
if (Olocal_heap[l]) .lag == 0)
{
#endif
/*BEGIN NON LAG VERSION*/
//Counter
int i;
//Calculate the velocity based on kinetics
double velocity = 1;
for (i = 1; i <= (*local_heap[l]).reactants_tail; i++)
{
velocity = velocity *
alphabet [Olocal_heap[l]) . r e a c t a n t s [ i ] ] . m u l t i p l i c i t y ;
}
velocity = velocity * (*local_heap[l]).constr;
( * l o c a l _ h e a p [ l ] ) . w a i t i n g t i m e = (1 / v e l o c i t y ) +
local_sim->simulation_time;
( * l o c a l _ h e a p [ l ] ) .memory_perc = 1.0;
/*END NON LAG VERSION*/
# i f d e f USE_LAGS
}
//Rule has Lag
else
•C

//Since the rule was just applied, WE KNOW that the tail must
//move forward, unlike the other calcWT methods
if ((*local_heap[l]).tau == 1)
{
taulhead++;
//Check if exceeded array size, and wrap around if needed
if (taulhead == MAXLAGS)
taulhead = 0;
//If there are no more in queue, set WT to infinity
if (taulhead == taultail)
{
/*DEBUG*/ printf("There are no more molecules to lag (taul)");
(*local_heap[l]).waitingtime = (1.0 / 0.0);
(*local_heap[l]).lagmultiplicity = 0;
}
else

•C
(*local_heap[l]).waitingtime = t a u l l a g s [ t a u l h e a d ] ;
(*local_heap[1]).lagmultiplicity—;
}

}
//Since the rule was just applied, WE KNOW that the tail must
//move forward, unlike the other calcWT methods
if ((*local_heap[l]).tau == 2)
{
tau2head++;
//Check if exceeded array size, and wrap around if needed
if (tau2head == MAXLAGS)
tau2head = 0;
//If there are no more in queue, set WT to infinity
if (tau2head == tau2tail)
{
/*DEBUG*/ printf("There are no more molecules to lag (tau2)");
(*local_heap[l]).waitingtime = (1.0 / 0.0);
(*local_heap[l]).lagmultiplicity = 0;
}
else
{

(*local_heap[l]).waitingtime = tau21ags[tau2head];
(*local_heap[l]).lagmultiplicity—;
}
}
}
#endif
/*DEBUG printf ("WT is NOW °/„lf\n", (*heap[l]) .waitingtime) ;*/
}//end method recalcAppliedWT
/*
* The method recalcTiedWT is called when the rules in the tied
* list may have moved, so we must recalculate the applied rule
* but it may not be in the head node position. So, it appears
* similar to the recalcAppliedWT method, but it doesn't go for
* the head node position.
*/
void recalcTiedWT(int index, struct protein ^alphabet,
struct reaction **local_heap, struct evolution *local_sim)
{
#ifdef USE_LAGS
if ((*local_heap[index]).lag == 0)
{
#endif
/*BEGIN N0N LAG VERSION*/
//Counter
int i;
//Calculate the velocity based on kinetics

154
double velocity = 1.0;
for (i = 1; i <= ( * l o c a l _ h e a p [ i n d e x ] ) . r e a c t a n t s _ t a i l ;
{

i++)

velocity = velocity *
alphabet[(*local_heap[index]).reactants[i]].multiplicity;
}
velocity = velocity * (*local_heap[index]).constr;
(*local_heap[index]).waitingtime = (1 / velocity) + local_sim->simulation_time;
(*local_heap[index]).memory_perc = 1.0;
/*END NON LAG VERSION*/
#ifdef USE_LAGS
}
//Rule has Lag
else
{
//Since the rule was just applied, WE KNOW that the tail must
//move forward, unlike the other calcWT
if ((*local_heap[index]).tau == 1)
{
taulhead++;
//Check if exceeded array size, and wrap around if needed
if (taulhead == MAXLAGS)
taulhead = 0;
//If there are no more in queue, set WT to infinity
if (taulhead == taultail)

•C
/*DEBUG*/ printf("There are no more molecules to lag (taul)");
(*local_heap[index]).waitingtime = (1.0 / 0.0);
(*local_heap[index]).lagmultiplicity = 0;
}
else
{

(*local_heap[index]).waitingtime = t a u l l a g s [taulhead];
(*local_heap[index]).lagmultiplicity—;
>
}
//Since the rule was just applied, WE KNOW that the tail must
//move forward, unlike the other calcWT methods
if ((*local_heap[index]).tau == 2)
{
tau2head++;
//Check if exceeded array size, and wrap around if needed
if (tau2head == MAXLAGS)
tau2head = 0;

//If there are no more in queue, set WT to infinity
if (tau2head == tau2tail)
{
/*DEBUG*/ printf("There are no more molecules to lag (tau2)
(*local_heap[index]).waitingtime = (1.0 / 0.0);
(*local_heap[index]).lagmultiplicity = 0;
}
else
{

(*local_heap[index]).waitingtime = tau21ags[tau2head];
(*local_heap[index]).lagmultiplicity—;
}
}
}
#endif
/* printf ("WT is NOW °/„lf\n", (*heap[l]) .waitingtime) ;*/
}//end method recalcAppliedWT
/*
* The method recalcAffectedWTAfter applying a rule, all
* affected rules (sharing reactants or products) must have
* their WT recalculated, and the heap must be fixed after
* each recalculation (handled in updateRules method)
*/
void recalcAffectedWT(int index, struct protein *alphabet,
struct reaction **local_heap, struct evolution *local_sim)
•C

#ifdef USE_LAGS
if ((*local_heap[index]).lag == 0)
{
#endif
//Counter
int i;
//Calculate the velocity based on kinetics
double velocity = 1;

for (i = 1; i <= ( * l o c a l _ h e a p [ i n d e x ] ) . r e a c t a n t s _ t a i l ;
{

i++)

velocity = velocity *
alphabet[(*local_heap[index]).reactants[i]].multiplicity;
>

velocity = velocity * (*local_heap[index]).constr;
//If the new WT is infinity (no molecules available)
if (velocity == 0.0)
{

if ((*local_heap[index]).waitingtime == ( 1 . 0 / 0 . 0 ) )
(*local_heap [index]) .memory_perc = 1.0;
else
{
//(amt_of_time_left_to_wait)/(total_time_to_wait)
(*local_heap[index]).memory_perc = ((*local_heap[index]).waitingtime local_sim->simulation_time) / (*local_heap[index]).memory_WT;
}
//Set to infinity
(*local_heap[index]).waitingtime = 1.0 / velocity;
}
//Elseif WT is smaller
else if (((*local_heap[index]).memory_perc*(l / velocity) +
local_sim->simulation_time) < (*local_heap[index]).waitingtime)
{
(*local_heap[index]).waitingtime =
(*local_heap[index]).memory_perc*(l.0 / velocity) +
local_sim->simulation_time;
(*local_heap[index]).memory_WT = (1.0 / velocity);
}
//Note: else, WT is not smaller and there are enough molecules
//to execute reaction, so do nothing
#ifdef USE_LAGS
}
//Rule has Lag
else
{
if ((*local_heap[index]).tau == 1)
{
//If we actually have another molecule to lag (due to the products
//of this rule, the former if statement will succeed when the product
//concentration changes — but there are no new reactants
if (alphabet[(*local_heap[index]).reactants[1]].multiplicity >
(*local_heap[index]).lagmultiplicity)
{
t a u l l a g s [ t a u l t a i l ] = local_sim->simulation_time +
(*local_heap[index]).lag;
taultail++;
//Check if exceeded array size
if (taultail == MAXLAGS)
taultail = 0;
(*local_heap[index]).lagmultiplicity++;
//Store FIRST lag value
if ((*local_heap[index]).lagmultiplicity == 1)
(*local_heap[index]).waitingtime = taullags[taulhead];
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}
if ((*local_heap[index]).lagmultiplicity == MAXLAGS - 5)
{
printWTs(heap);
printAlphabet(alphabet);
printf(M***********\nERROR: Out of lag array space for taul\n");
exit(l);
}
}
if ((*local_heap[index]).tau == 2)
{
//printf("Made it inside tau 2\n");
//If we actually have another molecule to lag (due to the products
//of this rule, the former if statement will succeed when the product
//concentration changes — but there are no new reactants
if (alphabet[(*local_heap[index]).reactants[1]].multiplicity >
(*local_heap[index]).lagmultiplicity)
{

tau21ags[tau2tail] = local_sim->simulation_time +
(*local_heap[index]).lag;
tau2tail++;
//Check if exceeded array size
if (tau2tail == MAXLAGS)
tau2tail = 0;
//Aggregate the lagmultiplicity, because that molecule is cued
//up in the lag array now
(*local_heap[index]).lagmultiplicity++;
//Store FIRST lag value
if ((*local_heap[index]).lagmultiplicity == 1)
(*local_heap[index]).waitingtime = tau21ags[tau2head];
}

if ((*local_heap[index]).lagmultiplicity == MAXLAGS - 5)
{
printWTs(heap);
printAlphabet(alphabet);
printf("***********\nERR0R: Out of lag array space for tau2\n");
exit(l);
}
}
}
#endif
}//end method recalcAffectedWT
//*************** STANDARD HEAP MAINTENANCE ***************//
/*

* Initially build the min heap so the smallest waiting time is the
* first element.
*/
void buildMinHeap(struct reaction **local_heap)
{
//Counter
int count;
for(count = (rules_tail/2); count >= 1; count—)
heapDown(count, local_heap);
}//end method buildMinHeap
//Check children of node to see if minheap property holds true
void heapDown(int node, struct reaction **local_heap)
{
//Set smallest
int min = node;
//Get right index
int right = 2 * node + 1;
//Get left index
int left = 2 * node;
//Check if left child exists
if (left <= rules_tail)
if ((*local_heap[left]).waitingtime < (*local_heap[min]).waitingtime)
{
min = left;
}
//Check if right child exists
if (right <= rules_tail)
if ((*local_heap[right]).waitingtime < (*local_heap[min]).waitingtime)
•C

min = right;
}
if (min != node)
{
swap(min,node, local_heap);
heapDown(min, local_heap);
}
}//end method heapDown
/*
* The Swap method swaps two nodes in the heap
*/
void swap(int a, int b, struct reaction **local_heap)
{
struct reaction *temp;
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temp = local_heap[a];
local_heap[a] = local_heap[b];
local_heap[b] = temp;
//Store the heap index in the reaction node,
//for reference of molecule reaction list

(*local_heap[a]).heap_index = a;
(*local_heap[b]).heap_index = b;
}//end method swap
//Readjust the heap for the node with changed WT
void fixHeap(int node, struct reaction **local_heap)
{
//Check parent of node for min-heap property
//Does parent exist?
if ((node/2) >= 1)
if ((*local_heap[node/2]).waitingtime >
(*local_heap[node]).waitingtime)
{
swap(node/2,node, local_heap);
fixHeap(node/2, local_heap);
}
//Check children of node for min-heap property
//Set smallest
int min = node;
//Check if left child exists
if ((2*node) <= rules_tail)
if ((*local_heap[(2*node)]).waitingtime <
(*local_heap[min]).waitingtime)
min = (2*node);
//Check if right child exists
if ((2*node+l) <= rules_tail)
if ((*local_heap[(2*node+l)]).waitingtime <
(*local_heap[min]).waitingtime)
min = (2*node+l);
if (min != node)
•C

swap(min,node, local_heap);
fixHeap(min, local_heap);
}
}//end method fixHeap*/
//******************** EXTRA METHODS ***********************//
//Check the maximum of reactions for a given protein
void findMaxReactionlist(struct reaction *rules,
struct protein *alphabet)

{
//Counter
int i;
//The max number of reactions associated to protein
int max = 0;
//Alphabet index of max
int max_index = 0;
for (i = 1; i < alphabet_tail; i++)
{
printf ("Protein °/„s has °/„d reactions\n",
alphabet[i] .id,alphabet[i].reactionlist_tail);
if (alphabet[i].reactionlist_tail > max)
{
max_index = i;
max = a l p h a b e t [ i ] . r e a c t i o n l i s t _ t a i l ;
}
}
printf("**************** " ) ;
p r i n t f ("Protein °/0s has °/„d r e a c t i o n s associated with i t . \ n " ,
alphabet[max_index].id,max);
}//end method findMaxReactionlist
//********** GILLESPIE METHODS ************//
/*
* The method printGillesp is used to check the values of h,
* a, aO, gtau, gmu to see if we are rocking and rolling.
*/
void printGillespRules(struct reaction *rules,
struct protein *alphabet)
{
printf("***************************\nPrinting Rules...\n");
int c,i;
for (c = 1; c <= rules_tail; C++)
{
printf ('"/.el: Reaction %s: a = %lf, constr = '/.If, k = */.lf\nREACTANTS:
c,rules[c].id,rules[c].a,rules[c] .constr,rules[c].kinetic);
for (i = 1; i <= rules[c].reactants_tail; i++)
printf ("°/0s ", alphabet [rules [c] . reactants [i]] .name);
printfO'V);
}
}//end method printReactionlist
/*
* The method prints the A vals for Gillespie
*/

void printGillespAvals(struct reaction *rules)
{
printf("***************************\nPrinting A vals...\n");
int c;
for (c = 1; c <= rules_tail; C++)
{
printf("7od:Reaction %s: a = %lf\n",c.rules[c].id,rules[c].a);
}
}
/*
* The gillespie is the implementation of the original Gillespie
*/
#ifdef USE_MPI
void gillesp(struct reaction *rules, struct protein *aiphabet,
int rank)
//END MPI BLOCK
#endif
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void gillesp(struct reaction *rules, struct protein *alphabet)
#endif
{
//Struct for maintaining all the information regarding an actual
//simulation run (simtimes, exporting times, etc.)
struct evolution sim;
//BEGIN MPI BLOCK
#ifdef USE_MPI
initializeSim(&sim,rank);
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
initializeSim(&sim);
#endif
//END NONMPI BLOCK
//aO to be passed as pointer to various functions
double aO;
//Create a 2D array to store the previous multiplicities
//per cycle of proteins
int multiplicities[ALPHABET][PREVIOUSMULT];
int multiplicities_tail = 0;
//Initially calculate h_is and a_is and aO
initializeGillesp(rules, alphabet, &a0);
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//Export the initial multiplicity of each protein to file on HD
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
exportGillespInitialMultiplicity(alphabet, &multiplicities_tail);
#endif
//END NONMPI BLOCK
#ifdef USE_MPI
exportGillespInitialMultiplicity(alphabet, &multiplicities_tail,rank);
#endif

//Initialize random Number Generator
unsigned int iseed = (unsigned int)time(NULL);
srand(iseed);
//Generate rl and r2
double rl = (rand()/((double)RAND_MAX+1));
double r2 = (rand()/((double)RAND_MAX+l)) ;
//Calculate gtau (In function and uses aO and rl) and
//gmu (do-loop, add up ai's until you equal or exceed r2*a0)
//gtau = what time to apply rule [gmu]
double gtau = calculateGtau(rules,alphabet,rl,a0);
//gmu = what rule to apply rule [gmu]
int gmu = calculateGmu(rules,alphabet,r2,aO);
//Time the program
time_t start, finish;
//Start timer
time(festart);
do
{
//Apply rule[gmu], update the multiplicities of products and reactants
applyRuleGillesp(rules,alphabet,gmu,&a0);
//Fix all as,hs, and aO THIS IS BAD!!!
initializeGillesp(rules,alphabet,&a0);
//Aggregate the simulation time
sim.simulation_time += gtau;
//Output the mutliplicities
if (sim.simulation_time / (sim.completed_cycles + 1) > 1)
//THEN a second has completed, so we must export

•C
//Aggregate completecycles
sim.completed_cycles++;

//Print current second on screen
printf ("°/„d\n" ,sim.completed_cycles);
storeMultiplicity(alphabet, &multiplicities_tail, multiplicities);
if (multiplicities_tail == PREVIOUSMULT)
//THEN the multiplicities arrays is full
{
printf ("Exporting at time t = °/0lf\n", sim.simulation_time) ;
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
//Export the multiplicity arrays
exportGillespMultiplicity(alphabet, &multiplicities_tail,
multiplicities);
#endif
//END NONMPI BLOCK
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Export the multiplicity arrays
exportGillespMultiplicity(alphabet, &multiplicities_tail,
multiplicities, rank);
#endif
//END MPI BLOCK
}
}
//Generate new rl and r2
rl = (rand()/((double)RAND_MAX+D);
r2 = (rand()/((double)RAND_MAX+l));
//Calculate gtau (In function and uses aO and rl) and
//gmu (do-loop, add up ai's until you equal or exceed r2*a0)
gtau = calculateGtau(rules,alphabet,rl,aO);
gmu = calculateGmu(rules,alphabet,r2,a0);
} while (sim.completed_cycles < (sim.goal_cycles));
//Export some debugging information
printGillespFinallnfo(rules,alphabet,sim,gtau,gmu,aO);
#ifndef USE_MPI
//Export the final multiplicity
exportGillespMultiplicity(alphabet, &multiplicities_tail,
multiplicities);
#endif
#ifdef USE_MPI
//Export the final multiplicity
exportGillespMultiplicity(alphabet, &multiplicities_tail,
multiplicities,rank);

#endif
time(&finish);
printf (,l******************************************************\n11) •

printf("* Simulator finished in %.2f seconds *\n",
difftime(finish, start));
printf (,l******************************************************\n1') •
}
/*
* The method initializeGillesp calculates all of the his, ais,
* and aO for the first time step his use constr instead of kinetic
*/
void initializeGillesp(struct reaction *rules,
struct protein *alphabet, double *a0)
•c

//temp for h
double temph;
//temp for aO
double tempaO = 0;
//Counters
int c,i;
for (c = 1; c <= rules_tail; C++)
{
temph = 1;
//Calculate h=Xl*...*Xn for all reactants involved in'reaction
for (i = 1; i <= rules[c].reactants_tail; i++)

•C
temph = temph * (double)alphabet[rules[c] . r e a c t a n t s [ i ] ] . m u l t i p l i c i t y ;
}
r u l e s [ c ] . h = temph;
/ / C a l c u l a t e a=h*c
rules[c].a = rules[c].h * rules[c].constr;
/*DEBUG if ( r u l e s [ c ] . a < 0)
{
printf("ERROR: 'a' is negative\n");
//printGillespRules(rules,alphabet);
printf("The problematic rule is %d",c);
for (i = 1; i <= rules[c].reactants_tail; i++)
{
temph = temph * a l p h a b e t [ r u l e s [ c ] . r e a c t a n t s [ i ] ] . m u l t i p l i c i t y ;
}
//printGillespRules(rules,alphabet);
exit(l);

}*/
}
//Calculate aO
for (c = 1; c <= rules_tail; C++)
{
tempaO += rules[c].a;
}
//Store new aO value
*aO=tempaO;
}
/*
* The method calculateTauO returns the gtau value
*/
double calculateGtau(struct reaction *rules, struct protein *alphabet,
double rl, double aO)
{
//return the value of gtau
return ((1/aO) * log(l/rl));
}
/*
* The method calculateGmuO returns the gmu value
*/
int calculateGmu(struct reaction *rules, struct protein *alphabet,
double r2, double aO)
{
//Counter
int c = 0;
double goal = r2 * aO;
double sum = 0;
//Find the index, c, of the array of rules whose a value is s.t.
//sum ai's up to ac is >= r2*a0
do
{
C++; //start at 1
sum += rules[c].a;
}while (sum <= goal);
return c;
}
/*
* The method applyRuleGillespO is similar to the method
* applyRule for the NWT algorithm. It updates the multiplities
* for the reactants and products of the rule[gmu].
*/
void applyRuleGillesp(struct reaction *rules,
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struct protein *alphabet, int gmu, double *a0)
{
//Counter
int i ;
double temph,olda;
rules[gmu].times_applied++;
//Update Multiplicities of reactants and products and a's and h's
//Reactants multiplicity

for (i = 1; i <= r u l e s [ g m u ] . r e a c t a n t s _ t a i l ;
{

i++)

alphabet[rules[gmu].reactants[i]].multiplicity—;
}
//Products multiplicity

for (i = 1; i <= rules[gmu].products_tail;
{

i++)

alphabet[rules[gmu].products[i]].multiplicity++;
}
}
/*
* The method exportlnitialMultiplicityO is used to export the
* multiplicities of all proteins for the time t=0. It is called
* only once. All other exporting of multiplicities is handled by
* the method exportMultiplicityO
*/
#ifndef USE_MPI
void exportGillespInitialMultiplicity(struct protein *alphabet,
int *multiplicities_tail)
#endif
#ifdef USE_MPI
void exportGillespInitialMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int rank)
#endif
{
//BEGIN MPI BLOCK
#ifdef USE_MPI
//Convert the rank to a string so we can create appropriate output
//file

char srank[100];
sprintf (srank, "resultsGillesp°/ 0 o.csv" ,rank+l) ;
FILE *ofp;
printf ("Begin exporting Values for thread °/„d. . An" ,rank) ;
printf ("Opening existing file ('resultsGillespyod.csvOXn" ,rank);
//File output
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//Open file with write prives
ofp = fopen(srank,"w");
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
printf("Begin exporting Values..An");
printf("Opening new file\n");
//File output
//Open file with write prives
ofp = fopen("resultsGillesp.csv","w");
#endif
//END NONMPI BLOCK
if (ofp == NULL)
{
fprintf (stderr, "Can't open output file °/,s!\n", "resultsGillesp.csv");
exit(l);
}
int i,c; //counters
for (i = 1; i <= alphabet_tail; i++)
{
if (i == alphabet_tail)
fprintf (ofp, "°/0d\n", alphabet [i] .multiplicity);
else
fprintf (ofp, "70d,", alphabet [i] .multiplicity);
}
fclose(ofp);
*multiplicities_tail = 0;
}//end method exportGillespInitialMultiplicity
#ifndef USE_MPI
void exportGillespMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int multiplicities[ALPHABET] [PREVIOUSMULT])
#endif
#ifdef USE_MPI
void exportGillespMultiplicity(struct protein *alphabet,
int *multiplicities_tail, int multiplicities[ALPHABET][PREVIOUSMULT] ,
int rank)
#endif
{
//BEGIN MPI BLOCK
#ifdef USE_MPI

//convert the rank to a string so we can create appropriate output
//file
char srank[100];
sprintf (srank,"resultsGillesp°/„o.csv" ,rank+l) ;
FILE *ofp;
printf("Begin exporting Values for thread %d..An",rank);
printf ("Opening existing file OresultsGillesp%d.csv')\n" ,rank);
//File output
//Open file with write prives
ofp = fopen(srank,"a");
if (ofp == NULL)
{
fprintf(stderr, "Can't open output file resultsGillesp.csv!\n");
exit(l);
}
#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
FILE *ofp;
printf("Begin exporting V a l u e s . . A n " ) ;
printf("Opening e x i s t i n g f i l e O r e s u l t s G i l l e s p . c s v ' ) \ n " ) ;
//File output
//Open file with write prives
ofp = fopenC'resultsGillesp.csv","a");
//END NONMPI BLOCK
if (ofp == NULL)
{
fprintf(stderr, "Can't open output file results.csv!\n");
exit(l);
}
#endif
//END NONMPI BLOCK
int i,c; //counters
for (c = 0; c < *multiplicities_tail; C++)
{
for (i = 1; i <= alphabet_tail; i++)
•c

if (i == a l p h a b e t _ t a i l )
fprintf (ofp, "°/„d\n" , m u l t i p l i c i t i e s [i] [c] ) ;
else
fprintf (ofp, "'/.d," .multiplicities [i] [c]) ;

}
}
fclose(ofp);
*multiplicities_tail = 0;
}//end method exportGillespMultiplicity
/*
* The method printGillespFinallnfo prints the final
* information on the simulation
*/
void printGillespFinallnfo(struct reaction *rules,
struct protein *alphabet, struct evolution sim, double
double aO)
•c

printfC'The simulator has terminated at t = %lf\n"+
"Next gtau = '/.If (t+gtau = °/„lf)\ngmu = °/0d\naO = %lf \n",
sim.simulation_time,gtau,sim.simulation_time+gtau, gmu, a
}//end method pringGillespDebugO
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//*************** CONSTANT DECLARATION ********************//
//Max length for XML line
#define READBUFF 200
//Max length for protein name
#define PROTEINNAME 50
//Max length for protein Id
#define PROTEINID 5
//Max length for reaction Id
#define REACTIONID 5
//Max length for compartment id
#define COMPARTMENTNAME 8
//Max # of previous cycles to be kept track of per protein
#define PREVIDUSMULT 10000
//Max # of proteins
#define ALPHABET 100
//Max # of rules
#define RULES 200
//Max # of reactants per reaction
#define MAXREACTANTS 5
//Max # of products per reaction
#define MAXPR0DUCTS 5
//Max # of reactions associated to a given protein
#define MAXREACTI0NS 21
//Avogadro's constant * Cell volume 10~-13
#define AV0 602.21415
//Max # of characters representing number for desired
//simtime in seconds e.g., 10000 seconds = 5 chars
#define SIMTIME 10
//Boolean operator
#define ISTRUE 1
//Boolean operator
#define ISFALSE 0
//Maximum number of lags in queue
#define MAXLAGS 90000
//Tolerance for comparing double values.
#define T0L .0000000000000001
//******************* PROTEIN STRUCT *********************//
/*
* Instantiation of struct represents one protein
*/
struct protein
{
char compartment[COMPARTMENTNAME];
int multiplicity;
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char name[PROTEINNAME];
char id[PROTEINID];
i n t r e a c t i o n i s t [MAXREACTIONS] ;
int r e a c t i o n l i s t _ t a i l ;
i n t multiplicities[PREVIOUSMULT];
};//end struct protein
//************* REACTIONS STRUCT ***********************//
/*
* Instantiation of struct represents one reaction
*/
struct reaction
{
//Id of reaction
char id[REACTIONID] ;
//The kinetic law of the Reaction
double kinetic;
//The kinetic constant (calculated from kinetic rate)
double constr;
//The waiting time of the Reaction (+simulation time)
double waitingtime;
//The waiting time of the reaction (not in the context of simulation)
double memory_WT;
//The percent of time the rule has already waited
double memory_perc;
//Lag time
#ifdef USE_LAGS
double lag;
//Keeps track of how many molecules have been queued, to be checked
//against the number of molecules available for queueing
//when recalcing WT
int lagmultiplicity;
//Which lag is it?
int tau;
#endif
//The index in the reactions heap\
//Needed for pointing from molecule to reactions, to be resorted
int heap_index;
//The number of times the rule has been applied during a simulation
int times_applied; /*DEBUG*/
//The number of times the rule was nondetermistically applied
int nondetermin;
//The number of times the rule was nondeterministically chosen,
//but could not be applied
int no_nondetermin;

//Lists for reactants and products of an instance of Reaction
int reactants[MAXREACTANTS] ;
int products[MAXPRODUCTS] ;
//Tail of reactants and products describes how many there are
int reactants_tail;
int products_tail;
double probability;
//*********Gillespie Variables**********//
double h;
double a;
};//end struct reaction
//******************** XIME STRUCT ************************//
struct evolution
•c

int completed_cycles;
int goal_cycles;
int rules_applied;
double simulation_time;
int export_counter;
};//end struct evolution
//**************** METHOD DECLARATIONS *********************//
//Extra Methods
void printAlphabet(struct protein * ) ;
void printRules(struct reaction *, struct protein * ) ;
void printWTs(struct reaction * * ) ;
void printKinetics(struct reaction *, struct protein * ) ;
void printReactionlist(struct reaction *, struct protein *,
struct reaction * * ) ;
//Membrane System without Lags
//BEGIN MPI BLOCK
#ifdef USE_MPI
void evolver(struct reaction *, struct protein *,
struct reaction **, int);
void exportMultiplicity(struct protein *, int *,
int [ALPHABET] [PREVIOUSMULT] , int);
void exportInitialMultiplicity(struct protein *, int *, int);
void printFinalInfo(struct reaction *, struct protein *, int,
int, int, int);
void printlnitialStepToFile(struct reaction **, double, int);
void printStepToFile(struct reaction **, double, int);
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#endif
//END MPI BLOCK
//BEGIN NONMPI BLOCK
#ifndef USE_MPI
void evolver(struct reaction *, struct protein *, struct reaction * * ) ;
void exportMultiplicity(struct protein *, int *,
int [ALPHABET][PREVIOUSMULT]);
void exportlnitialMultiplicity(struct protein *, int * ) ;
void printFinallnfo(struct reaction *, struct protein *, int,
int, int);
void printlnitialStepToFile(struct reaction **, double);
void printStepToFile(struct reaction **, double);
#endif
//END NONMPI BLOCK
void importSBML(struct reaction *, struct protein *,char * ) ;
void initializeMembraneSystem(struct reaction *, struct protein * ) ;
void initializeSim(struct e.volution *) ;
void applyRule(struct reaction *, struct protein *,
struct reaction **, struct evolution *, int *, int [MAXREACTIONS],
int *, int *, int * ) ;
void updateRules(struct reaction, struct reaction *,
struct protein *, struct reaction **, struct evolution * ) ;
void storeMultiplicity(struct protein *, int *,
int [ALPHABET][PREVIOUSMULT]);
void checkTie(int, struct reaction **, int *, int [MAXREACTIONS]);
int checkReactants(struct protein *, struct reaction **,
int *, int [MAXREACTIONS]);
int checkRule(int, struct protein *, struct reaction **,
int [MAXREACTIONS]);
void arraySwap(struct reaction *, int, int);
//Membrane System with Lags
void evolverlag(struct reaction *, struct protein *,
struct reaction * * ) ;
//Gillespie SSA methods
//BEGIN MPI BLOCK
#ifndef USE_MPI
void gillesp(struct reaction *, struct protein * ) ;
void exportGillespInitialMultiplicity(struct protein *, int * ) ;
void exportGillespMultiplicity(struct protein *, int *,
int [ALPHABET][PREVIOUSMULT]);
#endif
//END NONMPI BLOCK
//BEGIN MPI BLOCK
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#ifdef USE_MPI
void gillesp(struct reaction *, struct protein *, int);
void exportGillespInitialMultiplicity(struct protein *, int *, int);
void exportGillespMultiplicity(struct protein *, int *,
int [ALPHABET][PREVIOUSMULT], int);
#endif
//END MPI BLOCK
void initializeGillesp(struct reaction *, struct protein *,
double *r);
void printGillesp(struct reaction *, struct protein * ) ;
void printGillespAvals(struct reaction * ) ;
double calculateGtau(struct reaction *, struct protein *,
double, double);
int calculateGmu(struct reaction *, struct protein *, double, double);
void applyRuleGillesp(struct reaction *, struct protein *, int,
double * ) ;
void printGillespFinallnfo(struct reaction *, struct protein *,
struct evolution, double, int, double);
//Reaction methods
void initializeConstr(struct reaction * ) ;
void initializeWTs(struct reaction *, struct protein[]);
void initializeLag(struct reaction * ) ;
void changeLag(struct reaction *, struct protein * ) ;
#ifdef USEJLAGS
void caldnitialWTs(double *, double *, double, int [] , int,
struct protein[],double) ;
#endif
#ifndef USE_LAGS
void caldnitialWTs (double *, double *, double, int [] , int,
struct protein []);
#endif
void recalcAppliedWT(struct protein *, struct reaction **,
struct evolution * ) ;
void recalcTiedWT(int, struct protein *, struct reaction **,
struct evolution * ) ;
void recalcAffectedWT(int, struct protein *, struct reaction **,
struct evolution * ) ;
//Heap methods
void buildMinHeap(struct reaction * * ) ;
void heapDown(int, struct reaction * * ) ;
void swap(int, int, struct reaction * * ) ;
void fixHeapdnt, struct reaction **) ;
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//Other methods
void findMaxReactionlist(struct reaction *, struct protein * ) ;

APPENDIX D
FAS M E M B R A N E SYSTEM
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Our model consist of the following P system:

where:
• E = {FASL, FAS, FASC, FADD, FASC:FADD,
FASC:FADD2,
FASC:FADD3,
FASC:FADD2:CASP8,
FASC:FADD3:CASP8,
FASC:FADD2:FLIP,
FASC:FADD3:FLIP,
FASC:FADD2:CASP82,
FASC:FADD3:CASP82,FASC:FADD2:CASP8:FLIP,
FASC:FADD3:CASP8:FLIP,FASC:FADD2:FLIP2,
FASC:FADD3:FLIP2,
FASC:FADD:CASP8,
FASC:FADD:FLIP,
CASP8, FLIP, FASC:FADD3:CASP83,
FASC:FADD3CASP82:FLIP,
FASC:FADD3:CASP8:FLIP2,FASC:FADD3:FLIP3,
CASP8^41,CASP8*2,
CASP3,
CASP8*2:CASP3,
CASP3*, CASP8*:Bid, tBid, Bid, Bax, tBid:Bax,
tBid:Bax2,
Smac, Smac*, Cyto.c, Cyto.c*, XIAP, Smac* : XIAP,
Apaf,
Cyto.c*:Apaf:ATP,
CASP9,
Cyto.c*:Apaf:ATP:CASP9,
Cyto.c*:Apaf:ATP:CASP92,
CASP9*,
CASP9*:CASP3,
CASP9-.XIAP,
CASP3*:XIAP,
Bd2, Bcl2:Bax, Bd2:Bid,
Bcl2:tBid}.
• L = {e, s, c, m) We have four compartments - the outside environment (e), the
cell surface (s), the cytoplasm (c), and the mitochondria (m).
•

P1

[s[c[m Jmjcjs

and Mm are the sets of multiplicities (p r o tein m u " j p / t " t ! / ).

» Me,Ms,Mc
- Me =

{FASL1204}

- Ms =

{FAS6022}

- Mc = {FADD10ms,
CASP8200n,FLIP48779,
CASP3120442,
Bid15055,
Bax50182,XIAP1806e,
Apaf6022\ATP6022141CASP912044}
~ Mm = {Smacm221,Cyto.c60221

, J Bc/2 45166 }

• Re, Rs, Rc and Rm are the sets of rules associated to each compartment.
- Re = {ri}
-

Rs — { r 2, r 4,' r 6, r 8, n0) r ll, r 12, r 14, r 16, r 17, ^18, r 20, ^22,^24; r 26 > ?"28, r 30, r 32,
^34, r 36 j r 38 j r 40, r 42, ^44, ^46, r 48, ^50, r 52, r 54 , r 56, r 58, r 60, r 62, r 63 > r 64,
^65,^66}

-

Rc = ( r 3 , r5, r7, r 9 , r n , r 1 3 , r 1 5 , r17, r 1 9 , r2l, r23, r25,r27,r29,
r

r

Rm ~ {r97,r99S

r

r

r

r

r

r

r

r

r31,r33,
r

r

r 3 5 , r37,

39) 41, 43, ^45) 47, 49, 51, 53j 55> 57; ^59) 61, 67> 7*68) 69> 70, r71>
?"72 , ?~73, r 74 j ?"75, r 76, r 77 j r 78, r 79 , r 80 , r 81 ; r 82, ^83, r 84, r 85, 7*86, r 87,
^88, r89,7-90,7-91, r 9 2 , r 9 3 , r 9 4 , r 9 5 , r 9 6 , r 9 8 }
-

r

We list the four sets of rules we simulated, which are based upon the apoptosis
pathway. Each set incorporates a mechanism for Bcl2 involvement in the inhibition
of apoptosis.
Label

n
r2
rs
r4
r5
re
r7
r8
rg

no :
ni :
ri2 :
ns :
r14 :
rm •
r\e :

rn :
i"i8 :
^19 :
r

20

:

r2\ :
r22 :
?~23
?~24
^25

Rule
FASL[ FAS )s -» [ F A 5 C ] s
[ FASC }s -> F ^ 5 L [ Fy45C ] s
F^15C[ Fi4DD ] c -* FASC : FADD[ }c
FASC : FADD{ }c -> FASC[ FADD }c
FASC : FADD[ FADD )c -> FASC : FADD 2 [ ] c
FASC : FADD2[ }c -> F A 5 C : FADD[ FADD }c
FASC : FADD2[ FADD }c -^ FASC : FADD3[ ]c
FASC : FADD3[ }c -> FASC : FADD2[ FADD }c
FASC : FADD2 : C*A5P8[ F^IDD ] c ->
F ^ ^ C : F^F>D 3 : C,4SP8[ ]c
FASC : FADD3 : CA5P8[ ] c - •
FASC : FADD2 : CASP8[ FADD ] c
FASC : FADD 2 : FLIP[ FADD }c - •
F,4SC : FADD3 : FLJP[ ]c
FASC : FADD3 : FLIP[ ] c ->
F A S C : FADD2 : FZJP[ F^F»P ] c
FASC : FA£>£>2 : CA5P8 2 [ FADD }c ->
F>15C : FADD 3 : Cyl5P8 2 [ ] c
F^15C : FADD3 : C^15P82[ ] c - •
Fi45C : FAF>F»2 : CASP82[ FADD }c
FASC : FADD2 : CASP8 : F L / P [ FADD }c - •
F^15C : FAF>D3 : CA5P8 : F L / P [ ] c
FASC : FADD 3 : CASP8 : FLFP[ ] c -*
FASC : FADD 2 : C^15P8 : FLIP[ FADD }c
FASC : FADD2 : FL/P 2 [ FADD ] c - •
F A 5 C : FADDs : FL/P 2 [ ] c
FASC : FADD3 : FLIP2[ ] c - •
FASC : FADF>2 : FLFP 2 [ FADD }c
FASC : FADD : CASP8[ FADD }c - •
F A S C : FADF>2 : CA5P8[ ]c
FASC : FADD 2 : CASP8[ ] c - •
F A S C : FADD : CASPSf FADD ] c
FASC : F A D D : FLFP[ FADD ] c ->
F A S C : FADD2 : FLFP[ ] c
FASC : FADD2 : F Z J P [ ] c ->
FASC : FADD : FL1P[ FADD ] c
FASC : FADD3[ CASP8 ] c - • FASC : FADD3 : CASP8[
FASC : FADD3 : CASP8[ ]c -> FASC : FADD 3 [ CASP8
FASC : FADD3[ FLIP }c - • FASC : FADD 3 : FLIP[ }c

Rate
klf

fc2/
k2r
k2f
k2r
hf
k2r
k2f
k2r
k2f
k2r
hf
k2r
k2f
k2r
k2f
k2r
hf
hr
hf
hr
hf
hr
k 3/

Label
Rule
r26 : FASC : FADD3 : FLIP[ }c -> FASC : FADD3[ FLIP }c
r27 : FASC : FADD3 : C J 4 S P 8 [ CASP8 }c ->
FV1SC : F/1F>F>3 : CASP8 2 [ ] c
r28 : F ^ S C : FADD3 : CASP82[ ] c -»•
F.4SC : F ^ D D s : Ci4SP8[ C71SP8 ] c
r29 : F.4SC : FADD3 : CMSP8[ F L I P ] c -»•
FASC : FAF»D3 : C71SP8 : FZJP[ ] c
r30 : F A S C : FADD3 : CASP8 : F X / P [ ] c ->
F.45C : FAF>F>3 : CASP8[ FLIP ]c
r31 : F>15C : FAF>F>3 : FLIP[ CASP8 }c ->
F^ISC : F^ryF/s : CASP8 : FLIP{ }c
r32 : FASC : FAF)D 3 : CASP8 : FLIP[ }c - •
F.4SC : FADF>3 : F L / P [ CASP8 ] c
r 33 : FASC : FAF>A? : FZJP[ FLIP }c -»
FASC : FADF>3 : F U P 2 [ ] c
r34 : FASC* : FAF>D3 : FLIP2{ }c ->
FASC : FADD3 : F L / P [ F L / P ] c
r 35 : F A S C : FADD3 : C^5P8 2 [ C^,SP8 ] c -*
FASC : FADDs : CASP83[ }c
r36 : FASC : FADD3 : CA5P8 3 [ ] c ->
FASC : FAF>F>3 : C71SP82[ CA5P8 ]c
r37 : FASC : FADD3 : CASP82[ FLIP ]c ->
FASC : FADD3 : CA,SP8 2 : FLIP[ ]c
r38 : FASC : FADD3 : CASP82 : FLIP[ ] c - •
FASC : FylDF's : CA5P821 FLIP }c
r39 : FASC : FADD 3 : CA5P8 : FLIP[ CASP8 }c -»
F.4SC : F^DF> 3 : C^15P8 2 : FLIP[ }c
r40 : FASC : FADD3 : CASP82 : FLIP[ ] c - •
FASC : F,4DF>3 : 0 4 S P 8 : FLIP[ CASP8 ] c
r41 : F^15C : FAF>F>3 : CASP8 : P L / P [ F U P ] c - •
FASC : FylF>D3 : CASP8 : FL/P 2 [ ]c
r42 : FASC : FADD3 : CASP8 : FLIP2[ }c - •
F/15C : F^F)D 3 : CASP8 : FLIP[ FLIP ] c
r 43 : FASC : FADD3 : FLIP2[ CASP8 )c -*
FASC : FADD3 : CASP8 : FLIP2[ ]c
r44 : FASC : FylDF>3 : CASP8 : FL/P 2 [ ] c ->
FASC : FAF>F>3 : FL/P 2 [ CA5P8 ] c
r45 : FASC : FADD3 : FLIP2[ FLIP ]c ->
FASC : FADD3 : FLIP3[ }c
r46 : FASC : FylDF) 3 : FLIP3[ }c ->
F^15C : F,4r;F>3 : FL/P 2 [ F L / P ] c
r47 : F715C : FADD2[ CASP8 ] c -»• FASC : F/1F>F>2 : CA5P8[ ] c
r48 : FyiSC : F,4F>D2 : C^15P8[ ] c -> FASC : F,4Dr/ 2 [ CA5P8 ] c
r49 : F A 5 C : FADD2[ FLIP }c -)• F.4SC* : F ^ D D 2 : F L / P [ ] c

Rate
k3r
%
k3r
k3f
k3r
k3f
&3r
%
k3r
k3f
fc3r
k3f
k3r
k3f
fc3r.
k3f
&3r
4

3/

>-3r

k3f
k3r
k3f
A;3r
k3f

Label
r 50 :
r 51 :
r 52 :
r53 :
r54 :
r55 :
r 56 :
r57 :
r 58 :
r 59
r60
r 61
r 62
r63

:
:
:
:
:

r 64 :
r65 :
r66 :
r67
r 68
r 69
r 70
r 71
r 72
r73
r 74
r75
r 76
r 77
r 78
r 79
r80
r 81

:
:
:
:
:
:
:
:
:
:
:
:
:
:
:

Rule
FASC : FADD2 : FLIP[ ] c -> F A 5 C : F A P P 2 [ F L / P ] c
FASC : F/l£>£>2 : C A S P 8 [ CASP8 ] c - •
F^15C : F A P P 2 : C A S P 8 2 [ ] c
P . 4 5 C : FADD2 : C A S P 8 2 [ ] c - •
P ^ 5 C : P^.DP> 2 : CA,SP8[ C A S P 8 ] c
P / 1 5 C : FADD2 : C A S P 8 [ F L I P ] c ->
P y l 5 C : F A D D 2 : CL4SP8 : F L / P [ ] c
F A S C : FADD2 : C A S P 8 : FLIP[ ] c -»
F A S C : P^DP> 2 : CASP8[ FLIP }c
FASC : FADD2 : FLIP[ CASP8 ] c - •
F A S C : PylP/P>2 : C A S P 8 : FLIP{ }c
FASC : P^DP> 2 : CASP8 : F L 7 P [ ] c ->
FASC : FADD2 : F L / P [ C A S P 8 ] c
FASC : F ^ P T A , : P L / P [ FLIP ]c -»•
F A S C : P A P P 2 : F X / P 2 [ ]c
P A 5 C : P ^ 1 P D 2 : FLIP2[ ]c - •
P^15C : F , 4 D D 2 : P L / P [ P L 7 P ] c
F A S C : FADD[ CASP8 ] c - • F ^ S C : P ^ P P : Cv45P8[ ] c
F A S C : FADD : CA.SPSt ] c -* F A S C : P A P P [ C ^ 5 P 8 ] c
F A S C : FADD[ FLIP }c -» F A S C : F A P P : P L / P [ ] c
F A S C : FADD : FLIP[ }c - • FASC : F A P P [ F L I P ] c
F A S C : FADD2 : C A 5 P 8 2 [ ] c ->
F A S C : FADD2[ CASP8™
]c
F A S C : FADD3 : C A 5 P 8 3 [ ] c -»•
F A S C : F A P P 3 : C A 5 P 8 [ C A S P S ^ 4 1 ]c
FASC : F A P P 3 : CASP82 : FLIP[ }c -y
F A S C : FADF> 3 : F P / P [ CASP8%41 ] c
FASC : F A P D 3 : CASPSaf ] c ->
F A S C : F A P P 3 [ CASP8™
]c
[ CASP8™1 ] c -> [ CASP8*2 }c
[ CASP8*2, CASP3 }c ->• [ CASP8^ : C A S P 3 ] c
[ C A S P 8 * : CASP3 ] c -» [ CASP8*2, CASP3 ] c
[ CASP8*2, CASP3* }c -> [ C A S P 8 ; : C A S P 3 ] c
[ CASP8*2, Bid }c - • [ C A 5 P 8 * : Pzd ] c
[ C A 5 P 8 ; : Bid }c - • [ C A 5 P 8 ; , Pzd ] c
[ CASP8*2,tBid}c
-> [ C A 5 P 8 * : P i d ] c
[ tBid, Bax ]c -^ [ tBid : Bax ] c
[ tPzd : Bax }c -^ [ tBid, Bax ] c
[ tBid : P a x , Bax }c —> [ t P i d : P a x 2 ] c
[ tBid : Bax2 ]c —> [ tBid : Bax, Bax ] c
iP?<i : P a x 2 [ Srnac ]m —> 5?7iac*[ ] m
t P i d : Bax2[ Cyto.c]m —> C?/^o.c*[ ] m
[ Smac*,XIAP
}c ->• [ 5mac* : A 7 A P ] c
[ Smac* : XIAP ] c - • [ 5mac*, X / A P ] c

Rate
fc3r
%
k3r
k3f
k3r
k3f
k3r
fc3/
£;3r
k3f
fc3r
k3f
k3r
k4
fc4
k4
fc4
h
k6f
k6r
k7
fc8/
fc8r
fc7
k$f
fcgr
fcg/
/c9r
fcio
kw
jfcn/
kUr
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Label
r82
?~83
r

84

^85

r

86

r87

^88

^89
r

90

^91
TQ2
r

93

1*94
^95
?~96
?~97

Rule
[ Cyto.c*, >ipa/, A T P ] c -»• [ Cyto.c* : Apa/ : ATP ]c
[ Cyto.c* : Apaf : ATP}c-> [Cyto.c*, Apaf, ATP }c
[ Cyto.c* : ylpa/ : ATP, CASP9 ] c - •
[ Cyto.c* Apaf : ATP : C 4 S P 9 ] c
[ Cyto.c* : Apaf : ATP : CASP9 }c ->
[ Cyto.c* Apa/ : >irP, 0 4 S P 9 ] c
[ Cyto.c* : Apaf : ATP: C A S P 9 , C A S , P 9 ] C —
[ Cyto.c* Apaf : / I P P : C,4,SP92 ]C
[ Cyto.c* : Apaf : ,4TP: CASP9 2 ] c ->
[ Cyto.c* Apaf : ,4TP : CASP9, CASP9 }c
[ Cyto.c* : Apaf : ATP: CASP92 ] c - •
[ Cyto.c* Apa/ : ,4TP : CASP9, CASP9* }c
[CASP9*,CASP3]C~
> [ CASP9* : CAS PS ] c
[ CASP9* : CASP3 }c ->
- [CASP9*,CASP3] C
[ CASP9* : CASP3 ] c --v [CASP9*,CASP3*] C
[CASP9,XIAP}C^
[ C 4 S P 9 : XIAP }c
[ CASP9 : X / A P ] c -> ! C 4 S P 9 , X P 4 P }c
[CASP3*,XIAP]C^
[ CASP3* : XIAP ] c
[ CASP3* : I M P ] c -> [CASP3*,X/AP] C
Pax[ Pc/2 ] m -» [ Pe/2 P a x ] m
[ Bd2 : Bax ]m —>• Bax[Pc/2 m

Rate
ki2f
k\2r
k

nj

&13r

kuf
k\4r
kis

k16j
k\6r

kn
kisf
klSr
ki9f
k\9r
^20/
k2Qr

And with the alternative cases and rules of type 96', 96", 97', 97", 98, 99 as
follows:
Label
Rule
Rate
r9& : Bid[ Bcl2 ]m —> [ Pc/2 : Bid ]m
k20f
r9V : [ Bcl2 : Bid ]m —> Bid[ Bcl2 }m
k2oT
r96» : tBid[ Bcl2 ]m —> [ P d 2 : tBid }m k20f
r97» : [ P d 2 : tBid }m —> tBid[ Bcl2 ]m k20r
r 98 : tBid{ Bcl2 ] m -» [ Pc/2 : tBid )m k20f
r99 : [ Pc/2 : tBid ]m —> tBid[ Bcl2 }m k2or
The deterministic kinetic constants (reaction rates) mentioned in the previous
table are given in the following; we refer the interested reader to [47] for more details
about the rates and references for their estimation. The following tables give the
deterministic kinetic rates (reaction rates) used in the description of the reactions;

Table D.l Kinetics rates for the Fas model
kif = 9 . 0 9 £ - 0 5 n M " 1 s " 1
klr = 1.00E-04S" 1
k2f = 5 . 0 0 £ - 0 4 n M " 1 s " 1
k2r = 0.2s" 1
k3f = 3.50E - 03nM~1 s'1
k3r = 0.018s"1
k4 = 0.3s" 1
k5 = 0.1s _1
k6f =
\ME-QhnM~ls~l
k6r = 0.06s"1
k7 = 0.1s" 1
A;8/ = 5 . 0 0 E - 0 3 n M " 1 s " 1
k8r = 0.005 s" 1
fc9/ = 2.00£ - 04nM" 1 s" 1
k9r = 0.02s"1
fc10 = l . O O ^ - O S n M " ^ " 1
knf =
7.00E-03nM-1s~1

kUr = 2 . 2 1 £ - 0 3 s" 1
k12f = 2.78E - 0 7 n M " 1 s - 1 n M ' i
kl2r = 5.70E - J ) 3 s" 1
£i3/=:2.84£-04nM-1s-1
knr = 0.07493s"1
kw = 4 . 4 1 £ - 0 4 n M " 1 s " 1
fc\4r

=

U.I5

fc15 = 0.7s" 1

fcie/ = 1.96£ - OSnM"^" 1
fc16r = 0.05707s"1
k17 = 4.8s" 1
fcis/ = l-06£ - 04nM" 1 s" 1
fc18r - 1.00E - 03s" 1
fc19/ = 2A7E - 03nM~ls~l
k19r = 2.40£ - 03s" 1
fc20/ = 2.00£ - OSnM^s-1
k20r = 0.02s"1

We must add the following aspects to the Fas Membrane System to model HIV1-related effects:
• £' = {HIVRNA, RT, HIVCDNA,
HIVLTR,
NFAT, CDK9, CycUnTl, PTEFb,
HIVLTR : NFAT, Tat, Nef, Vpr, UIVW, mRNATat,mRNAVvr,
mRNANef,
mRNAHIVpr,HIVLTR
: NFAT : Tat,HIVLTR : NFAT : Tat : PTEFb,
Vpr : Bcl2, PTPC, Vpr : PTPC).
• L' = {n} Besides the other four compartments we have added a nucleus (n).
M

[s[e|m J m [ n Jrajcjs

• Me, Ms, Mc, Mm, Mn are the sets of multiplicities ( p r o tein m u "' p h c i t y ).
- Me = {F/1SL 1204 }
- M s = {FAS 6022 }
- M c = {FAD/J 10038 , C A S ^ 2 0 0 7 1 , FLIP48779, CASP3120442, Bid15055,
Baxbm82,XIAPl80m,
Apaf60221,ATP6022l41CASP912044}
- Mm = {Smacm221 ,Cyto.c60221 ,Bd2 45166 }
• i?^, i? c , R'm, and i?^ are the sets of rules which must be unioned with the
previous rules (except Rn, since it has no counterpart in the Fas model).
" K = {ri52>

R'c — VIOO; r 101i r 103, r 104) r 129, r130> r 1 3 1 , r 132, r 1 3 3 , r 134, ?"l35, r 136, r 137, r 141)
'~142>'"l43) r 'l48}
-Rm = {^144, r 145,' r 146,' r 147 5
Rn

r

r

101

r

102

r

103

7*104
7*105
7*106
7*107
7*108
7*109
7*110

nn
7*112
r-ii3
7*114
7*115

rue

nn
^118
?~119

7*120
7*121
^122

7-123
7-124

7-125

:

U9j

— {^102, r 105, r106, 7*107 > r108> r109> r110> rlll > r 112,r 113,r 114, ^115, r 116, r117,
r

Label
rwo

r

118) r 119, r 120; r121 j r 122, r 123, rl24,

r

125; r 126; r127> r 128, r138) r139) r 140,

150,r151 ir153J

Rule
[ HIVRNA RT )c —> [ HIVcDNA, RT }m
HIVcDNA [ ]n ~> [ HIVcDNA )n
[ HIVcDNA )n-^[HIVLTR]n
NFAT[ }rt->[NFAT]n
CDK9[ ]n - [ CDK9 }n
[ CyclinT .,CDK9]n-+[PTEFb]n
[ NFAT, HIVLTR }n - [ HIVLTR : NFAT }n
}n - [ HIVLTR • NFAT : Tat }n
[
HIVLTR NFAT,Tat
: Tat, PTEFb }n - •
[
HIVLTR NFAT
[ HIVLTR • NFAT : Tat : PTEFb }n
[ HIVLTR „ - *
[HIVLTR,mRNATat}n
mRNAVpr]n
[
HIVLTR n ^ I HIVLTR,
]n
[ HIVLTR n -> [ HIVLTR,mRNAHIVpr
[HIVLTR,mRNANef]n
[ HIVLTR n ^
{ HIVLTR NFAT }n - [ HIVLTR NFAT,mRNATat}n
AVpr]n
[
HIVLTR NFAT }n -+ [ HIVLTR NFAT,mRN
[ HIVLTR NFAT}n->
[HIVLTR NFAT,mRNAHIVpr]n
[HIVLTR NFAT, mRNANef
}n
[ HIVLTR NFAT}n^
[ HIVLTR NFAT : Tat }n - •
[ HIVLTR : JVFAT : Tat, mRNATat
}n
[ HIVLTR NFAT : Tat )n ->
[ # / V L T * : A^Fv4T : Tat, mRNAVpr
]n
: T a t ] n ->
[
HIVLTR NFAT
[ # / V L T K : N F A T : Tat, mRNAHJVpr
}n
: T a t ] n ->
[
HIVLTR NFAT
[ HIVLTR : N F A T : Tat,mRNANef
)n
: Tat : PTEFb }n ->
[
HIVLTR NFAT
[ ^ / V L T H : NFAT : Tat : PTEFb, mRNATat
]„
iVFAT
:
Tat
:
PTEFb
]
->
[
HIVLTR
n
[ F / y t r i ? : A^TAT : T a t : PTEFb, mRNAVpr
}n
NFAT
:
T
a
t
:
PTEFb
]„
•
[
HIVLTR
[ / / / y L T « : 7VTAT : T a t : PTEFb, mRNAHIVpr
]„
[
HIVLTR JVFAT : Tat : P T F F 6 ] n - •
[ HIVLTR • NFAT : Tat : PTEFb, mRNANef
}n
[ mRNATlit \n
^mRNATat[
}
n

Rate
hi

h2
hi
hi
k24
hb

he
hi

ha
hg

hs
hd
h9

ho
ho
ho
ho
fcsi

hi
hi
hi

h2
h2
h2
h2
^33

185
Labe:1
?~126
^127
»"l28
r

129

'"ISO
»"l31

n32
?"l33
7"134
^135
r

136

ri37

riss
r\39
r

UO

?"l41
r

142

r

143

?"144
r

145

^146
r

147

r

148

»"l49
»"l50
»*151
»"l52
>"l53

Rule
[ mRNANef }n - • mRNANef[ ] n
[ mRNAVpr ]n —> mi^A^^vprf ]„
[ mRNAHJVpr }n - • mRNAH1Vpr[ ]„
[ mRNATat ]c -> [ mRNATat, Tat ]„
[ mRNANef ] c -» [ mRNANef, We/ }n
[ mRNAVpr ] c —> [ mRNAVpr, Vpr }n
[ mRNAHIVpr }c -> [ mRNAH1Vpr,HIVpr
}n
[ mRNATat
}c^[]c
[ mRNANef ] c -> [ ] c
[ mRNAypr }c^ [ }c
[ mRNAHIVpT
}c^[]c
Tat[ }n -> [ Tat }n
[ Tat }n - • [ Tat }nCASP8
[ Tat }n -»• [ Tat ] n 5 d 2
[ Tat }n ->• F>4SL[ Tat ] n
[ Tat, Bc/2 ] c -> [ Tat ] c
Vpr[ }m - V > [ 5c/2 ] m
[ Vpr, 5 a x ] c -> [ Vpr }c
[ Vpr, Bcl2 }m ->[Vpr: Bcl2 ]m
[ Vpr : Bcl2 }m -> [ Vpr, Bd2 ] m
[ Vpr, PTPC ]m -^[Vpr: PTPC ]m
[Vpr: PTPC, Cyto.c }m - • Cyto.c*[ Vpr : PTPC }m
[ ///Vpr, C.4SP8 }c -> [ #/V p r , Casp8* }m
HIVpr[Bcl2}m~^HIVpr[
}m
[Nef)n^[Nef,FAS)m
[Nef}n^[Nef,FASL]m
[ FASL }s -> FAST[ }s
[ Tat ]n —> Tat[ ]n

Rate
^33
^33

hs
hi
hi
hi
hi
hs
hd
hs
hb
h&f
hi
hs
hg
^40

hi
kA2
h3
hi
hb
K4Q

hi
k48
^49
^50

hi
her

The kinetic rates for the additional HIV-1 rules are given in the table below:
Table D.2 Additional kinetic rates for HIV-1-infected model
k21 = 0.0334563416666667nM"1s"1
k22 = 0.000555555555555556s-1
k23 = 100s"1
k24 = 400s"1
k25 = QAnM~1s-1
k26 = 5 . 0 £ - 0 0 5 n M " 1 s " 1
k27 = 0.1nM- 1 s _ 1
k2S = 200nM" 1 s" 1
k29 = 2.8E - 004s" 1
£;3o = 2.8E - 003s" 1
k31 = 0.071s"1
k32 = 0.71s"1
k33 = 0.2s"1
k34 = 0.04s"1
/c35 = 0.033s"1
k36f = 0.002s"1

k36r = 0.0019s"1
k37 = i.OE - 006s" 1
k38 = 2.0E - 006s"1
k39 = 2.0E - 007s" 1
/c4o = 2 . 0 £ - 0 0 8 n M " 1 s ~ 1
k4l = LIE - 0 0 6 s " 1
k42 = 2 . 0 £ - 0 0 8 n M " 1 s " 1
k43 = 2 . 0 £ - 0 0 8 n M " 1 s " 1
k44 = 2.0E - 006s"1
£;45 = 2.0£ - 006s" 1
k46 =
1.0E-005nM-1s-1
k47 =
e.OE-QUnM^s-1
k48 = 3 . 0 £ - 0 0 8 n M " 1 s " 1
k49 = 3.0E - 009s"1
k50 = 1.0E-007S-1
kbl = 2.0E - 006s" ]
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